Hepatic Adrenergic Mechanisms and The Metabolic Control of Lactation. by Dunphy, Andrea Maria.
HEPATIC ADRENERGIC MECHANISMS AND 
THE METABOLIC CONTROL OF LACTATION
A thesis submitted to the 
University of Surrey
by
ANDREA MARIA DUNPHY, B.Sc.
in fulfilment of the requirements for 
the award of the degree of
DOCTOR OF PHILOSOPHY
School of Biological Sciences, 
University of Surrey, 
Guildford,
Surrey, U.K.
October, 1992
© A.M. Dunphy (1992)
ProQuest Number: 27558574
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com p le te  manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uest
ProQuest 27558574
Published by ProQuest LLO (2019). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C ode
Microform Edition © ProQuest LLO.
ProQuest LLO.
789 East Eisenhower Parkway 
P.Q. Box 1346 
Ann Arbor, Ml 48106- 1346
ABSTRACT
Lactation dictates a co-ordinated adaptation of the maternal metabolism in the whole 
animal, and the occurrence and timing of these metabolic changes varies between 
species. The number and coupling efficiency of 13-adrenoceptors in liver membranes 
and intact hepatocytes were compared as between lactating and non-lactating female 
rats to assess whether or not attenuation of this signalling system could contribute 
towards the changed pattern of hepatic metabolism during lactation. In view of the 
contrasting adaptations of hepatic metabolism to lactation in ruminants, the 
adrenoceptor profiles o f sheep liver membranes were also determined. No changes 
in the number or affinity o f hepatic 13-adrenoceptors were found in rats or sheep when 
lactating and non-lactating individuals were compared. Sheep liver was found to have 
a greater concentration o f 13-adrenoceptors than rat liver, and a much higher ratio of 
13 : «1 adrenoceptors. Post-receptor responses at two steps distal to cAMP generation 
were also evaluated in rat hepatocytes in response to the 13-adrenoceptor agonist 
isoprenaline. The sensitivity and responsiveness of cAMP generation in response to 
isoprenaline were similar in hepatocytes prepared from lactating and non-lactating 
rats, although the response to saturating concentrations of glucagon was diminished 
in hepatocytes from lactating rats. The activity ratio of cAMP-dependent protein 
kinase (A-kinase) similarly showed no difference with respect to both responsiveness 
and sensitivity to isoprenaline in these two groups of hepatocytes. In contrast, the 
sensitivity of rat hepatocyte glycogen phosphorylase activity to isoprenaline challenge 
was greatly diminished during lactation. These results indicate that: (a) lactation has 
no impact on the hepatic adrenoceptor population of the rat or sheep; (b) the
diminished sensitivity of lactating rat liver glycogen phosphorylase to isoprenaline 
activation appears to arise at a post-receptor level; and (c) hepatic adrenergic 
mechanisms other than the B-adrenergic signalling pathway may participate in the 
post-receptor system which counteracts the activation of glycogen phosphorylase.
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CHAPTER 1
INTRODUCTION
11.1 INTRODUCTORY REMARKS
The work described in this thesis was aimed at achieving a greater understanding of 
the biochemical mechanisms underlying some aspects of the changes in liver 
metabolism accompanying lactation. The particular focus has been on the hepatic 
provision of metabolites to aid the mammary biosynthesis o f carbohydrate and lipid 
constituents of milk. Two different animal experimental models, the rat and sheep, 
were chosen in view of their known differences in hepatic metabolism and adaptations 
of such metabolism during various physiological and reproductive changes. Both 
animal models were studied during lactation and also under non-lactating conditions 
and by analysis of selected components of the adrenergic signalling systems in liver 
preparations from these animals, it was intended to investigate the extent to which 
such mechanisms were responsible for controlling the distinctive features of rodent 
and ruminant metabolism during lactation.
Lactation is a process that provides a balanced diet for a suckling animal due to the 
ability of the mammary gland to assemble and secrete a combination o f lipids, 
carbohydrates, proteins and minerals and present these in the form of milk. 
However, lactation involves more than just the production o f nutrients specially 
adapted for the needs of the new-born young, as it provides protection against various 
pathogenic organisms and foreign antigens due to the presence of immunoglobulins 
in milk. Additionally, in the context of human lactation this process aids the 
establishment of a strong relationship between mother and infant as well as 
suppressing maternal fertility, which is the most important contraceptive o f any kind
in a global sense.
The basic structure of the mammary gland is laid down in the fetus, although there 
appear to be stages involved in the development of the mammary gland. There is an 
important postnatal phase of development which involves duct elongation which 
begins before, and in some cases continues through puberty. The mammary gland 
also undergoes cycles of proliferation, differentiation, function and regression during 
the adult female reproductive cycle in mammals and the final stages of development 
of the lobules of alveolar cells which secrete milk, occurs during pregnancy and 
lactation (see Johnson and Everitt, 1984). Such mammary development requires the 
complex interplay of many hormones and the majority of the studies have been 
performed in rodents, which have shown them to operate a triplex system of 
hormones from the ovaries, adrenal glands and hypothalamic - pituitary axis (Forsyth, 
1989).
Milk secretion does not usually start until after parturition and a number o f hormones 
including oestrogen, progesterone, prolactin and in the case of humans, placental 
lactogen, play a role in the initiation of milk secretion (lactogenesis). The 
disappearance of oestrogen and progesterone from the maternal circulation at 
parturition is believed to be the key to lactogenesis, in so far as they appear to inhibit 
milk secretion by acting directly on mammary tissue and may cause the breast to 
remain unresponsive to prolactin. However, prolactin is critical for the maintenance 
of milk secretion (galactopoiesis) and plasma levels o f this hormone remain high for 
the duration of lactation, in addition to the bursts o f prolactin secretion which occur
3during suckling episodes. In species other than man, additional hormones such as 
growth hormone, insulin and adrenal steroids may also play an essential role in 
galactopoiesis (Johnson and Everitt, 1984).
1.2 MAMMARY GLAND METABOLISM
The components of milk are either taken up by the lactating mammary gland from the 
blood stream and secreted with or without metabolic modification, or uniquely 
synthesised by the gland through processes such as lipogenesis and lactogenesis. The 
uptake of metabolites and subsequent secretion of milk components may be studied 
using techniques employing blood sampling and measurements o f specific metabolite 
and/or product concentrations and such studies have shown the importance of glucose, 
acetate, ketone bodies, triacylglycerols and amino acids as substrates for the lactating 
mammary gland (Dils and Parker, 1982). The major components of milk include 
fats, proteins (eg: caseins, B-lactoglobulin, a-lactalbumin), carbohydrates (mainly 
lactose), water, amino acids, vitamins and minerals. However, considerable variation 
in the proportion of these particular components occurs between species.
1.2.1 Synthesis of Milk Fat
Of all the components of milk, milk fat shows the greatest species variation, although 
the proportions of different classes of lipid are remarkably constant, with 
triacylglycerols predominating and the remaining components being associated with 
the milk fat-globule membrane (Dils, 1989). The proportions of individual fatty acids
4in the triacylglycerols show extraordinary diversity as for example, ruminant milk is 
characterized by a low proportion of long-chain polyunsaturated fatty acids. Long- 
and short-chain fatty acids are taken up by the gland from circulating lipoproteins and 
fatty acids may also be synthesised de novo in the mammary gland. However, 
medium-chain fatty acids are tissue specific products synthesised by the mammary 
gland and not by any other mammalian tissue so far investigated.
The pathway of fatty acid synthesis from glucose is outlined in Figure 1:1. The 
major source of acetyl-CoA for fatty acid biosynthesis in the non-ruminant mammary 
gland is glucose and this is converted to pyruvate via glycolysis. The pyruvate which 
enters the mitochondria is converted to acetyl-CoA, but since no mechanism for 
acetyl-CoA transport exists in the inner mitochondrial membrane it cannot directly 
reach the cytosol. It’s major route of further metabolism via the TCA cycle is 
condensation with oxaloacetate to form citrate. This then translocates into the cytosol 
and is cleaved by ATP-citrate lyase to oxaloacetate and acetyl-CoA. The oxaloacetate 
regenerates pyruvate via reactions which involve NAD^ and NADP^ - dependent 
malate oxidoreductases which results in the production of NADPH, which can then 
be utilised by the reductive steps of fatty acid synthesis (Munday and Hardie, 1987).
By contrast, the ruminant mammary gland cannot effectively use glucose for fatty 
acid synthesis de novo, since the activity o f ATP-citrate lyase in this tissue is very 
low (Dils and Parker, 1982). This may be an adaptive response due to the 
characteristic mode of digestion of ruminant animals. Sheep, and other ruminants, 
have a complex stomach system which contains extensive populations of bacteria and
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Figure 1:1 Outline o f the pathway of fatty acid synthesis from glucose.
KEY : DHAP =  Dihydroxyacetone phosphate
6protozoa which degrade carbohydrates present in the diet, mainly to acetate, 
propionate and butyrate (for example, see Madge 1975; Carton, 1977). Butyrate is 
further metabolised by the rumen wall to ketone bodies, mostly D-3-hydroxybutyrate. 
As a consequence of this digestive process, the liver thus receives little glucose from 
the diet, and must maintain a high rate of gluconeogenesis to meet the requirements 
of the animal (Lindsay, 1978). Consequently, acetate and 3-hydroxybutyrate are the 
predominant precursors for fatty acid synthesis in the ruminant mammary gland. The 
proposed metabolic pathway for supplying acetyl-CoA and NADPH for lipogenesis 
in the ruminant mammary gland is outlined in Figure 1:2, in which acetate 
participates as both an acetyl precursor and a major source of NADPH (Gumaa et al, 
1973). The main feature of the scheme is the efflux of citrate from the mitochondria 
and its conversion to isocitrate which is followed by conversion to 2-oxoglutarate by 
isocitrate dehydrogenase (EC 1.1.1.42), with the concomitant formation of NADPH 
and the return of 2-oxoglutarate to the mitochondria. In the mitochondria, the 2- 
oxoglutarate is partitioned, one half proceeding around the tricarboxylic acid cycle 
to produce oxaloacetate and NADH and the other half is recycled to isocitrate and 
citrate by reversal of the tricarboxylic acid cycle which is believed to be driven by 
glutamate dehydrogenase (EC 1.4.1.3) acting as a transhydrogenase to generate 
intramitochondrial NADPH. Although the ruminant mammary gland is adapted to 
conserve glucose and use acetate as the sole substrate, it does have access to some 
glucose, and when present, this may participate in the pentose phosphate pathway, so 
producing additional NADPH, essential reductive power for lipogenesis. Evidence 
has shown that the incorporation of acetate into lipid in the gland is indeed enhanced 
by the presence of glucose and that this increase is directly linked to the pentose
7phosphate pathway (Gumaa et al., 1973). Hence, glucose appears to be the lipogenic 
precursor in the mammary gland of lactating rat whereas in the ruminant acetate 
efficiently feeds lipogenesis, although the presence of glucose increases the efficiency 
of this system.
As previously illustrated, fatty acid synthesis de novo requires acetyl-CoA both as a 
"primer" and a precursor of malonyl-CoA, needed for the two carbon elongation of 
the primer by fatty acid synthase (EC 2.3.1.85), together with NADPH for the 
reductive steps of the pathway. The carboxylation of acetyl-CoA to malonyl-CoA is 
an irreversible reaction catalysed by the enzyme acetyl CoA-carboxylase (EC 
6.4.1.2). This cytosolic enzyme exists either in the inactive state or as an active 
filamentous polymer and it’s interconversion between these states is allosterically 
regulated by citrate concentrations within the cytosol (Lehninger, 1982; Stryer, 1988). 
In addition, acetyl-CoA carboxylase is subject to acute regulation by reversible 
phosphorylation (Hardie, 1989). This reaction is the first step committed to fatty acid 
biosynthesis and following this, the intermediates of fatty acid synthesis are attached 
to acyl carrier proteins which subsequently enter the elongation cycle catalysed by the 
fatty acid synthase enzyme system (Dils and Knudsen, 1980; Dils and Parker, 1982). 
The esterifying enzymes responsible for the elaboration of acylglycerols require the 
CoA esters o f fatty acids as substrates. In the case of ruminants this is already 
achieved without the intervention of the fatty acid activating enzymes to some extent 
as medium- and short-chain fatty acids are synthesised as acyl-CoA esters (Knudsen 
and Grunet, 1982).
Figure 1:2 Outline of the pathway of fatty acid synthesis in the ruminant 
mammary gland.
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1.2.2. Lactose Synthesis
The supply of glucose to the mammary gland of all species during lactation is of 
utmost importance both as a fuel and as a biosynthetic precursor. Among the several 
metabolites absorbed, triacylglycerol fatty acids and in the ruminant 3- 
hydroxybutyrate and acetate are mainly channelled into milk fat. However, the 
majority of glucose taken up by the ruminant mammary gland is utilised to synthesize 
lactose compared to the rat mammary gland which commits a large proportion of 
glucose absorbed to glycolysis (Kuhn, 1978). The extensive conversion of glucose 
into lactose in the ruminant mammary gland (approximately 60%) compared with rats 
(10-20%) is believed to reflect both the greater concentration of lactose in ruminant 
milk and the lesser importance of mammary glycolysis, as a consequence of the 
differences between ruminant and non-ruminant metabolism (Kuhn, 1978; Dils and 
Parker, 1982).
Lactose is the main carbohydrate found in milk. In addition to its calorific value, it 
is essential for the maintenance of milk secretion as it is the major osmotic component 
of milk (Dils and Parker, 1982). This disaccharide is synthesised uniquely by the 
mammary gland from the substrates glucose and galactose. A sequence of enzyme 
catalysed events occurs in the cytosol of mammary epithelial cells and leads to the 
formation of UDP-galactose (Lehninger, 1982; Dils and Parker, 1982). The final 
step in the synthesis of lactose from UDP-galactose and glucose is catalysed by 
galactosyltransferase (EC 2.4.1.151) which is located on the inner surface of Golgi 
membranes (Kuhn et al., 1980).
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1.2.3. Milk Protein Synthesis
There are several families of proteins in milk and the major types include caseins, a- 
lactalbumin, B-lactoglobulin and the immunoglobulins. As with the other main 
constituents of milk, the amount and type of protein present exhibits species variation 
thus reflecting the contribution made by milk proteins to the total energy supplied by 
milk in individual animals (Dils and Parker, 1982).
For the synthesis and output of milk proteins, the mammary gland has a high 
requirement for amino acids. The uptake of both essential and non-essential amino 
acids by the lactating mammary gland has been shown in a variety of species 
including the rat (Vina and Williamson, 1981) and ewe (Davis et aL, 1978) and a 
comparison with amino acid composition of milk proteins shows that the uptake of 
methionine, phenylalanine and tyrosine is balanced by their output in milk in all the 
ruminant species studied (Dils and Parker, 1982). In addition, these amino acids 
appear to undergo no further catabolism once taken up by the mammary gland and 
are incorporated solely into milk. However, in the rat alanine, serine, threonine and 
glycine are quantitatively the most important amino acids taken up by the gland (Vina 
et al. , 1983). Hence, variation exists in the amount and type of amino acids extracted 
by ruminant and non-ruminant mammary glands, which is probably related to a 
number of factors including differences in diet, nutritional status and basic 
metabolism.
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1.3 INTER-ORGAN INTEGRATION OF METABOLISM 
DURING LACTATION
The process of lactation makes a large demand on the body for substrates to be 
utilised in milk production, and during this process the mother undergoes a variety 
of physiological and metabolic changes. To maintain a sustained output of milk, it 
is essential to increase the maternal intake of food as well as change both the 
absorption and distribution of nutrients. The specific physiological changes that occur 
include the following: an increase in cardiac output; hypertrophy of the liver, heart, 
intestine and mammary gland, and an increase in dietary intake (see Williamson, 
1980; Vernon, 1989). The net result of such changes being that a high proportion 
o f essential substrates is re-directed to the mammary gland.
Specific alterations in tissue metabolism in both ruminants and non-ruminants also 
occur, and as might be expected, the mammary gland itself undergoes marked 
changes concerning glucose utilization (Linzell, 1968; Hawkins and Williamson, 
1972; Jones and Williamson, 1984), lactose synthesis (Carrick and Kuhn, 1978; 
Wilde and Kuhn, 1979; Hove, 1978), lipogenesis (Robinson et al., 1978) and amino 
acid uptake and protein synthesis (Davis et al., 1984). In addition, in both ruminants 
and rodents there is a decrease in the rate of lipid synthesis and in the activity of 
lipoprotein lipase in white adipose tissue (Smith, 1973; Flint et al., 1979; Sinnett- 
Smith et al., 1980; Vernon et al., 1981), which essentially decreases the requirement 
of this tissue for lipid precursors. A simultaneous increase in lipolysis has also been 
shown to occur in the adipose tissue of both animal groups (Nobel et al., 1971; Smith
12
and Walsh, 1976; Bauman and Currie, 1980) and so changes the role o f adipose 
tissue from one of lipid storage to one of lipid mobilization, ensuring the preferential 
provision of precursors to the mammary gland. In conjunction with these changes, 
there is a reduction in the glucose utilization of adipose tissue in ruminants (Vernon 
et al., 1987) and rodents (Smith, 1973, Bumol et al., 1986) which appears to provide 
another sparing mechanism for possible precursors required by the lactating mammary 
gland.
In contrast to the similar alterations in adipose tissue metabolism seen in the rat and 
ewe during lactation, adaptations of liver metabolism are markedly different in these 
two animals (see Vernon, 1989), reflecting differences in the nutrients absorbed. 
However, hepatic metabolism is indeed greatly altered and hypertrophy of this tissue 
(Vernon et al., 1986; Williamson, 1980) is also accompanied by changes in the 
activity of a number of enzymes concerned with carbohydrate and lipid metabolism.
In the rat the activity of glucokinase (EC 2.7.1.2) increases at peak lactation (Smith, 
1975) and similarly an increase in the uptake of gluconeogenic precursors occurs 
during this time (Casado et al., 1987a,b). Diurnal variations in hepatic glycogen 
content have been reported in the lactating rat and findings seem to suggest that 
during the light period hepatic glycogen may have an important role in supplying the 
demand for carbohydrate in the lactating rat, possibly providing precursors for hepatic 
and/or mammary gland lipogenesis (Clark et al., 1974; Munday and Williamson, 
1983; Roberts et al., 1982). Indeed, the importance of hepatic gluconeogenesis and 
glycogen stores has been emphasized using the inhibitor of hepatic gluconeogenesis.
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mercaptopicolinic acid, which when injected upon re-feeding of starved (24 hr) 
lactating rats caused a significant decrease in the normal rapid stimulation of 
mammary gland lipogenesis seen upon re-feeding, and prevented the deposition of 
hepatic glycogen (Williamson et al., 1985). The large demand for glucose by the 
secreting mammary gland is also responsible for the elevated rates of gluconeogenesis 
observed in the liver of ruminant animals, a proportion of this increase is derived 
from the enhanced food intake at this time (Lindsay, 1971), and the remaining as a 
result of increased activities of several gluconeogenic enzymes (Vernon et al., 1987). 
As for hepatic glucose utilization during this period, it is uncertain as to whether this 
parameter alters, although evidence so far shows that the activities of several 
glycolytic enzymes do not change during lactation in sheep liver (Smith and Walsh, 
1982; Vernon et al., 1987).
Hepatic glucose utilization has been shown to be increased during lactation in the rat 
and hepatic glycolysis has been shown to have an important role in the supply of 
carbon for fatty acid synthesis de novo (Smith, 1973b). Similarly, acute changes in 
hepatic lipogenesis have been shown to occur between the different reproductive states 
of the adult female rat, such that the capacity for hepatic fatty acid synthesis is 
elevated during pregnancy and lactation compared to virgin animals (Benito et a l. , 
1982; Vernon and Flint, 1983; Lorenzo et al., 1983). In contrast to the rat, the liver 
is considered to play a relatively minor role in lipogenesis in sheep (Ballard et a l. , 
1969), contributing less than 10% of the total fat synthesized in the intact animal 
(Ingle et al., 1972a,b). Indeed, this difference between the rat and sheep is observed 
in the absolute rates of hepatic lipogenesis, in which sheep liver slices have been 
shown to incorporate radiolabelled glucose and acetate into fatty acids at 1.5 and
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14.0% respectively, of the rates seen with rat liver slices (Hanson and Ballard, 1967). 
Consequently, rates of fatty acid synthesis are very low in the livers o f ruminants and 
during lactation this rate is believed to show only a negligible change, based upon low 
acetyl-CoA carboxylase activities (Vernon et al., 1987). In addition, much evidence 
supports the view that little glucose is used for lipogenesis in the liver (or other 
tissues) o f the ruminant and that the main substrate for the formation o f fatty acids 
is acetate (see Ballard et al., 1969; Bell, 1981). Hence, the use o f acetate as a major 
substrate for fatty acid synthesis would appear to be a useful physiological adaptation 
of tissue metabolism in the ruminant, with the result that it effectively spares glucose.
The synthesis o f fatty acids de novo, is not the only alteration in hepatic lipid 
metabolism observed in the lactating rat, as changes in the partitioning of fatty acids 
between oxidation and estérification also occur (Whitelaw and Williamson, 1977; 
Zammit, 1980, 1981). Additionally, cholesterol ester uptake from very-low-density 
lipoproteins has been suggested to make a substantial contribution towards the 
cholesterol requirement of the lactating rat mammary gland (Gibbons et a l . , 1983) 
and more recently, the activity of 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) 
reductase, the proposed rate limiting enzyme of cholesterogenesis, has been shown 
to change in parallel with the alteration in the rate of hepatic cholesterol biosynthesis 
during lactation in vivo (Easom and Zammit, 1987). In contrast to the lower rate of 
ketogenesis observed in hepatocytes isolated from lactating rats compared to adult 
females (Whitelaw and Williamson, 1977), ruminant animals become increasingly 
susceptible to ketosis during pregnancy and lactation (Bergman, 1971; Baird et al., 
1975) and ovine hepatocytes isolated from lactating animals have been shown to have
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approximately a 30% increase in ketogenesis when compared to cells from non- 
lactating ewes (Faulkner and Pollock, 1991). Finally, when considering ruminant 
fatty acid catabolism, the significant release of acetate from the liver in vivo should 
be mentioned. In lactating ewes a net release of "endogenous acetate" has been 
shown in vivo and measurements in vitro have shown that the enzymatic capacity of 
the liver is sufficient to produce acetate from acetyl-CoA and hence account for the 
observed in vivo effect (Costa et at., 1976). Such a mechanism has been suggested 
as an alternative to ketogenesis, as a means o f relieving an intra-mitochondrial build 
up of acetyl-CoA resulting from fatty acid oxidation. However, the precise metabolic 
significance of this suggestion requires further investigation, although the advantage 
of acetogenesis in the lactating ruminant liver would seem clear, in view of the 
importance of acetate as a carbon source for mammary gland lipogenesis.
Finally, the last major process of hepatic adaptation during lactation involves protein 
metabolism. A pronounced simulation of total protein synthesis has been observed 
in the livers of lactating rats (Siebrits et al., 1985) and similarly, an associated 
increase in the hepatic extraction of amino acids has been demonstrated (Tedstone et 
al., 1990). Such experiments have also shown that a reciprocal relationship appears 
to exist between mammary and hepatic uptake of amino acids which is dependent 
upon the lactational and the nutritional state of the rat, with the result that amino 
acids are preferentially directed to the mammary gland during active lactation.
Metabolic alterations in other tissues have also been observed, with particular 
emphasis on the lactating rodent. For example, the activities of enzymes in the
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intestinal mucosa which are involved in energy metabolism and protein absorption, 
have been shown to increase during lactation in the rat (Burdett and Reek, 1979) and 
the capacity of brown adipose tissue to produce non-shivering thermogenesis has also 
been shown to be diminished during lactation (Trayhum and Richard, 1985), so 
providing an energy saving device for the lactating mother. The final tissue of 
interest is skeletal muscle, although the metabolic adaptations made during lactation 
are not yet fully elucidated. However, in both ruminants and non-ruminants there is 
a common reduction in glucose utilisation of muscle (Bumol et al., 1987; Vernon, 
1989) and a systematic loss of muscle protein evidenced both in the rat (Sainz et al., 
1986; De Santiago et al., 1991) and ewe (Cowan et al., 1979; Vernon et al., 1987). 
Hence, such changes will provide mobilized amino acids suitable for uptake by both 
the mammary gland and liver.
1.3.1 Regulation of the Metabolic Changes during Lactation
The mammary gland becomes highly metabolically active during the process of 
lactation and as previously described marked alternations in the metabolism o f the 
whole animal occur to enable the partitioning of nutrients to supply the demands of 
this gland. The demand of the mammary gland to initiate a sustained milk production 
is so extensive that rats at peak lactation are generally in negative energy balance, in 
spite of the large increase in food intake (Tachi et al., 1981) and consequently fat 
reserves accumulated during pregnancy are mobilised to help meet the energy 
demands of lactation (Naismith et al., 1971). A similar cycle is also observed in 
dairy cows (Moe et al., 1971) and sheep (Vernon et al., 1981).
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Several studies have indicated that mammary gland metabolism responds to altered 
nutritional and hormonal states of the lactating animal and the majority of studies 
have been made using the rat. Removal of food for a period as short as six hours 
decreases by 80-90% the rate of lipogenesis (Williamson et al., 1983); greatly 
reduces lactose synthesis (Carrick and Kuhn, 1978) and decreases glucose extraction 
(Jones and williamson, 1984) in the lactating mammary gland in vivo. Similar 
findings have been reported after longer periods, such as 24 hour starvation, when 
the rate o f uptake of glucose by the mammary gland decreases (Robinson and 
Williamson, 1977a; Page and Kuhn, 1986) and the rate of mammary gland 
lipogenesis in vivo decreases by up to 98%, but is rapidly restored (within 2 hours) 
by refeeding with chow diet (Robinson et al., 1978; Munday and Williamson, 1981). 
Lactose synthesis also shows the same response to nutritional change, as overnight 
starvation almost completely abolishes this biosynthetic process in the intact lactating 
rat mammary gland and refeeding for a period of 5 hours returns this process back 
to 80% of the fed state value (Bussmann et al., 1984). From such studies, it has 
been speculated that the rapid recovery of lipogenesis following starvation - refeeding 
may be due to the activation of key enzymes rather than their induction and that the 
flow o f glucose carbon into fatty acid is achieved at the expense o f lactose synthesis.
Similarly, several studies have indicated that liver metabolism, like mammary 
metabolism, responds to altered nutritional and hormonal states o f the lactating animal 
and again, most o f the studies have been made using the rodent. Experiments have 
shown both short term food withdrawal (Williamson et al., 1983) and long term 
starvation (Robinson et al., 1978) of lactating rats caused a significant decrease in
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hepatic lipogenesis in vivo. However, unlike the mammary gland response, refeeding 
starved (24 hour) lactating rats for 2 hours did not completely reverse the observed 
change in hepatic lipogenesis. In contrast to the hepatic lipogenesis in the rat, 
gluconeogenesis is the predominant biosynthetic pathway in the ruminant liver and 
starvation in this group of animals results in a decrease in the rate of glucose 
synthesis and a resultant dependence on lipid as an energy source (Bergman, 1973; 
Chaiyabutr gr a /., 1982).
Mammary gland metabolism has also been shown to respond to changes in dietary 
constituents, and the transfer of lactating rats from a normal laboratory chow to a 
high fat content (cafeteria) diet was shown to decrease the rate of lipogenesis in the 
mammary gland in vivo and was well correlated with decreases in glucose uptake and 
lipogenesis in vitro, in acini isolated from the same animals (Agius et al., 1980). 
This implies that the lactating rat switches from synthesizing fatty acids de novo, to 
utilizing those of dietary origin in its provision of milk lipid, which would seem to 
be of physiological advantage since it would spare lipogenic precursors such as 
glucose, when an abundance of triacylglycerol was available. Further studies 
examining the effect of diets containing long- or medium-chain triacylglycerols on 
lipogenesis in lactating mammary gland have supported such evidence, since they too 
show a dramatic inhibition of fatty acid synthesis (Aguis and Williamson, 1980). The 
reactivation of lipogenesis in the gland following starvation/refeeding also shows 
extreme sensitivity to substrate supply and this is demonstrated by the suppression of 
lipogenesis by acarbose, a glucosidase inhibitor, which delays carbohydrate digestion 
in the gut and so decreases glucose availability during the refeeding period (Mercer
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and Williamson, 1987). In common with lipogenesis, lactose synthesis has also been 
shown to be affected by decreased dietary intake (Wilde and Kuhn, 1979), although 
whether a change in composition of the diet would alter such a process is unknown.
In addition to the hyperphagia seen during lactation of the rat, a diurnal pattern of 
food intake still remains, such that animals housed under conditions o f alternating 12 
hour periods o f light and darkness, consume 65% of the diet during the dark period. 
In such animals the patterns of liver and mammary gland fatty acid synthesis have 
been shown to parallel the pattern of food intake (Munday and Williamson, 1983). 
Diurnal variations in the rate of lactose synthesis in rat mammary gland in vivo have 
also been reported (Carrick and Kuhn, 1978) and this too appears to be sensitive to 
the amount o f food consumed (Wilde and Kuhn, 1979). This evidence, along with 
the previous observations, confirms the sensitivity of the biosynthetic processes o f the 
lactating mammary gland and liver in relation to the nutritional status o f the mother. 
Such correlations of hepatic and mammary lipogenesis related to food intake (Munday 
and Williamson 1983) and inhibition of such mechanisms during short-term (6 hour) 
food withdrawal (Williamson et al., 1983) suggests that there may be a signal which 
informs the liver and mammary gland of the dietary status of the lactating rat. When 
considering the regulation of hepatic lipogenesis and mammary lipogenesis and lactose 
synthesis, there are several potential sites of modulation and consequently, it is 
probable that there will be more than one signal.
Several hormones have been proposed to play a key role in the modulation of the 
integrated metabolic changes during lactation. Some of the potential regulators are
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considered individually in the following sections, and in view of the differing 
metabolic profiles of rodents and ruminants it is conceivable that the potential 
regulators may have different levels of importance in these two groups of animals. 
However, the central hypothesis of this thesis is concerned with the possible 
differences in the efficacy of hepatic counter-regulators o f insulin action, both 
between the rodent and ruminant and between lactating and non-lactating individuals 
in each model.
PROLACTIN
The pituitary hormone prolactin which is secreted reflexly in response to suckling and 
acts to maintain galactopoiesis, has been implicated as a potential signal in the co­
ordinated integration of mammary metabolism with that o f other tissues during 
lactation in the rat. A variety of experimental procedures exist to assess the 
biochemical contribution made by a particular hormone. For example, the surgical, 
pharmacological or immunological manipulation o f whole animal models enables the 
ablation of hormone output and so may emphasize the physiological importance of the 
hormone of study. Such procedures have been applied in experiments studying the 
importance of prolactin, as in rodents an initial surge in serum prolactin concentration 
occurs at or just prior to parturition and blocking such a release prevents the normal 
onset o f lactogenesis (Bohnet etal.,  1977; Bauman and Currie, 1980; Forsyth, 1986). 
Pharmacological (bromocryptine treatment) and surgical (hypophysectomy) 
manipulations to produce prolactin-deficient lactating rats have also shown that this 
hormone appears to play a role in co-ordinating lipid metabolism in adipose tissue and
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liver, in a manner to partition nutrients to the lactating mammary gland (Zinder et 
ah, 1974; Agius et ah, 1979; Flint et ah, 1981). Also, the exploitation of 
physiological means have been employed to modulate hormone levels, such as 
premature weaning to cause a fall in serum prolactin levels (Agius et ah, 1979) and 
starvation-refeeding episodes to alter the insulin: glucagon ratio (Robinson et ah,
1978). In general, studies have concluded that a high serum concentration of 
prolactin is critical for lactation in rodents but appears to be less important in 
ruminants once lactation is established (Forsyth, 1986).
GROWTH HORMONE (Somatotropin)
However, growth hormone another anterior pituitary hormone which is structurally 
related to prolactin, has been implicated to play a role in the changing energy balance 
of the ruminant throughout the duration of lactation. A rise in serum growth 
hormone concentration occurs in ruminants during early lactation and declines as 
lactation progresses (Collier et ah, 1984) but such a rise is not found in rodents 
(Madon et ah, 1989). Additionally, bovine growth hormone has been shown to be 
galactopoietic, such that daily injections to lactating dairy cattle (Peel et ah, 1983; 
Chilliard et ah, 1988) and goats (Hart et ah, 1980) achieve an increased milk yield 
along with increased fat, lactose and protein secretion. However, the action of 
growth hormone in the lactating ruminant is believed to be an indirect one, such that 
it may selectively act by partitioning nutrients away from liver and adipose tissue 
(Keys and Djiane, 1988; McDowell et ah, 1987). Consequently, future work is 
required to elucidate the precise regulatory role of this hormone in the lactating ruminant.
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INSULIN
Since the mammary gland has been shown to be highly sensitive to changes in the 
nutritional state of the mother, insulin may seem to be a natural candidate for the 
regulation of lipogenesis and lactose synthesis, in view of its ability to stimulate 
hepatic glycogen formation and encourage fatty acid synthesis. Work by Robinson 
and colleagues (Robinson et al., 1978) showed a 50-fold decrease in rat mammary 
gland lipogenesis following 24 hour starvation which was rapidly reversed upon 
feeding. In parallel with such findings they also noted the plasma insulin 
concentration to fall 2-fold during the period o f starvation and this too was restored 
to the fed lactating rat value on re-feeding. Neither glucagon, nor prolactin 
concentrations showed such parallel changes, which seemed to suggest insulin as a 
regulator of this process in the gland.
Insulin has been shown to be a key factor in the regulation of lipogenesis in vivo in 
the rat mammary gland (Robinson et al, 1978; Bumol et al., 1983; Jones et al., 
1984) and the restoration of mammary gland lipogenesis during re-feeding of starved 
lactating rats is prevented by insulin deficiency (Robinson et al., 1978). Glucose 
oxidation and subsequent incorporation into lipid are also decreased in mammary 
gland slices and cells from lactating rats made insulin-deficient with alloxan (Martin 
and Baldwin, 1971a) or anti-insulin serum (Walters and McLean, 1968; Martin and 
Baldwin 1971b) and such an impairment can be reversed by administration of insulin 
in vitro. However, preparations of mammary gland tissue in vitro have not been 
more than partially effective in illustrating the effects of insulin (Robson et al., 1984)
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since some have been shown to be relatively unresponsive to this hormone and other 
common counter-regulators (Robinson and Williamson, 1977a; Agius and Williamson, 
1980; Williamson et al., 1983). Such results raise the possibility that in vitro 
preparations may not reflect the metabolic characteristics o f the tissue in the living 
animal and that the observed response to the hormone in vivo may be the result o f a 
secondary action o f that hormone on another tissue. However, an in situ perfused 
mammary tissue preparation (Clegg and Calvert, 1988) has helped to distinguish 
between the opposing results from in vivo and in vitro experiments and has confirmed 
the findings that insulin plays a key role in the regulation of mammary gland 
lipogenesis.
In contrast to the evidence that insulin is involved in the short term regulation of 
glucose metabolism and lipogenesis in the lactating rat mammary gland, there is little 
support for an effect o f this hormone on lactose synthesis (Carrick and Kuhn, 1978; 
Wilde and Kuhn, 1979). Starved lactating rats injected with insulin showed no 
stimulation of the rate o f lactose synthesis nor was a consistent relationship between 
changes in lactose synthesis and plasma concentrations of insulin observed in the rat. 
Such a lack of evidence for a clear role of insulin in the regulation of lactose 
synthesis appears to suggest that mammary gland lipogenesis and lactose synthesis 
may not have a common hormonal control.
While the acute effects of insulin deficiency in the rat are well documented, 
comparable information in ruminants is less abundant. However work by Hove using 
lactating goats has observed a similar finding as compared with experiments with rats.
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that mammary secretion of lactose is unaffected by short term changes in plasma 
concentrations of insulin (Hove, 1978a). In other studies, in which glucose was 
infused concomitantly with insulin in order to prevent hypoglycaemia (Hove, 1978b), 
or in which glucose was infused alone to give an increased plasma insulin 
concentration (Chaiyabutr et al., 1983), there were no obvious changes in mammary 
glucose uptake. Thus, ruminant mammary gland appears refractory to acute affects 
o f insulin during lactation, even though mammary tissue possesses specific insulin 
receptors (Oscar et al., 1986) and the number of microsomal receptors is altered by 
the stage of pregnancy and lactation (Campbell et al., 1987). More recently, there 
is a growing body of evidence suggesting that the ruminant mammary gland responds 
to insulin-like growth factor-1, IGF-1 (Winder and Forsyth, 1987) and that IGF-1 in 
combination with growth hormone may play an essential role in the regulation of 
ruminant mammary gland metabolism, such that IGF-1 may perform the same role 
that insulin plays in the control of mammary metabolism in the rodent.
Hypoinsulinaemia is a characteristic feature of the lactating rat and serum insulin 
concentrations have been shown to be 60% lower than in virgin or non-lactating rats 
(Robinson et al., 1978). Additionally, diurnal variation in plasma insulin levels have 
been reported for lactating rats (Carrick and Kuhn, 1978; Munday and Williamson, 
1983), with minimum values occurring during the daylight hours, although the 
decrease in concentration during this period was not more than 50%. Such changes 
have been shown to parallel the pattern of food intake, and in view of the hyperphagia 
and the high rates of glucose metabolism in the mammary gland it is somewhat 
paradoxical that such relatively low levels of plasma insulin prevail, with the absence
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of any large changes in its concentration. Temporal changes in the circulating insulin 
concentration during limited (bolus) re-feeding of starved (18hr) lactating rats have 
been measured (Mercer and Williamson, 1986) and show that upon such re-feeding 
there is a significant 2-fold increase in the plasma insulin concentration within 5 
minutes of re-feeding, which continues to increase to peak at 20 minutes at a level 20- 
fold higher than the basal starved value. However, between 20 and 30 minutes of re­
feeding the insulin level falls sharply and remains low for the remainder of the 90 
minute period. Similarly, time course studies of plasma glucose levels mirror this 
insulin pattern, with the exception that between 20 and 30 minutes there is only a 
slight decrease in the glucose concentration and the values remain well above the 
basal starved value. In conjunction with this, rates of lipogenesis in vivo in mammary 
glands of starved and re-fed lactating rats show a large increase in the rate of 
lipogenesis between 30 and 90 minutes after the onset of refeeding (Mercer and 
Williamson, 1986; Williamson et al., 1985; Robinson et al., 1978), which 
corresponds to the time when the circulating insulin levels are relatively low 
following the transitory hyperinsulinaemia. Similarly, arteriovenous glucose 
differences across the mammary gland of re-feeding, starved lactating rats has shown 
that glucose uptake approaches its maximum after the surge in plasma insulin, at a 
time when the insulin concentration is subsiding (Page and Kuhn, 1986). Several 
explanations may be responsible for the activation of mammary function during this 
period of re-feeding whilst relatively low plasma insulin levels prevail. For example, 
if  following the initial hyperinsulinaemia there was a large increase in blood flow to 
the mammary gland and hence a faster rate of hormone and substrate delivery this 
would be consistent with the observed plasma insulin levels. However, mammary
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gland blood flow measurements show only a modest increase in starved re-fed 
lactating rats (Mercer and Williamson, 1986; Jones and Williamson, 1984). The 
second approach was to investigate the initial peak o f hyperinsulinaemia and 
experiments were performed where streptozotocin was administered to starved 
lactating rats, 30 minutes after the start of re-feeding (ie: after the initial plasma 
insulin surge) (Mercer and Williamson, 1986). Such procedures were shown to 
abolish the normal lipogenic switch on in the mammary gland during the re-feeding 
period and so indicating that the transient hyperinsulinaemia response to re-feeding 
is not in itself sufficient to maintain the activation o f mammary lipogenesis and 
strongly suggests an acute increase in insulin-sensitivity of the mammary gland. A 
similar conclusion was also drawn by Page and Kuhn (1986), that soon after re­
feeding has commenced, the mammary gland acquires some independence of 
circulating insulin, possibly through a greater sensitivity towards it. Indeed, the 
importance of insulin sensitivity has also been emphasized by Jones et al., (1984), 
who regard such increased insulin-sensitivity as a possible cause o f the low plasma 
concentration of this hormone.
A substantial amount of experimental work claims that insulin sensitivity is a property 
of lactating rat mammary tissue (Bumol et al., 1983; Jones et al., 1984; Bumol et 
al., 1986) and more recent evidence suggests that this tissue is the most insulin- 
sensitive tissue in the lactating rat (Bumol et al., 1987). Euglycemic 
hyperinsulinaemic clamp studies showed mammary glucose utilization to represent 
20% of the total glucose tumover rate. -
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These results show that during lactation the 
basal level of glucose utilization is decreased in many tissues with the exception of 
the mammary gland, which shows a high sensitivity to insulin with the net result that 
glucose utilization is favoured in the mammary gland at the expense of other tissues, 
both in the basal state as well as under insulin stimulation. Additionally, the effect 
o f insulin on glucose metabolism in a number of tissues has been shown to vary. In 
particular an insulin-resistance has been demonstrated in white adipose tissue and 
skeletal muscle of the lactating rat (Bumol et al., 1987), whereas the liver, like the 
lactating mammary gland, has been shown to be hypersensitive to insulin (Bumol et 
al., 1986). The precise mechanisms for the changes in insulin-sensitivity in the 
various tissues of the lactating rat are as yet unknown, although with the mammary 
gland a significant increase in the number of insulin receptors per mammary cell has 
been found (O’Keefe and Cuatrecasas, 1974; Flint, 1982) following parturition and 
exists during the period of lactation. However, certain discrepancies have been 
observed in white adipose tissue between numbers o f insulin receptors and changes 
in insulin-sensitivity (Flint, 1985), which suggest that post-receptor events may well 
be involved in such changes in responsiveness.
When considering mminant mammary tissue, such an increase in sensitivity would 
not be anticipated as this tissue has been shown to be insensitive to insulin (Hove, 
1978b). However, insulin does play a role in regulating the partition of nutrients and 
as with the rat, during lactation plasma concentrations of insulin are low (Vemon and 
Flint, 1983), so providing an environment where normal anabolic processes are 
suppressed such that more nutrients are available for milk synthesis. Indeed ovine
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adipose tissue in vitro, has been shown to have a decreased sensitivity to insulin 
during lactation (Vemon and Taylor, 1988). However, more recently the use of the 
euglycaemic hyperinsulinaemic clamp technique has shown that glucose utilization 
increases 3-fold during lactation in ewes and that insulin also stimulates glucose 
utilization several fold (Faulkner and Pollock, 1990). Such findings are somewhat 
surprising considering that there is no evidence that glucose metabolism in the 
mammary gland of mminants is sensitive to insulin and hence suggests that the 
sensitivity and response of glucose metabolism to insulin in the lactating mminant 
may be more complex compared to the lactating rat.
In summary, insulin has been shown to provide an essential role in the regulation of 
mammary gland glucose metabolism and lipogenesis during lactation and several 
possible sites o f insulin action have been suggested. Possible sites o f insulin 
regulation o f mammary gland metabolism include phosphofmctokinase-1 (Martin and 
Baldwin, 1971; Williamson eta l.,  1974; Jones et ah, 1984a; Mercer and Williamson
1987), pymvate dehydrogenase (Coore and Field, 1974; Robinson and Williamson, 
1977a, 1978a; Baxter and Coore, 1978; Baxter et al., 1979; Kilgour and Vemon,
1987) and acetyl-CoA carboxylase (Hardie and Guy, 1980; McNeillie and Zammit, 
1982; Munday and Williamson, 1982; Munday and Hardie, 1986; 1987).
In accordance with the importance of insulin in the regulation of mammary 
lipogenesis in the lactating rat, the elevated rates of hepatic lipogenesis are somewhat 
unexpected in view of the characteristic hypoinsulinaemia observed in the animal 
during this period (Robinson et al., 1978). A similar paradox involving the lipogenic
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rates of lactating mammary tissue have been described earlier and the findings of an 
increased insulin-sensitivity of this tissue (Bumol et ah, 1983; Jones et al., 1984; 
Bumol et al., 1986) during lactation has shed some light upon the types of 
mechanisms involved. With regard to the liver, measurements o f insulin-sensitivity 
have involved glucose production rates and it has been shown that the liver of 
lactating rats has an increased sensitivity to insulin when compared to non-lactating 
animals (Bumol et al., 1986). However, unlike the mammary gland tissue of 
lactating rats, the density of insulin receptors in hepatocytes remained similar to 
values found in hepatocytes from virgin animals (Flint, 1980), which may suggest that 
the increased sensitivity could be mediated at a postreceptor level.
The two major enzymes believed to be the rate limiting factors in the synthesis of 
fatty acids are pyruvate dehydrogenase and acetyl-CoA carboxylase. No change in 
pymvate dehydrogenase activity in the liver has been observed during lactation 
(Kilgour and Vemon, 1987), although in agreement with the elevated rates of hepatic 
lipogenesis, acetyl-CoA carboxylase in rat liver has been shown to have a high 
activation ratio during lactation (Zammit and Corstorphine, 1982a). The activation 
ratio of the enzyme was also shown to decrease when the animal was starved and the 
plasma insulin levels were lower, but reached a maximum when the fed lactating rats 
were weaned, a condition where insulin levels have been shown previously to be 
elevated approximately 2-fold (Agius et al., 1979). Hence, these findings , with the 
exception of the hepatic lipogenic rate during lactation, are in agreement with the fact 
that insulin enhances the activity of hepatic acetyl-CoA carboxylase (Stansbie et a l., 
1976; Geelen et al., 1978). The apparent lack of correlation between plasma insulin
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levels and hepatic lipogenesis during lactation seems to suggest that other factors 
together with insulin (and any changes in insulin-sensitivity of this tissue) may have 
a role in the regulation of liver lipogenesis.
In contrast to the rat, the diminished levels of serum insulin in the ruminant (Vemon 
and Flint, 1983) and the increased rates o f hepatic gluconeogenesis and negligible 
rates of fatty acid synthesis during lactation presents no paradox. Indeed, the plasma 
glucagon concentration is believed to undergo no significant change (Vemon, 1989) 
and hence the low semm insulin:glucagon ratio would seem to facilitate the rise in 
gluconeogenesis during this period of lactation, as this hormone is capable of 
stimulating gluconeogenesis and glycogenolysis.
In view of the evidence for a central role for insulin in the modulation of the 
metabolic profile of the lactating rat and the paradoxical elevated rates of hepatic 
lipogenesis in the characteristic hypoinsulinaemic conditions during this time, a search 
for putative counter-regulators of insulin action has been initiated.
GLUCAGON
In conjunction with the key role of insulin in the regulation of mammary tissue 
metabolism, this hormone must warrant an interest as a possible counter-regulatory 
hormone. Like insulin, glucagon is secreted from the pancreatic islets but in contrast 
to insulin, it has glycogenolytic, gluconeogenic, lipolytic and ketogenic actions such 
that it is considered to be a hormone of energy release. Release of glucagon is
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stimulated by sympathetic innervation of the pancreas and a variety of physiological 
stimuli such as stress and exercise as well as by amino acids, B-adrenergic agonists, 
gastrin and cortisol and secretion is inhibited by a rise in plasma glucose, which also 
requires the presence of insulin. Due to the opposite effects o f these two pancreatic 
hormones, their blood levels must be strictly regulated in any given situation so that 
the metabolic needs o f the body may be met.
In the mid-lactating rat, the mammary gland is the major lipogenic tissue and 
consequently fatty acid synthesis must be reduced in adipose tissue (Agius et al.,
1979). Since both tissues are insulin-sensitive, the animal must acquire a circulating 
insulin concentration which is able to maximise lipogenesis in the mammary gland 
whilst simultaneously inhibiting lipogenic steps in adipose tissue. A possible 
mechanism for such a selective sensitivity to insulin proposed that a second hormone 
acting antagonistically to insulin, may affect adipose tissue but not mammary tissue. 
Glucagon appeared to be a possible candidate in view o f its opposing action to insulin 
and ability to inhibit key steps in the pathway of lipogenesis from glucose in isolated 
adipocytes (Zammit and Corstorphine, 1982). In contrast to effects on adipocytes 
from lactating rats, studies have shown that glucagon has no effect on the rate of 
lipogenesis in mammary acini in vitro, nor does it antagonize the maximal stimulatory 
effect of insulin in such preparations (Robson et al, 1984). Additionally, no specific 
binding of glucagon could be detected in these preparations of acini, which showed 
normal binding values for assays using radiolabelled insulin. In accordance with the 
reciprocal changes in insulin-sensitivity of adipose tissue and mammary tissue from 
lactating rats (Jones et al., 1984b; Flint, 1985), changes have been shown in the
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sensitivity to glucagon of lipolysis in adipocytes during the transition from pregnancy 
to mid-lactation (Zammit, 1988), such that at the stage of late pregnancy the rats 
showed little sensitivity to glucagon but this steadily increased to reach the highest 
sensitivity at peak lactation. Measurements o f plasma glucagon concentrations in 
lactating rats have been shown to be similar to those of non-lactating animals, 
whereas hypoinsulinaemia is a characteristic of lactating rats (Robinson et aL, 1978). 
Thus, an elevated plasma glucagon : insulin molar ratio, which appears to be an 
important determinant of the balance between lipolysis and lipogenesis in these tissues 
and the elevated sensitivity to glucagon of adipose tissue, will favour triacylglycerol 
mobilisation from adipose tissue with the resultant provision of lipogenic substrates 
for the lactating mammary gland.
Changes in serum glucagon are less well documented in the ruminant but evidence 
suggests that as with the rat, there is little change during lactation in the ruminant 
(Vemon, 1989). However, serum growth hormone levels are known to be elevated 
in sheep during lactation when insulin levels are lowered (Vemon et al., 1981). 
Hence, it may be possible that the growth hormone : insulin ratio may have a role in 
regulating the partitioning of nutrients between the mammary gland and adipose tissue 
in lactating ruminants, as growth hormone has been shown to have an insulin- 
antagonistic effect upon fatty acid synthesis of sheep adipose tissue m vitro (Vemon 
e t a l . ,1991).
As a result of previous measurements of plasma insulin and glucagon concentrations 
(Robinson et al., 1978), the insuliniglucagon ratio has been estimated to decrease 2- 
fold in lactating rats compared to virgin female animals. As previously mentioned,
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such conditions would suggest that a situation in the liver should exist where glucose 
production would be favoured and glucose utilization and lipogenesis inhibited (see 
Geelen et al., 1980). However, as previously described, the opposite of these 
predicted changes occur in the lactating rat liver. Glucagon is known to have an 
antilipogenic effect in isolated hepatocytes (Holland et al., 1984), although whether 
the antilipogenic response to this hormone changes during the course o f pregnancy 
or lactation in the rat is unknown. Glucagon has also been shown to stimulate 
glycogenolysis and gluconeogenesis in isolated rat liver cells (Garrison and Haynes, 
1973). As described earlier, hepatic glycogen seems to paly a role in supplying the 
lactating mammary gland’s demands for carbohydrate, by providing precursors for 
lipogenesis and lactogenesis. The breakdown of glycogen is controlled mainly by 
glycogen phosphorylase through mechanisms involving the phosphorylation and 
dephosphorylation o f the enzyme and glucagon is believed to stimulate glycogenolysis 
by increasing the amount of phosphorylase a (phosphorylated active form) in the liver 
(see Hems and Whitton, 1980). In contrast, insulin is known to promote glycogenesis 
and inhibit glycogen breakdown and it is proposed that it may achieve the latter by 
antagonizing the glycogenolytic effect of glucagon (see Martin, 1988; Hems and 
Whitton, 1980). How the prevailing low serum insulin:glucagon ratio regulates the 
balance of glycogen metabolism in the liver of the lactating rat is as yet uncertain, as 
such mechanisms may be modified if any sensitivity changes to these hormones are 
operating.
In agreement with the lactating rat, a low serum insulin:glucagon ratio prevails in the 
lactating ruminant (Vemon, 1989) and unlike the rat, such conditions are in
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accordance with the reported negligible rates o f fatty acid synthesis observed during 
lactation (Vernon et al., 1987; 1989). Also, such a plasma hormone ratio would 
seem to facilitate the observed rise in the rate o f gluconeogenesis during the period 
of lactation, as glucagon is capable of stimulating gluconeogenesis and 
glycogenolysis. It is generally accepted that glucagon enhances hepatic 
glycogenolysis via activation of two signal transduction pathways, namely the 
adenylate cyclase system and the breakdown o f inositol phospholipids, as shown in 
isolated rat hepatocytes (Wakelam et aL, 1986), However, experiments using ovine 
hepatocytes have shown that glucagon appears to exert its action on hepatic 
glycogenolysis by altering the cytosolic concentration of cAMP only (Morand et al., 
1988). Additionally, dose response curves for glucagon on these cells showed that 
high levels of cAMP were not required for the stimulation of glycogen phosphorylase, 
a similar phenomenon being known to be true o f rat hepatocytes (Blackmore and 
Exton, 1986) and adipocytes (vis-a-vis lipolysis) (Honnor et al., 1985), and that the 
glucagon-induced activation of glycogen phosphorylase appeared to be greater in 
sheep than in rat liver cells. Such findings indicate the existence in sheep liver of a 
glycogen phosphorylase highly responsive to hormones, which would also imply the 
importance of the glycogenolytic action of glucagon. Recent studies have verified the 
far greater effect of glucagon on glycogen breakdown than on gluconeogenesis in the 
isolated hepatocyte from fed sheep, and such findings were shown to be the same in 
hepatocytes prepared from livers of lactating and non-lactating ewes (Faulkner and 
Pollock, 1990). This contrasts with the situation in the rat, where both processes are 
stimulated by glucagon (Cherrington et al., 1976), and the response in the sheep may 
be a consequence of the different nutritional status o f the animal and the glucose-
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sparing mechanisms operating in the ruminant.
Hence, in both the rodent and ruminant the factors which determine the metabolic 
profile o f the liver during lactation are far from established. Catecholamines are 
known to play an important regulatory role in the control of hepatic carbohydrate 
metabolism and they are one of the most important antilipogenic regulators in 
mammals.
CATECHOLAMINES
Catecholamines have been implicated as potential counter-regulatory hormones to the 
key role played by insulin in the regulation of glucose uptake and fatty acid synthesis 
in the lactating mammary gland. This class of hormones have been shown to be anti­
lipogenic in the intact animal, with a significant decrease in rat mammary lipogenesis 
following a subcutaneous injection of adrenaline (Bussmann et al., 1984). There also 
appears to be an abundance of adrenergic receptors on acinar cells of both lactating 
rat (Clegg and Mullaney, 1985; Lavandero et al., 1985) and ruminant (Clegg, 1988) 
tissue and binding studies have shown B-adrenergic binding capabilities in the range 
of 200-400 fmols/mg membrane protein on lactating rat acinar cells, with a 
predominance of the Bz-subtype of the receptor (Clegg and Mullaney, 1985; 
Lavandero et al., 1986). Additionally, it has been shown that virgin and involuting 
rat mammary tissues show about one fifth of the number o f B-adrenergic receptors 
present during pregnancy and lactation (Lavandero et al., 1986) and that the specific 
radioligand binding of «j- and ^ 2-adrenoceptor ligands with lactating rat acini
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membranes show a virtual absence of both o f these subtypes o f adrenoceptors 
(Mullaney e / a / , , 1987; Clegg, 1988).
It has been previously documented that changes in the basal concentration of cAMP 
occur during the course of pregnancy and lactation in rat mammary tissue (Sapag- 
Hagar and Greenbaum, 1974) and such studies have led to the expectation that 
alterations in the cAMP content o f secretory cells may be involved in the regulation 
of mammary lipogenesis during lactation. Subsequently, the adrenergic receptors 
found in rat mammary tissue have been shown to involve a stimulatory coupling to 
adenylate cyclase (EC 4.6.1.1), leading to an increase in the intracellular 
concentration o f cAMP (Ladha et al., 1985) which could then act through various 
protein kinases present in mammary tissue (Munday and Hardie, 1984), to modify the 
activity of acetyl-CoA carboxylase (Hardie and Guy, 1980) and hence the rate of 
lipogenesis. However, adrenergic challenge of mammary acini in vitro (Clegg et al., 
1986) shows a negligible rise in the cAMP content and no effect upon the rate of 
lipogenesis, as do in situ perfusion studies on rat mammary gland (Clegg and Calvert, 
1988). In contrast to the negative effect on acinar cAMP of stimulation by B-agonists 
alone, in the presence of phosphodiesterase inhibitors such stimulation causes a 
significant increase in the intracellular content of cAMP (Clegg and Mullaney, 1985; 
Mullaney and Clegg, 1985) but no corresponding inhibition of lipogenesis or effect 
upon the initial activity of acetyl-CoA carboxylase (Clegg et al., 1986).
A possible explanation for the paradox that catecholamines cause a decrease in the 
rate of mammary gland lipogenesis in vivo (Bussmann et al., 1986) but are without
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effect in vitro, may be that the observed response to adrenergic agonists in the intact 
animal is a secondary consequence o f actions o f such hormones on another tissue. 
For instance, it may be that the observed in vivo effect is the result o f an inhibition 
of lipogenic substrate supply from the liver, since the liver has an extremely 
important role during lactation in providing glucose to the mammary gland 
(Williamson, 1980), especially in the ruminant where the liver is in a permanent 
glucose producing state (Lindsay, 1978) and lactation only imposes a further 
requirement for hepatic glucose provision.
The mammalian liver receives it adrenergic nerve supply via the splanchnic nerve and 
the combination of fluorescence methods and electron microscopy, have shown the 
adrenergic innervation of the liver parenchyma and the synaptoid connections between 
adrenergic nerve terminals and hepatocytes (Moghimzadeh et al., 1982). Also, 
physiological studies with cats have shown that the selective stimulation o f hepatic 
sympathetic nerves causes a prompt increase in arterial plasma glucose concentrations 
(Jarhult et al., 1980). Such findings thus appear to implicate a direct role of the 
sympathetic nervous system in liver function. The adrenal medulla also secretes the 
catecholamines adrenaline, noradrenaline and dopamine. This endocrine organ is in 
effect a sympathetic ganglion, in which the postganlionic neurones have lost their 
axons and have become secretory cells. These cells then secrete when stimulated by 
the preganglionic nerve fibres that reach the gland via the splanchnic nerves. 
Physiological stimuli are known to affect medullary secretion and the metabolic 
effects of circulating catecholamines are also believed to be important with regard to 
catcholamine secretion (see Ganong, 1985).
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The role o f catecholamines in the control o f hepatic carbohydrate metabolism is a 
well established phenomenon (see Garrison and Haynes, 1973; Schmelck and 
Hanoune, 1980) and much work has concentrated on the hepatic glycogenolysis 
induced by catecholamines (see Hems and Whitton, 1980). Much controversy has 
existed in the scientific literature over the years, with regard to the adrenergic 
pathway through which adrenaline activates glycogenolysis in the rat liver, whether 
it be a B-adrenergic pathway which increases intracellular cAMP or an a-adrenergic 
mechanism involving a rise in cytosolic calcium. Work on the rat has shown that 
there are differences between males and females in the adrenergic regulation of 
hepatic glycogenolysis, and that females utilize both a- and B-adrenergic pathways, 
whereas the adult male has predominantly an a-mediated calcium dependent pathway 
(Studer and Borle, 1982). Indeed, variations in the responsiveness of rat liver to a- 
and B-adrenergic agents are well documented and have been shown to be dependent 
upon the sex (Bitensky et al., 1970; Studer and Borle, 1982; Studer and Ganas,
1988), age and developmental status (Bitensky et al., 1970; Morgan et al., 1983a; 
Katz et al., 1985) and hormonal status (Bitensky et al., 1970; Malbon et al., 1978; 
Munnich et al., 1981) of the animal. Such variations have been shown to correlate 
with changes in hepatic adrenoceptor density in several physiological states, and the 
number of B-adrenergic receptors has been shown to be increased in foetal and 
immature individuals (Snell and Evans, 1988; McMillian et al., 1983), females 
(Studer and Ganas, 1988), and individuals undergoing hepatic regeneration (Hureta- 
Bahena et al., 1983).
Similarly, in the ruminant, catecholamines are believed to be important in the
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regulation of hepatic carbohydrate metabolism and experiments using isolated ovine 
hepatocytes show that adrenaline appears to exert its action on hepatic glycogenolysis 
by altering the cytosolic concentrations o f both cAMP and calcium (Morand et al.,
1988). Hence, in the ruminant and the adult female rat, adrenaline regulates hepatic 
glycogenolysis via the same two signal transduction pathways. Also, as previously 
mentioned for the hormone glucagon, adrenaline too, has been shown to exert a 
greater activation of glycogen phosphorylase in the liver o f the ruminant than in the 
rat (Morand et al., 1988), which is probably not surprising in view of the role of the 
liver in the provision of glucose in the ruminant animal. There are also changes in 
the hepatic adrenoceptor population of sheep during various developmental stages, 
newborns having an abundance of B-adrenoceptors and this level decreases during 
adulthood, without any significant increase in «-adrenoceptors (Apatu et al., 1986). 
Thus, such findings seem to imply that the mobilization o f liver glycogen by 
catecholamines in the sheep is likely to be mediated by B-adrenoceptors at all ages.
In view o f the adrenergic control of hepatic glucose production and the lipolytic and 
antilipogenic actions of the catecholamines already mentioned as well as the known 
adrenergic control of these processes in white adipose tissue (see Saggerson, 1985 and 
Vernon and Clegg, 1985), it is possible that these hormones may play a role in the 
regulation of the metabolic profiles of key tissues involved in the process of lactation. 
Recent evidence has shown that some tissues in lactating rats express diminished 
responsiveness to noradrenaline, with regard to the ability of this agent to activate 
pyruvate dehydrogenase (Kilgour and Vernon, 1987). In contrast, ruminant adipose 
tissue has been shown to have an increased response to the lipolytic effect of
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catecholamines during lactation (Vemon, 1989).
The paradox o f the increased rates of hepatic lipogenesis in association with the 
prevailing hypoinsulinaemia in the lactating rat, would be reconciled if  it were the 
case that a lessening in the effectiveness of an antilipogenic regulator occurred during 
lactation, to an extent that overcame the effects of the decrease in the concentration 
of insulin. However, in the ruminant, the diminished levels of serum insulin and the 
increased rates of gluconeogenesis during lactation presents no paradox, and hence 
no changes are anticipated involving the action of antilipogenic regulator(s) in the 
lactating ruminant liver. In light of the known metabolic actions of catecholamines 
and the plasticity of adrenoceptors in liver, and in the pursuit o f the above outlined 
hypothesis, we sought to characterize the adrenoceptor population in lactating and 
non-lactating rat and sheep liver and to measure a range of catecholamine-induced 
post-receptor events in isolated hepatocytes, as described in section 1.5 AIMS OF 
THE STUDY.
1.4 ADRENERGIC MECHANISMS
1.4.1 Adrenoceptors
1.4.1.1 Receptor Theory
The original concept of receptor sites with which drugs reacted to produce their 
effects was introduced independently by Langley (1906) and Ehrlich (1913). Ehrlich 
was responsible for a more general concept of receptors based upon his work with 
tissue stains, immunity, and chemotherapy, in which he emphasises the essential
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binding of drugs to "receptors" to produce a cellular response. Such an emphasis is 
summed up in the most frequently quoted of his words (1913):
"If the law is true in chemistry that corpora non agunt nisi liquida, then for 
chemotherapy the principle is true that corpora non agunt nisi fixata" [substances 
do not act unless bound].
It is generally accepted that a receptor is a form of transducer that is activated by 
interacting with an agonist, which produces a conformational change in the receptor 
protein so modulating part of a cellular mechanism and eliciting a characteristic 
biological response. Schematically, this may be represented as:
affini ty e f f icacy
D t  R D R    DR* —  EFFECT
where: D: free drug
R: free receptor
DR: drug-receptor complex
DR*: drug-receptor complex with receptor in activated form
The affinity of D for R will influence the formation of DR and DR* equally, whereas 
the capacity of a drug to initiate a response once it occupies receptor sites, which is 
termed efficacy by Stephenson (1956) or intrinsic activity (Ariens 1954), will 
influence the drug receptor complex of the form DR*. Thus, response depends on 
both affinity and efficacy.
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Receptors bind their ligands with remarkable selectivity and with high affinity, 
permitting a given physiological response to be elicited with great specificity in the 
target tissue. The coupling of agonist-receptor interactions to responses may involve 
one of many mechanisms, including a coupling to ion channels; activation of a 
second messenger cascade and an intrinsic enzyme activity (eg: tyrosine kinase) of 
the receptor macromolecule.
1.4.1.2 Classification
Located in the membrane at the cell surface, adrenergic receptors provide the initial 
transduction mechanism for the hormonal and neural actions o f the catecholamines 
adrenaline and noradrenaline.
Adrenoceptors were first classified as «  or 13 by virtue o f the relative potency of a 
number of adrenergic agonists in eliciting physiological responses via such receptors 
(Alquist, 1948). The «-adrenoceptors were defined as those which had the potency 
order of: adrenaline >  noradrenaline >  isoprenaline and such responses included 
vasoconstriction, excitation of the uterus, contraction of the nictitating membrane, 
dilation of the pupil and inhibition of the gut. In contrast, at 13-adrenoceptors the 
order of potency was isoprenaline >  adrenaline >  noradrenaline and responses 
included vasodilation, inhibition of the uterus and myocardial stimulation.
However, not long thereafter, the 13-adrenergic receptors were subclassified into 13j 
and 132 subtypes (Lands et al., 1967). The two subtypes were defined by their relative 
affinities for adrenaline and noradrenaline. They found that the B-adrenoceptors
43
(primarily responsible for increases in heart rate and contractility) displayed 
approximately equivalent affinities for the two agonists, whereas the Bg-adrenoceptors 
(primarily responsible for the relaxation o f smooth muscle) had a considerably greater 
affinity for adrenaline than for noradrenaline. From this work, the notion was 
derived that only one subtype (B% or B2) was present in any organ. However, this 
hypothesis was dismissed in 1972, when Carlsson and colleagues provided 
pharmacological evidence that both B-adrenoceptor subtypes were present and 
functional in cat heart (Carlsson et al., 1972). Further work has reinforced this 
hypothesis and evidence shows inter-species variability, with regards to B- 
adrenoceptor heterogeneity and homogeneity within tissues.
Since the classification of B-adrenoceptors into B^  and B2 subtypes, additional B- 
adrenoceptors have been implicated in the control of various metabolic processes by 
catecholamines (Wilson et al., 1984; Bojanic et al., 1985) and have given rise to a 
proposed atypical B-adrenoceptor. Recently, a human gene has been isolated that 
encodes a third B-adrenoceptor which has been described as a Bg-subtype (Emorine 
et al., 1989). As yet, it is unclear as to whether this is the atypical receptor, or one 
of a class o f atypical receptors.
The alpha-adrenoceptor class may also be further divided, and initially this was 
thought of as being either pre-synaptic («2-subtype) or post-synaptic («-subtype) 
(Langer, 1974). However, « -  and « 2-adrenoceptors became primarily defined in 
terms of the development of selective antagonists for these receptors: «-adrenergic 
responses being blocked by prazosin and «2-adrenergic responses by yohimbine
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(Starke, 1981). More recently, evidence of further subdivisions of «-adrenoceptors 
subtypes has been shown. Evidence o f « 2-adrenoceptor heterogeneity was proposed 
(Bylund, 1985) and has now been conclusively shown by molecular cloning and 
expression studies (Regan et al., 1988) and along similar lines, «-adrenergic receptor 
heterogeneity has also been proposed (Morrow and Creese, 1986; Johnson and 
Minneman, 1987). To date, the proposed classification o f «-adrenoceptor subtypes 
is as follows: «i^, «^b (McGrath and Wilson, 1988) and « 2a, « 2b> « 2c (Bylund, 1988).
1.4.1.3 Transduction Mechanisms
The effects of catecholamines are mediated via binding to membrane bound 
adrenoceptors and the subsequent generation of an intracellular second messenger. 
Indeed, functionally, receptors can be classified according to the types of signal 
transduction pathways they stimulate. These classes include 1) multi-subunit 
receptors that are ion channels, such as the nicotinic acetylcholine receptor (Karlin 
et al., 1986); 2) growth factor receptors that have intrinsic tyrosine kinase activity, 
such as the receptors for insulin and epidermal growth factor (Hunter and Cooper, 
1985); 3) receptors that transport ligands such as low-density lipoproteins or 
transferrin across the cell membrane (Anderson et al., 1982); and 4) receptors that 
couple to effector proteins through guanine nucleotide binding regulatory proteins (G- 
proteins) (Dolphin, 1987).
The largest class of receptors are those that mediate their actions by coupling to G- 
proteins. The signal transduction pathway common to these receptors is initiated by
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the binding of agonist ligands to specific receptors in the plasma membrane of the 
cell, which stimulates the interaction o f the receptors with specific G-proteins 
(Gilman, 1987). There are several known G-proteins (Graziano and Gilman, 1987) 
all of which display a common, heterotrimeric structure, with the subunits designated 
« , B and y  and are associated with the plasma membrane. When in an inactive state 
in the cell membrane, the G-protein has GDP bound to the «-subunit. However, 
interaction of the G-protein with an appropriate agonist-receptor complex promotes 
the dissociation of GDP and allows the binding of GTP. This association between 
GTP and the «-subunit is believed to promote dissociation from a complex o f B and 
7 -subunits and then becomes the activated form of the G-protein, which can then 
activate the effector protein modulating the intracellular levels of specific second 
messengers. Effector systems identified as being coupled to G-proteins include 
adenylate cyclase (EC 4.6.1.1) and guanylate cyclase (EC 4.6.1.2), phospholipases 
C (EC 3.1.4.3) and A2 (EC 3.1.1.4), phosphodiesterases, and Ca^ "^  and channels.
Despite the wide variety of functions mediated by G-protein linked receptors, 
considerable structural homology exists between the primary structures of the 
receptors in this class. The members of this receptor family include the visual opsins, 
the «- and B-subtype adrenoceptors, the M -M 4 muscarinic cholinergic receptors, the 
5H T-la and 5H T-lc serotonin receptors, the substance K receptor, chemoattractant 
receptors, and the mas gene product, which has been shown to correspond to an 
angiotensin receptor. The distinctive feature of these receptors as determined by 
hydropathy analysis of their primary structural sequences is the existence o f seven 
hydrophobic stretches of 20-25 amino acids each, which are surrounded by eight
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hydrophilic regions o f variable length. From this, a model has been proposed such 
that each of the seven hydrophobic domains of the receptor forms a transmembrane 
«-helix, with the intervening hydrophilic loops exposed (alternately) intracellularly 
and extracellularly; the amino-terminal region is exposed on the extracellular face of 
the membrane and the carboxyl terminal region on the cytoplasmic face. However, 
although the G-protein linked receptors share considerable structural similarities, they 
do not all share the same second messenger signal pathway. The two major signal 
pathways known include 1) the adenylate cyclase cascade which employs the second 
messenger cAMP and 2) the inositol phosphate pathway which employs a combination 
of second messengers that includes calcium ions, inositol trisphosphate (IP3) and 
diacylglycerol (DAG). These pathways have been excellently reviewed by Berridge, 
(1985).
Activation of B-adrenoceptors results in the stimulation of adenylate cyclase and 
formation of cAMP (Levitzki, 1987). This sequence o f events was first elucidated 
by Gilman and colleagues (Gilman, 1984), who have suggested that upon hormone 
activation many G-proteins are activated by collision coupling and as a consequence 
the G-protein dissociates such that its «-subunit alone activates the catalytic subunit 
of adenylate cyclase and so instigates the formation of cAMP. Once the GTP is 
hydrolysed the «-subunit reassociates with the By complex of the protein and is then 
ready for another cycle of activation. Additionally, it is believed that two types of 
G-protein appear to be involved in the regulation of hormone-sensitive adenylate 
cyclase, one of them stimulatory (GJ and the other inhibitory (GJ (Dolphin, 1987). 
The B-adrenoceptors have a stimulatory effect upon adenylate cyclase and are believed
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to mediate their actions through the G* component (Levitzki, 1987). This signal 
transduction pathway forms an amplifying cascade, since one hormone bound receptor 
is able to activate numerous G, components so instigating the activation of the enzyme 
adenylate cyclase, with the resultant increase in the formation of cAMP. This then 
enters the final step in the cascade via a cAMP-dependent protein kinase (A-Kinase), 
which is responsible for phosphorylating particular proteins involved in a variety of 
actions, ranging from opening ion channels to activating key cellular enzymes.
The transduction mechanisms involved with «-adrenoceptor activation are less well 
characterized in contrast to the work involving B-adrenoceptors. For the « 2- 
adrenoceptor subtypes, the transduction mechanism is believed to be the inhibition of 
adenylate cyclase and hence reduction of intracellular cAMP levels (for review see 
Exton, 1981). In this instance, the inhibitory G-protein, G;, appears to be involved 
in the transduction process, although the hormonal inhibition o f adenylate cyclase is 
not as well understood as hormonal stimulation, and it is possible that the G / «  
subunit does not directly complex and inhibit the catalytic subunit of adenylate cyclase 
and may possibly involve the G /B y  components scavenging more readily the 
stimulatory G - «  subunits, making them less available to the catalyst (Levitzki, 
1987). In contrast, the «-adrenoceptor molecular mechanism appears to involve a 
cAMP-independent pathway, with an increase in cytosolic Ca^ "^  ions appearing to be 
the most significant event triggered by receptor activation (Keppens et al., 1977; 
Assimacopoulos-Jeannet et al., 1977; Blackmore et al., 1978). An increase in the 
hydrolysis of phosphatidylinositol-4,5-bisphosphate is also seen when « -  
adrenoceptors are activated, and this has been proposed to be involved with the
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generation o f the calcium signal (Berridge, 1984; Berridge, 1985). The hormonal 
activation o f inositol phosphate hydrolysis proceeds via a G-protein linked mechanism 
to activate the enzyme responsible, which is a phosphodiesterase, commonly referred 
to as phospholipase C. The action of this enzyme upon phosphatidylinositol-4,5- 
bisphosphate produces the two major signalling products, inositol-1,4,5-trisphosphate 
and diacylglycerol. The former is believed to be responsible for the release of Ca^ "^  
from intracellular stores and for the maintenance of elevated Ca^^ levels during a 
given response (Berridge and Irvine, 1984), whereas diacylglycerol has been proposed 
to activate the membrane bound protein kinase C (Nishizuka, 1984). From this stage 
onwards, the actions of these two second messengers serve to affect a diverse number 
o f cellular events.
1.4.1.4 Receptor Regulation
Observations over the years have shown that cells, tissues and animals can exhibit 
refractoriness (tachyphylaxis) to the effects of administered neurotransmitters and 
hormones, indicating that variation in the response of a cell to the same concentration 
of an effector is possible. Similarly, states of "super responsiveness" can be induced 
in tissues of animals after surgical or pharmacological manipulation o f neural 
pathways or hormone secreting organs. From such observations, it appears that the 
capacity of cells to respond to signals is a dynamic rather than a static process, and 
such processes must be adequately regulated.
Regulation of adrenoceptor response both in vivo and in vitro may be brought about
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by an excess or deficiency of hormones. Catecholamines themselves may produce 
a reduction in adrenoceptor responsiveness and prolonged periods of reduced 
noradrenergic nerve activity result in increased adrenoceptor responsiveness (Perkins, 
1981). The self regulation of adrenoceptor responsiveness by adrenergic agonists and 
antagonists is described as homologous, whereas other factors that regulate adrenergic 
receptors are known as heterologous. The so called homologous desensitization of 
adrenoceptors may involve a reduction of receptor number ("down-regulation"), or 
a decrease in the association of receptor occupation and the internal transduction 
mechanisms ("uncoupling"), and has been shown with all adrenoceptor subtypes, 
although such regulation appears to be tissue specific (Insel, 1984). The B-adrenergic 
receptor adenylate cyclase system is one of the most widely studied models of 
desensitization and several biochemical mechanisms have been shown to contribute 
and include the following: 1) a rapid functional uncoupling of the receptors from the 
G-protein, G,, which can be triggered by the phosphorylation of the receptors by 
either protein kinase A or by the B-adrenergic receptor protein kinase (Benovic et al. , 
1988; Roth et al., 1991); 2) rapid sequestration of the receptors away from the cell 
surface into an as yet ill-defined membrane compartment, where they are physically 
separated from G ;^ and 3) a slow reduction of the total cellular receptor complement 
(ie: down-regulation), which is believed to involve multiple mechanisms which may 
include phosphorylation and changes in receptor gene expression (Collins et al., 
1991). However, such mechanisms are believed not to be confined to the B- 
adrenoceptors and recently studies have been made of the homologous desensitization 
of the adrenoceptor « -(Izzo  et al., 1990) and « 2"(Convents et al., 1989) subtypes.
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The heterologous regulation of adrenoceptors have also been documented and have 
been shown to be affected by the thyroid status of the animal, although a degree of 
tissue dependence o f the effects o f thyroid hormones seems to exist (Hoffman and 
Lefkowitz, 1980; O ’Donnell and Wanstall 1987). Additionally, in certain tissues and 
cell culture lines, glucocorticoids enhance catecholamine action by increasing the 
number (up-regulation) of B-adrenoceptors (Scarpace et ah, 1988; Collins et ah, 
1991). As with homologous regulation, the precise mechanisms involved have as yet 
still to be clarified, although the proposed post-translational modifications and the 
modulations of receptor gene expression demonstrate the complexities o f such 
mechanisms.
1.4.2 Techniques of Receptor Characterization
1.4.2.1 Pharmacological
In early work concerned with the characterization of receptors, information was 
obtained by the use o f an indirect approach measuring drug response reactions on 
various isolated tissues. Such work is important in the initial understanding of the 
nature of receptors, by measuring biological responses to drugs and establishing 
structure activity relationships (for review see Albert, 1971). One of the most 
informative ways of finding out how specific a chemical structure is needed for a 
biological action, is by preparing a homologous series of compounds and in most 
cases there are marked differences in the type of pharmacological activity between 
members of the homologous series and a rank order of potency may be constructed. 
Historically, it was this approach which allowed the initial classification of
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adrenoceptors (Ahlquist 1948) into the «  and B subtypes.
1.4.2.2 Isolation and Purification
The most direct way to classify a receptor is to isolate the receptor protein in a pure 
form. A number of cell surface hormone receptors have been isolated and 
information of their primary, secondary and tertiary structure obtained. Both a- and 
B-adrenoceptors have been isolated, by first solubilising them from the plasma 
membrane using detergents such as digitonin (Hubbard 1954), Lubrol (Haga et al., 
1977) and Triton X-100 (Fraser and Venter 1982) and then purifying the isolated 
receptors. Two approaches were intiailly used and included purification of solubilised 
receptors by affinity chromatography (Kunos, 1984; Stiles et al., 1984; Graham et 
al., 1982) and covalent labelling of the receptor followed by SDS-polyacrylamide gel 
electrophoresis (SDS-PAGE) (Kunos et al., 1983; Guellaen et al., 1982; Leeb- 
Lundberg et al., 1984).
The technique of affinity labelling has been widely used in the purification, 
identification and characterization of the catalysis mechanism of many enzymes and 
its use for characterizing receptors is a relatively new approach (Stiles et al., 1984). 
A variety o f both affinity and photoaffinity probes for adrenergic receptors have been 
described in recent years (Lefkowitz et al., 1983; Leeb-Lundberg et al., 1984) and 
all are analogues which possess a high affinity and specificity for the site to be 
labelled. All can be easily labelled to high specific radioactivity and possess a
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reactive group that can be readily covalently incorporated into the binding site of 
interest. The procedure fundamentally involves incubation of the affinity or 
photoaffinity probe with a membrane preparation, followed by purification by an 
affinity chromatography stage or an SDS-PAGE procedure and autoradiograms 
developed from resulting gels. One of the most important validations of such 
experiments is the inclusion of a variety o f ligands that specifically occupy the 
receptor in question, to show that the incorporation of the affinity probe may be 
specifically blocked.
All of the above mentioned techniques indicate that the purified polypeptides do in 
fact contain the ligand binding site of the specific receptor in question. However, the 
ultimate proof that these purified polypeptides also contain the functional coupling 
domains of the receptor, require the reconstitution and expression of such receptors 
in another system different from that of isolation, and to show that such receptors 
confer a functional responsiveness in such a system.
1.4.2.3 Receptor Cloning
The advent of molecular biology has increased greatly our understanding of receptors, 
their subtypes and mechanisms of action and the first to be studied in such a way was 
the nicotinic acetylcholine receptor. It was the first receptor to be isolated and 
physically characterized (Changeux et al., 1984), to be functionally reincorporated 
into membrane (Barnard et al., 1981) and to be cloned and sequenced (Changeux et 
al., 1984; Noda et al., 1982; Noda et al., 1983).
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The genes encoding the « -  (Cotecchia et al., 1988), « 2- (Kobilka et al., 1987), B - 
(Yarden et al., 1986) and B2- (Dixon et al., 1986) adrenergic receptors have been 
isolated. These receptors are part of a large family that includes other G-protein- 
coupled receptors for many hormones, drugs and neurotransmitters, and cloning has 
revealed that all are composed of a single polypeptide chain with seven 
transmembrane helical domains spanning the lipid bilayer. Of the genes characterized 
in this family, several probes from such genes have been used to identify additional 
receptor subtypes, such as subdivisions of the « 2-^drenoceptor (Kobilka et ah, 1987; 
Bylund 1988) and the emergence of the Bg-adrenergic receptor (Emorine et al., 1989; 
Nahorski et al., 1990).
Consequently, the convergence of evidence from both pharmacological and molecular 
cloning techniques provides a more definitive characterization o f receptors and in 
conjunction with radioligand binding studies, provides a fuller picture of receptor 
structure, affinities, classification and distribution.
1.4.2.4 Radioligand Binding Studies
Radioligand binding studies have been successfully applied to the study of a wide 
range of hormone and neurotransmitter receptors (Cattabeni and Nicosia, 1984). 
Such techniques have allowed the investigation o f the properties and distribution of 
various receptors, as well as the effects of drugs and disease on these receptors.
Receptors are assumed to be divisible into three functional components: a transmitter
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binding site which selectively recognizes the transmitter; a transducer system which 
is activated by agonist binding and transmits such binding into a biochemical signal, 
such as a change in membrane ion permeability or synthesis o f a variety of second 
messengers, and finally the physiological response. Radioligand binding studies are 
concerned only with the recognition site of receptors and care must be taken when 
using a ligand that stereoselectively binds to a site, as it does not necessarily 
constitute a functional receptor. This is due to the existence of acceptor sites which 
unlike receptors are composed solely of a binding site and are without a signal 
transmission component into the interior of the cell through the binding site. Such 
acceptor sites may be involved with uptake and transport processes and may constitute 
a non-specific binding component. Hence, in order to improve the likelihood that the 
binding assay is selectively measuring the recognition site portion of a receptor, a 
number of experimental principles should be met and a set of criteria established to 
be valid under the conditions of the assay. The most important of these is considered 
to be the demonstration that the specificity of binding parallels the physiological or 
the pharmacological response.
Historically, one of the first ligand binding studies was performed with cholinergic 
receptors of the smooth muscle of the guinea pig ileum (Paton and Rang, 1965) and 
with hormone receptors such as those for insulin (Cuatrecasas, 1971). In principle, 
the technique involves incubating membranes or cells containing the receptor(s) of 
interest, with a radioactively labelled compound (the radioligand) with known affinity 
for the receptor. The radioligand not bound to the membrane is then removed, 
usually by a process of rapid filtration under vacuum or by centrifugation and in both
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cases extensively washed. Measurement of the radioactivity associated with the 
membrane then allows the determination of the size of the receptor population. Since 
the advent of highly labelled, stable ligands and the simplicity o f the technique, the 
radioligand binding assay has become a widely used tool in pharmacological research 
and allows detailed study of receptor number, kinetic characteristics and 
pharmacological properties. However, while the assay is relatively simple to 
perform, the interpretation of results remains more complicated and requires an 
understanding of the basic theoretical and methodological principles involved. These 
principles have been excellently reviewed by Cattabeni and Nicosia (1984) and 
Laduron (1984).
ASSAY TECHNIQUES AND ANALYSIS
Radioligand binding assays may be considered to be of two basic types: equilibrium 
(protein dilution profile, saturation assay and inhibition profile) or kinetic (association 
and dissociation time course).
Protein dilution profile
This is usually the first type of assay performed with any radioligand, in order to 
determine a working concentration of protein to be used in subsequent assays. 
Varying amounts of membrane are incubated with a fixed concentration o f radioligand 
in two parallel assays, one performed in the presence and the other in the absence of 
a large quantity of unlabelled ligand, to give the non-specific and total binding 
components respectively, at equilibrium for each protein concentration. From such
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studies, any protein concentration within the range at which the concentration of 
ligand specifically bound is linearly related to the protein concentration is considered 
to be suitable.
Saturation binding
This assay involves measuring radioligand binding as a function o f increasing 
concentrations o f labelled ligand in the presence of a fixed concentration of protein 
when the reaction has reached equilibrium. The non-specific binding component 
represents the amount of binding in the presence of a fixed saturating concentration 
o f unlabelled ligand, and total binding as the amount of radioligand adhering to the 
membrane in the absence of unlabelled ligand. From these two components the 
binding data can be corrected to yield the specific binding by subtracting the fraction 
of radioactivity nonspecifically bound from the total binding. The basic principle of 
this assay is that the radioligand will bind in a saturable manner to the receptor of 
interest and that attachment of the radioligand to non-receptor components is less 
saturable, and therefore the unlabelled ligand will selectively inhibit radioligand 
binding to the receptor and will not influence binding to non-receptor components.
Indeed, saturability is one of the basic criteria which must be met for all radioligand 
binding studies. Saturation is indicated when the amount of specific binding becomes 
constant as a function of radioligand concentration. In contrast, the amount of 
radioactivity bound in the presence of unlabelled ligand normally increases in a linear 
fashion, since the number of non-specific binding sites is virtually infinite. Several 
other assumptions must be met for an accurate analysis of equilibrium. The labelled
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and unlabelled ligand must behave identically and the tracer compound must be 
sufficiently pure such that maximum bindability is achieved. Also, it is essential that 
the bound and free ligand can be separated without perturbing the equilibrium and 
that the ligand is univalent, such that one ligand molecule reacts with one binding site 
and that ligand molecules bind independently, excluding any ligand-ligand 
interactions. In conjunction with this, binding sites must also be independent and no 
site-site (cooperative) interactions must exist between binding sites.
The final assumption is that the basic ligand binding model involves the reversible 
interaction of the ligand (L) with a single class of receptor (R). Hence the reaction 
may be described as a simple, bimolecular, reversible second ^  first-order reaction 
and the condition of equilibrium deduced from the law of mass action is:
[R] + [L] ^  [RL]
K
where [RL] is the concentration of bound ligand; is the association-rate constant 
and kj is the dissociation-rate constant.
Thus:
k, MM
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where is the equilibrium association constant (units M‘^ ), and is the equilibrium 
dissociation constant of the ligand for the receptor (Units M).
Assuming that there are a finite number of receptors, termed B ^ ,  then:
and the amount of binding, B =  RL, then:
[L]
B =
If  a series o f determinations of B are made with a constant amount o f homogenate and 
differing [L], then a saturation isotherm plotting [L] against B is achieved and has the 
characteristic shape o f a rectangular hyperbola (see Figure 1:3a). B^^x can be 
estimated as the plateau value of B as [L] approaches infinity and IQ as that value of 
[L] producing half maximal binding. However, the most common analysis of IQ and 
B ^  are made by means of the Scatchard plot (Scatchard, 1949) which is based upon 
a simple manipulation of the saturation equation:
such that a plot of B/[L] vs. B gives a straight line if the ligand binds to a single 
population of receptors (see Figure 1:3b). The intercept on the ordinate is B^ a^x 
the Kj value is the reciprocal of the slope. It is clear from the literature that linear
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Figure 1:3 Graphical representation of binding data.
(A) Representative curves for a radioligand 
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Scatchard plots are taken to indicate a single binding site and Scatchard pointed out 
in his original paper, that "curvature may indicate different intrinsic constants or 
deviations from independent probabilities" (Scatchard, 1949). However, it is 
recognized now, that it is possible for such a linear plot to conceal two sites for 
which the ligand may have equal affinity and conversely, a non-linear plot may have 
several interpretations. The most common interpretation o f an upward curved 
Scatchard plot is the existence of two or more dissimilar binding sites, but equally 
this could be obtained when there is negative cooperativity in binding, or in cases 
when there is non-specific binding in addition to the specific binding component.
As mentioned previously, there are some pitfalls in binding studies and most of the 
problems centre around the question of how to accurately distinguish specific binding 
related to receptor sites, from non-specific ligand binding. In the same way, there 
are pitfalls in the analysis of Scatchard plots. There appear to be three main problem 
areas: firstly the subjectivity of drawing a straight line through a scatter of data 
points; secondly the tendency of fitting a straight line to points that display a definite 
curvilinear relationship and thirdly the need to extrapolate the curve outside the data 
range to estimate parameters such as As far as the first problem is concerned, 
linear regression is applied to the Scatchard plot but this in itself is not sufficient as 
both variables are measured quantities. Computerised, nonlinear, least squares 
regression analysis of untransformed data is an alternative approach and such 
computer programs include SCTFIT (Hancock et al., 1979) and LIGAND (Munson 
et al., 1980), which define dependent and independent variables and often designates 
the total ligand concentration as the independent variable. Additionally, such
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programs are able to analyse data to fit a one site or multiple site model so resolving 
the Scatchard plot into its components if necessary. Other advantages include the 
ability to pool results from more than one binding assay and also to give the 
correlation between the parameters of and for different experiments. These 
principles have been excellently reviewed by Biirgisser (1984) and Munson (1984).
Inhibition studies
This approach allows the characterization of the radioligand binding site in terms of 
its interaction with a range of unlabelled compounds. Studies involve incubating a 
fixed concentration of membrane protein with a single concentration of radioligand 
and a range of concentrations of displacer. The competitive displacement of the 
specific binding of a radioligand from its binding site by the displacer, which also 
binds to the site of interest, can be analysed by means of the Hill Plot (Hill, 1910).
The Hill equation resembles the hyperbolic equation relating to the saturation of 
binding sites on a protein, but includes a term which permits the mathematical 
description of the binding of a ligand to multiple sites in a co-operative manner. The 
Hill plot can be utilized when analysing saturation binding data, although Scatchard 
analysis is more commonly used, and for analysing inhibitor studies.
The Hill equation can be derived by assuming that a receptor, R, has n binding sites 
for a ligand, L, and that the binding of L is co-operative, such that as soon as one 
site on R is occupied, the remaining sites are immediately occupied. Taking this
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assumption to be true then, it is only necessary to consider the equilibrium between 
R and RI^.
Thus:
[R] + [L] ^  [RLJ
and
(1)
where =  the dissociation constant for binding of L to R.
The amount of binding (B) o f L as a fraction of total possible binding ( B ^  therefore 
is:
B = ____________________________________ (2)
m  +  RL.
substituting from (1):
B = — (3) 
K,  + W"
The value of n is known as the Hill coefficient and can be derived from measurement 
of B at various concentrations of L. Equation (3) can be arranged to give:
B _ [LY
and taking logs to produce a linear transformation:
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Blog  -----   = nlog{L\-\og
Thus, a plot of log vs. log [L] should be a straight line with slope n and
I when there is no co-operativity, n equals 1 .0 , and the 
intercept on the abscissa is a measure of the Kj. However, Hill plots do deviate from 
linearity at the extremes and consequently only the central portion of the plot should 
be used to determine the values.
In summary, the value of n is commonly taken as a measure of the cooperativity of 
the binding, and ligands which bind only to one site without any cooperativity have 
a Hill coefficient of unity. An n value greater than unity may implicate the presence 
of two sites which interact in a positive manner and a value less than unity may 
suggest multiple sites which may be interacting in a negative manner. However, 
when analysing equilibrium saturation binding by means of a Hill plot an estimate of 
Bmax is required, most commonly obtained by Scatchard analysis, meaning that the 
same experimental data is used in both plots. For this reason, it is necessary to 
confirm a simple second order reaction by studying the kinetics of association and 
dissociation and determining the kinetically.
In inhibition studies, binding sites are labelled with radioligand and displaced by 
increasing concentrations of inhibitor, I. For such studies the Hill equation is altered 
in such a way as to include the term IC50, which for a competitive interaction is the 
concentration of displacer, (I), which inhibits specific binding by 50% at equilibrium.
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Thus:
log a ,
B-Bj
= -lo g  [/] + 72log IC50
where is the amount of radioligand specifically bound in the presence of inhibitor 
and B is the amount of radioligand specifically bound in the absence of competitive 
inhibitor. Again this plot is linear and has a slope of -n and an intercept on the 
abscissa equal to the IC50. Hence, IC50 values can be estimated from Hill plots and 
also directly from inhibition curves.
From the IC50 value the equilibrium dissociation constant of the displacing agent (KJ 
may be calculated using the Cheng and Prusoff equation (Cheng and Prusoff, 1973):
where M is the concentration of radioligand (units M) and Kj is the equilibrium 
dissociation constant of the radioligand (units M), usually determined by Scatchard 
analysis. In relation to their Kj values, the relative potencies of displacing compounds 
for a radioligand may be established and consequently the receptor type and subtype 
being labelled may be inferred.
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Association time course
This type of assay is essential to discover the time taken to reach equilibrium and 
involves incubating fixed concentrations of radioligand and protein for various time 
periods, total and non-specific binding are determined and specific binding calculated 
at each time point.
The association of a radioligand (L) and with its receptor (R) is a second order 
reaction:
where Kj and K.j are the kinetic constants for association and dissociation (rate 
constants) respectively and the equilibrium and kinetic constants are related such that:
The kinetic association constant, Kj, can be determined from such a time course of 
association by using an integrated version of the second order rate equation. 
However, a simplification of this is acceptable if less than 10% of the ligand present 
is specifically bound at equilibrium, as this means that most of the ligand remains free 
and hence the equation assumes a pseudo first order reaction and is described by the 
rate equation:
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In B.
B -B.
— K^.t.
L.B^
B.
where: B.
Bt
B„
Kl
concentration of ligand specifically bound at equilibrium 
(moles per mg protein)
concentration of ligand specifically bound at time t
(moles per mg protein)
concentration of radioligand at zero time (M)
receptor concentration (moles of ligand specifically
bound per mg protein)
association rate constant (M'* s' )^
From this equation, a linear plot is obtained if
L.B_
is plotted against
However,
B
time (in seconds) and the slope is equal to ^
determination of Ki using either second order or pseudo first order plots has the 
disadvantage that an independent determination of is required, and this is usually 
achieved by Scatchard analysis of a saturation isotherm performed on the same tissue 
sample. Such plots will be linear if the binding reaction is a simple second order 
process and biphasic or curvilinear plots may imply a more complex reaction such as 
heterogeneity of binding sites or ligand, cooperativity, or a ligand induced 
conformational change in the receptor.
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Dissociation time course
The determination of the dissociation constant, K.j, is less complicated than 
determination of Kj, since the dissociation of a radioligand is a first order reaction 
and K.i is a first order rate constant. Using this approach involves adding excess 
competing ligand to a fixed concentration o f radioligand and membrane protein at 
equilibrium. Measurements are then made of total and non-specific binding at zero 
time and varying times after addition of the competitive compound.
The first order integrated rate equation of dissociation can be described as:
In A
B.
where: =  concentration of ligand specifically bound at equilibrium (moles
per mg protein)
B^  =  concentration of ligand specifically bound at time t (moles per mg
protein)
K 1 =  dissociation rate constant (s'^)
Changing natural log to log,o gives:
Log
B.
K_,.t
2.303
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If the experiment is carried out correctly and for a sufficiently long time, all specific 
binding will eventually be displaced, indicating that the reaction is fully reversible. 
If the reaction is fully reversible, the first order plot of log [B /B J vs. time (in 
seconds) will be linear and the slope will be equal to K /2 .3 0 3 . Again, non-linear 
plots imply more complicated reactions.
The association and dissociation rate constants are informative in themselves 
regarding the kinetics of receptor-ligand interactions. In addition, once these rate 
constants are known, the association constant (KJ and dissociation constant (K^) of 
the radioligand may be calculated as follows:
and
RADIOLIGANDS FO R ADRENOCEPTORS
Since ligand binding may be influenced by several criteria including the way the 
tissue is prepared, the incubation conditions and the stability of the radioligand, it is 
clear that the choice of ligand is an important consideration. There are four basic 
considerations that affect the selection of a radioligand. The first is that the substance 
must be selective for the receptor and secondly, it must have high affinity for the 
receptor, and for this reason antagonists are generally used in preference to agonists. 
Thirdly, the ligand must be chemically stable such that it is resistant to change under 
the assay conditions and finally a high specific activity is required, since only small 
quantities of radioligand are used in the assay, and for this reason tritiated and
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iodinated compounds are widely used.
Radioligand binding assays of adrenoceptors have been carried out for some years 
now (for review see Hoffman & Lewfkowitz, 1980 and Stiles et al., 1984). The 
variety of ligands available has increased enormously, with many of the more recently 
developed compounds having the advantages of good specificity for the receptor, 
and/or high specific activity. One difference between a- and 13-adrenoceptors is that 
whilst radioligands are available with selectivity for each of the main a-adrenoceptor 
subtypes, only non-subtype selective 13-adrenoceptor radioligands are available.
Tritiated forms of adrenaline and noradrenaline (UTrichard and Snyder, 1977; El- 
Refai et al., 1979) have been used for radioligand binding assays. However, 
antagonist compounds are generally preferred as radioligands as they often have a 
higher affinity for the receptor and commonly physiological ligands for adrenoceptors 
have a poor subtype selectivity. Additionally, it is found that antagonists, unlike 
agonists, do not show an alteration in their affinity for adrenoceptors which is 
dependent upon guanine nucleotides. The possible involvement of nucleotides in 
affinity changes was first recognised by Rodbell et al. (1971), by a reduction in the 
affinity of agonists for 13-adrenoceptors resulting from the binding of guanine 
nucleotides to the receptor. It is now well documented, with reports of similar 
regulation of agonists binding to hepatic aj-adrenoceptors (Goodhardt et al., 1982) 
and hepatic ^ 2-adrenoceptors (Hoffman et al. 1980) by guanine nucleotides. In 
contrast, nucleotides have been widely shown to have no effect on the affinity of 
antagonists for adrenoceptors (for review see Lefkowitz et al., 1983). Finally,
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physiological ligands for adrenoceptors also have the disadvantage that it is necessary 
to include a monoamine oxidase inhibitor (eg: pargyline) in the assay to reduce non­
specific catechol interactions.
pHjDihydroergocryptine is the most commonly used non-subtype selective a- 
adrenoceptor radioligand (Williams & Lefkowitz, 1976; Guellaen et al., 1978). 
Additionally, for characterizing «i-adrenoceptors, the arselective antagonist [^H] 
prazosin is generally used (Greengrass and Bremner, 1979; Hoffman et al., 1981; 
Goodhardt et al., 1984), although recently a novel antagonist compound [^H] 
bunazosin has also been employed (Kobatake et al., 1991). For selective labelling 
of « 2-adrenoceptors the following are the preferred radioligands, pH]yohimbine 
(Hoffman et al., 1981; Bobik, 1982; Petrash and Bylund, 1986) and its 
diastereoisomer pHjrauwolscine (McMillian et al., 1983; Kobatake et al., 1991) and 
finally pH] RX781094 (Howlett et al., 1982; Doxey et al., 1983; Pimoule et al., 
1983). All of these ligands are antagonist compounds and RX781094 is a preferential 
o!2-adrenoceptor antagonist, with a higher o!2/ai-selectivity ratio than yohimbine or 
rauwolscine (Dettmar et al., 1981; Doxey et al., 1983) and hence a more suitable 
radioligand.
The first reports of direct radioligand binding methods for studying the beta- 
adrenergic receptors were made in 1974; ligands used were (-)-pH]dihydroalprenolol 
(Lefkowitz er û /., 1974), (±)-p^^I]iodohydroxybenzylpindolol (Aurbach e ta l.,  1974) 
and (±)-pH]propranolol (Atlas et al., 1974). Since these initial studies with 13- 
adrenergic antagonists, the agonists (±)-pH]hydroxybenzylisoproterenol (Lefkowitz
71
and Williams, 1977) and (±)-pH]isoproterenol (Malchoff and Marinetti, 1976) have 
also been used. More recently other ligands have become available for the direct 
assay of 8 -adrenoceptors and include the following radiolabelled antagonist 
compounds: (-)-[^^^I]iodocyanopindolol (Engel et al., 1981); (-)-p^^I]iodopindolol 
(Barovsky and Brooker, 1980); and pH] CGP-12177 (Staehelin et al., 1983).
The advantage of these newer radioligands is that some of the discrepancies noted 
with earlier 8-adrenoceptor antagonist ligands, are believed to be due to the high lipid 
solubility of the compounds (Dax and Partilla, 1982), whereas the more recent ligands 
are more hydrophillic. In particular, the compound pH] CGP-12177 appears to be 
an ideal label when performing binding assays in intact cells, as its hydrophilicity is 
believed to contribute to the low nonspecific binding component encountered, and to 
the fact that the ligand will bind only to external cell surface receptors, so excluding 
any internalised receptors (Studer and Ganas, 1988). In contrast to this, the iodinated 
pindolol derivatives are more sensitive than the tritiated ligands and are consequently 
the compounds of choice when the quantity of preparation is limited. However, they 
are more hydrophobic in comparison, but still achieve reasonably low amounts of 
nonspecific binding with membrane preparations.
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1.5 AIMS OF THE STUDY
1.5.1 To characterize the hepatic adrenoceptor population in lactating and non-
lactating rats.
1.5.2 To characterize the hepatic adrenoceptor population in lactating and non-
lactating sheep, for comparison with our data reported for the rat.
1.5.3 Prepare hepatocytes from lactating and control female rats and determine 
the dose/response relationships between the 8 -agonist isoprenaline and the 
following post-receptor phenomena:
(a) intracellular cAMP content
(b) A-kinase activity and activation ratio
(c) glycogen phosphorylase activity and activation ratio.
1.5.4 To draw conclusions from the above, regarding the changes in the
adrenergic sensitivity and responsiveness of liver during lactation.
CHAPTER 2
MATERIALS AND METHODS
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2.1 RADIOLIGAND BINDING EXPERIMENTS
2.1.1 Animals
Wistar albino (University of Surrey strain) rats were used and "adult" male and 
female rats weighed 200-250g whereas "young" females were o f body weight 100- 
120g. Weight-matched female and primiparous mid-lactating (10-14 days) animals 
with 8 to 10 pups were used. Rats were given food and water ad libitum and were 
fed on Animal Laboratory Diet no. 1 (rodent diet, Special Diet Services). All 
animals were maintained on a constant lighting schedule (lights on 08:00 - 2 0 :0 0 h) 
and all experiments were started between 09:00 and 10:(X)h. All animals were killed 
by cervical dislocation and tissues were immediately excised.
Sheep were Finn-Dorset Horn cross-breds, between 2 and 5 years of age. Liver 
samples were taken from primiparous ewes in their 14th week of pregnancy, between 
days 15-25 o f lactation and from non-pregnant, non-lactating females. They were fed 
on hay ad libitum, plus a cereal mix (425g/day until day 105 of pregnancy and 
thereafter until the lambs were removed at 50 days after birth) which was fed as two 
meals at approximately 07:(X)h and 16:30h. A cannula was inserted into a  jugular 
vein the day before sampling and on the day o f sampling the animal was deeply 
anaesthetized by intrajugular infusion of sodium pentobarbitone (30mg/Kg body 
weight). Subsequently, the throat was cut, the animal was bled and portions o f tissue 
removed. All experiments were started between 09:30 and 10:30h.
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2.1.2 Materials
The sources o f chemicals, drugs and radioligands are given in Appendix 1.
2.1.3 Liver Membrane Preparation
Liver membranes were prepared from freshly-excised tissue using a method based on 
that o f Witkin and Harden (1981) as modified and used previously by Evans (1986). 
Whole rat livers were used, whereas samples of sheep liver were from the ventral 
lobe.
Homogenisation medium was 145mM NaCl, 2mM MgCl2, 20mM Tris-HCl, pH 7.5. 
Storage medium was 250mM sucrose, 5mM MgCl2, 50mM Tris-HCl, pH 7.5.
All steps were carried out at 4°C.
(1) Livers were rinsed in homogenisation medium, scissor minced and 
homogenised for 10 seconds in about 10 volumes of homogenisation medium using 
a Silverson type homogeniser (Vortmix mixer/emulsifier), followed by 6  plunger- 
strokes in a  Potter homogeniser (glass vessel-teflon plunger). In the case o f the sheep 
liver sample, a 25g fresh weight portion was homogenised in 100 ml homogenisation 
medium.
(2) The homogenate was centrifuged at 2,000g for 10 minutes (MSB Coolspin for 
rat and Sorvall SS34 for sheep homogenate).
(3) The pellet was discarded and the supernatant centrifuged at 40,000g for 15 
minutes (Beckman L5-65 Ultracentrifuge for rat supernatant and Sorvall OTD Combi 
centrifuge for sheep preparation).
(4) The supernatant was discarded, the pellet resuspended in homogenisation 
medium (25ml for rat pellet and 40ml for sheep pellet) using the Potter homogeniser
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as above and centrifuged at 40,000g for 15 mins.
(5) Step 4 was repeated.
(6) The supernatant was discarded and the pellet resuspended in storage medium 
(10-15ml) using the Potter homogeniser.
(7) 1ml aliquots were taken into capped polypropylene tubes and were snap frozen 
in liquid N2 and used after storage at -60°C to -80°C.
Rat brain membranes I  were prepare^ using the same membrane preparation 
procedure as used for rat livers and freshly excised whole rat brains minus the 
cerebellum were used (Howlett et al., 1982).
The protein concentration of each membrane preparation was determined using the 
method of Lowry et al., (1951) and the above mentioned liver membrane preparation 
procedure gave a membrane yield of 5-12 mg protein/g tissue for the rat and 3-7mg 
protein/g tissue for the sheep. Similar measurements with rat cortical membranes 
gave a membrane yield o f approximately 30-45 mg protein/g tissue.
2.1.4 Radioligands used for Binding Assays 
(-)-[125j]io d OPINDOLOL (pniPIN )
The number o f B-adrenoceptors in liver membrane preparations was determined by 
saturation binding assay, using the highly selective B-antagonist [^^I]IPIN (Barovsky 
and Brooker, 1980). In all saturation binding assays 10-12 concentrations of 
[^^I]IPIN, ranging from 10-600pM were used. All incubations (150/d) were carried 
out in triplicate at 25 °C in polypropylene tubes containing incubation medium
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(145mM NaCl, 2mM MgClj, ImM  ascorbic acid, 20mM Tris-HCl buffer, pH 7.5). 
The reaction was started by the addition of 100/xl of liver membrane preparation (rat 
using 0.2mg protein/tube and sheep use O.lmg/tube) and was continued for 45 
minutes for saturation, protein dilution and displacement binding assays. The amount 
o f non-specific binding was determined by incubating the aliquot o f membrane 
preparation and radioligand in the presence of 0.2mM (-)-isoprenaline, and the total 
binding component by incubating the membrane and radioligand in the presence of 
incubation medium alone. Consequently, specific non-displaceable binding was 
defined as the difference between the total and non-specific binding components.
For time course, protein dilution and displacement assays, aliquots of liver membrane 
were incubated with p ^ ljlP lN  at a concentration of 70-100pM. Incubations for time 
course assays were continued for various periods of time and the dissociation time 
course was measured by adding 0.5mM (-)-isoprenaline, once equilibrium binding had 
been attained (45 mins). For displacement assays the following agents were used : 
ICI 118551, (-)-isoprenaline and atenolol, over the concentration range o f O.lnM  - 
ImM. All drugs were dissolved in a solution of ImM ascorbic acid, expect f^ l] lP lN  
stock which was made up in incubation medium.
In all cases, incubation was terminated by the addition o f 2 ml ice-cold wash buffer 
(145mM NaCl, lOmM Tris-HCl, pH 7.5) followed by immediate and rapid filtration 
through Whatman GF/C glass fibre filters (Whatman Lab. Sales Ltd., Maidstone, 
Kent) using a Millipore 1225 vacuum filtration manifold (Millipore (UK) Ltd., 
Harrow, Middlesex). The incubation tubes were then rinsed with a further 2ml ice-
77
cold wash buffer and the filters were washed with this and with 2 x 5ml o f ice-cold 
wash buffer.
Filters were folded into semi-circles and placed in disposable polypropylene tubes. 
Membrane bound [^^I]IPIN trapped on the filters was then counted in a gamma 
counter (LKB 1260 Multigamma II model for rat liver membranes and LKB 1270 
Rackgamma II model for sheep liver membranes). Aliquots of [^^IjlPIN were placed 
in polypropylene tubes and counted to allow accurate calculation o f the concentration 
of ligand present in incubations.
This binding assay protocol was used for the B-adrenoceptor investigation for all the 
liver membrane preparations and the rat brain cortical membranes used in our study.
PH]Prazosin
Alpha-1 adrenoceptors were characterized using the «i-selective antagonist pH]- 
prazosin. In all saturation binding assays 10-12 concentrations o f pH]prazosin, 
ranging from O.OlnM - lOnM were used. All incubations (150/d) were carried out 
in triplicate at 25°C in polypropylene tubes containing incubation medium (lOmM 
MgCl2, 0.75mM ascorbic acid, 50mM Tris-HCl, pH 7.5). The reaction was started 
by the addition of 100 /tl o f liver membrane preparation (containing 0 .2 mg 
protein/tube for both rat and sheep) and was continued for 30 minutes for saturation, 
protein dilution and displacement binding assays. Non-specific binding was 
determined as the amount of binding of pH]prazosin in the presence o f 10/iM 
phentolamine in rat liver membranes, or lOOfiM (-)-adrenaline in sheep liver membranes.
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For time course, protein dilution and displacement assays, aliquots of liver membrane 
were incubated with pHjprazosin at a concentration o f 0 . 5 n M .  The dissociation time 
course assay was performed by adding 2 5 / x M  phentolamine to rat liver membranes 
and 2 5 0 / i M  (-)-adrenaline to sheep liver membranes, once equilibrium binding had 
been achieved ( 3 0  mins). For displacement assays the following agents were used: 
yohimbine, prazosin, methoxamine, (-)-adrenaline, phentolamine and phenylephrine, 
all o f which were made up in a solution of ImM ascorbic acid. The stock solution 
of pH]prazosin was made up in incubation medium.
Incubation was terminated by the addition of 2ml ice-cold wash buffer (lOmM MgCl2, 
50mM Tris-HCl, pH 7.5), followed by immediate and rapid filtration through 
Whatman GF/C glass fibre filters using a Millipore 1225 vacuum filtration manifold. 
The incubation tubes were then rinsed with a further 2ml ice-cold wash buffer and the 
filters were washed with this and with 2 x 5 ml of ice-cold wash buffer.
Filters were folded into semi-circles and placed in disposable polypropylene 
scintillation vials (Packard LKB, FSA Lab. Supplies, Loughborough, Leicestershire). 
In the case o f the rat liver membranes trapped on the filters, 5ml of a scintillation 
cocktail made up of Unisolve E liquid scintillation fluid (4.5ml) and 20% solution o f 
Triton X-100 in toluene (0.5ml) was added to the scintillation vials, whereas with the 
sheep membranes 10ml of Opti-Fluor O was used. All vials were capped, shaken 
well and left to stand overnight in the dark before counting the following day. Liquid 
scintillation counting was performed on a LKB Wallac 1215 Rackbeta Liquid 
Scintillation Counter.
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pH]RX781094
The measurement o f «g-adrenoceptors on rat and sheep liver membrane preparations 
were made using the « 2-selective antagonist pH]RX781094. Saturation assays were 
performed using 8-10 concentrations of radioligand, ranging from I 6nM - 0.5mM. 
All incubations (150/d) were carried out in triplicate at 25°C in polypropylene tubes 
containing incubation medium (lOmM MgCl2, 0.75mM ascorbic acid, 50mM Tris- 
HCl, pH 7.5). The incubation was started by the addition o f 100/d membrane 
preparation (containing 0 .2 mg protein/tube for both rat and sheep) and was continued 
for 30 minutes for saturation, protein dilution and various displacement assays. The 
non-specific binding component was determined using 10/tM phentolamine in the case 
o f rat liver membranes, and 100/tM (-)-adrenaline in the case o f sheep liver 
membranes.
For protein dilution profiles and various displacement assays 4nM pH]RX781094 was 
used. Radioligand stock solutions were made up in incubation medium and all other 
drugs were made up in a solution of ImM ascorbic acid.
Incubation was terminated by the addition o f 2ml ice-cold wash buffer (lOmM MgCl2, 
50mM Tris-HCl, pH 7.5), followed by immediate and rapid filtration through 
Whatman GF/C glass fibre filters using a Millipore 1225 vacuum filtration manifold. 
The incubation tubes were then rinsed with a further 2ml ice-cold wash buffer and the 
filters were washed with this and with 2 x5ml ice-cold wash buffer.
Filters were folded into semi-circles and placed in disposable polypropylene
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scintillation vials. In the case of the rat liver membranes, 5ml of a scintillation 
cocktail comprising of 4.5ml Unisolve E and 0.5ml of a 20% solution of Triton X- 
100 in toluene was added to the filters, whereas 10ml Opti-Fluor O was used for 
sheep liver membranes. In all cases, the vials were left overnight in the dark and 
then counted the following morning on an LKB Wallac 1215 Rackbeta Liquid 
Scintillation Counter.
This binding assay protocol was employed for all the pH]RX781094 binding 
experiments (both for rat liver and rat brain cortical membranes) undertaken in this 
study.
2.1.5 Radioactivity Counting
For gamma counters, the efficiency of counting was determined using standards and 
gave a reliable counting efficiency of 80% for the LKB 1260 Multigamma II counter 
and 75 % for the LKB 1270 Rackgamma II counter. Samples were counted for 100 
seconds and in all cases a measurement of background radioactivity was subtracted 
to give the measured count as c.p.m.
For the Rackbeta machines, a standardized tritium labelled hexadecane (Amersham 
International pic, Amersham, Bucks) was used as an external standard. Alternatively, 
quench curves were constructed and the machine was calibrated to convert c.p.m . to 
d .p.m . In both cases, the counting efficiency for tritium was in the range o f 40-50%.
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2.1.6 Analysis of Data
The receptor number (B J  and the affinity (IQ) were determined by Scatchard 
analysis o f the binding data and a computerised routine called LIGAND : SCAFLT, 
was used to establish best fit between curves and experimental data (Munson and 
Rodbard, 1980).
Data is presented as means ±  standard error of the mean (S.E.M .). The S.E.M . was 
calculated from the formula:
S.E.M. =
\fn
where the standard deviation (S.D.) is calculated from the formula:
S.D. = E {x-mf 
n - l
and where m =  arithmetic mean of n observations 
X =  an observed value 
n =  number of observations
The significance of differences between means was determined using Student’s ’t’ 
test. The value o f ’t ’ was calculated using:
M. -  M, 
r  = 1 2
S.D.\ S.D.\
«, «2
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where M, and Mg are means of two groups of observations from different samples 
and ni and ng are the number of observations in each group.
When ni =  n 2, the formula f o r ’t’ reduces to :
M. -  M ,  
t  = ---------------:------- -
The probability (P) that the difference between two means was significant was 
obtained from the value o f ’t’ and the number o f degrees of freedom (n^  4- ng - 2) by 
reference to probability tables (Clarke, 1984). Differences were considered 
significant when P < 0 .05 .
2.2 ISOLATION OF HEPATOCYTES FROM RATS
Liver cells are supported in an extracelluar matrix composed primarily o f collagen, 
and held together by desmosomes and areas of cell contact, gap and tight junctions 
(Berry and Friend, 1969). The basic procedure for the isolation o f cells can be 
divided into three stages. Initially, the liver is subject to a non-recirculating perfusion 
with calcium-free medium plus EGTA, which causes the dissociation o f the 
desmosomes and the other areas of cell contact. The cells are then freed from the 
supporting matrix by a recirculating perfusion with the enzyme collagenase in the 
presence o f calcium, as this divalent cation has been shown to greatly accelerate the 
enzymatic dispersion of isolated perfused liver, in view o f the calcium - requirement
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of collagenase (Seglen, 1972). Finally, after disintegration of the extracelluar matrix, 
gap and tight junctions, gentle mechanical manipulation allows the dispersion o f cells.
This procedure is based on the method of Berry and Friend (1969) and incorporates 
modifications by Seglen (1976). Practical details will now be described.
2.2.1 Animals
Virgin female and primiparous mid-lactating (10-14 days) Wistar albino rats were 
used at a body weight o f 200 - 250g. Conditions o f feeding, housing and lighting for 
rats were as reported previously in section 2 . 1 . 1 .
All experiments were started between 09:30 and 10:30h when rats were anaesthetized 
by intraperitoneal injection o f sodium pentobarbital (60mg/Kg body wt).
2 .2 .2  M aterials
The sources o f enzymes and chemicals are given in Appendix 1.
2.2.3 P reparation  of Isolated R at Hepatocvtes 
SOLUTIONS
(A) Krebs-Henseleit bicarbonate buffer (KHB) had the following composition: 
llS m M  NaCl, 4.75mM KCl, 1.2mM KH2PO4, 1.2mM MgSO^, 25mM 
NaHCOg and 2.5mM CaCl2. Buffer was made up freshly for each experiment 
and gassed with a mixture of 95 % Og: 5 % CO2, before addition o f CaCl2. 
The final pH was 7.4. The batch o f KHB was divided into two aliquots of
84
500ml each, to give Ca^^-ffee KHB (containing 12mM glucose, 0.5mM 
EGTA, 5mM Hepes and O.lmg/ml heparin) and "full" KHB (containing 
12mM glucose, 5mM Hepes and 2.5mM C aC y .
(B) Bovine Serum Albumin (BSA) fraction V (essentially fatty acid-free) was 
dialysed to remove metabolites and small molecules. A solution o f BSA 
(fraction V) was prepared at 0.5g/ml in a 0.9% (w/v) solution o f KCl and 
placed into a dialysis bag. The solution was dialysed for 24 hours at 4°C  
against 2 x 10 volumes of 0.9% KCl and 3 x 10 volumes o f double-distilled 
water. Following this the sample was freeze dried and stored at 4°C . 
PROCEDURE
Anaesthetized rats were placed in a supine position and taped by hind and forelimbs 
to a dissection board. The abdominal cavity was opened and the viscera deflected to 
the animal’s left so that the hepatic portal vein and inferior vena cava were exposed. 
Ligatures were placed loosely around these blood vessels. A 16 gauge hypodermic 
needle was inserted into the hepatic portal vein and the inferior vena cava was 
cannulated with an intravenous cannula, and both cannulae were secured with 
ligatures. Additionally, the anterior portion of the vena cava (above the liver and 
below the heart) was tied with a ligature to prevent any loss o f perfusate and to 
prevent the possibility o f pressure build-up and liver swelling.
Perfusion of the liver, in situ, commenced in a physiological direction with 500ml 
Ca^'^-free KHB. The perfusate was gassed with 95% O2 : 5% CO2 and maintained 
at 37°C and a flow rate o f 55-60 ml/min. Flow was maintained by a hydrostatic 
pressure head o f approximately 45cm, kept constant by a medical infusion delivery
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attachment, fed from the bubble-trap at the base o f the multi-bulb oxygenator, thereby 
avoiding pulsatile flow and air bubbles during recirculating perfusion. The trap was 
kept filled with oxygenated and warmed medium by recirculation through the 
oxygenator at a rate of 250ml/min using a Watson Marlow peristaltic pump via an 
overflow outlet from the bubble trap, and returning the output through the vena caval 
cannula to the same reservoir.
The Ca^^-free KHB perfusate was discarded and immediately, a recirculating 
perfusion was established with 150ml "full" KHB containing 60mg collagenase (0.4% 
w/v) and 5mg soyabean trypsin inhibitor. The same flow rate was maintained and 
the recirculating perfusion was continued for 9-10 minutes, until the liver became 
"blotchy" and leaked medium rapidly.
After this, the liver was carefully removed and placed into a petri dish containing 
"full" KHB. The capsule surrounding the liver was then disrupted using sharp 
forceps and liver cells were released by combing gently with a small polycarbonate 
rod.
2.2.4 Purification of Parenchymal Cells
Intact parenchymal liver cells were separated from cell debris, Kupffer cells, 
erythrocytes and pieces o f connective and vascular tissue by filtration and 
centrifugation. The cell suspension was filtered through a nylon mesh (pore size 
2 5 0 / i m )  held tightly over a funnel and then through a second nylon mesh (pore size 
5 0 ) L t m )  in the same manner. Parenchymal cells were then collected by gentle
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centrifugation at 50g for 90 seconds (MSB Coolspin bench top centrifuge) in 
polycarbonate centrifuge tubes. The supernatant was removed and the cells gently 
resuspended in "full" KHB and centrifuged again. This washing procedure was 
repeated once more and then the cells were resuspended in 10-15 ml KHB incubation 
medium ("full" KHB containing 1.5% (w/v) dialysed BSA), to produce an appropriate 
final cell concentration for pipetting into incubation flasks.
To reduce cell adhesion all vessels and containers used were made of polycarbonate.
2 .2 .5  Cell Incubations
After isolation, the washed suspension of rat hepatocytes were incubated in KHB 
incubation medium, under an atmosphere of 95% O2 : 5% CO2 at 37°C. This pre­
incubation was carried out for 40 minutes in a 25ml polycarbonate conical flask in a 
shaking water bath shaking at 60-80 cycles/min. This pre-incubation procedure was 
found to improve cell viability and allow the cells to become fully dispersed within 
the suspension, and to recover intracellular ATP content to in vivo levels.
Incubations were usually carried out in the same polycarbonate conical flasks and 
1.0ml portions of cell suspension were pipetted into flasks containing 4.0ml o f KHB 
incubation medium. To avoid cell damage when pipetting, the fine ends of the plastic 
pipette tips were cut off. In some cases the incubation volumes were altered and 
depending upon the measurement to be made, the times of incubation varied. All 
flasks were stoppered with rubber Suba-Seals (Gallenkamp and Co. Ltd, Widnes, 
Cheshire) and each was served by gas inlet and exhaust lines to enable constant
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gassing of the suspension with 95 % O2 : 5 % CO2. Incubations were carried out at 
37°C in a shaking water bath shaking at 60-80 cycles/minute. Hormones were added 
in 100^1 aliquots injected through the Suba-Seal stopper as appropriate. Incubations 
were terminated in a variety of ways depending upon the measurement being made, 
and these will be described in later sections in this chapter.
2.2.6 Hepatoevte Viability
It is important to have an index of cell viability to ensure that only metabolically 
competent cells are used for experiments. Samples o f hepatocyte suspension were 
taken towards the end of the pre-incubation period, prior to the start o f the hormone 
incubation period. Trypan blue exclusion staining was used as the method to 
determine cell viability and this was carried out in a haemocytometer under a light 
microscope. A number o f other methods are available for the determination of cell 
viability, including metabolic integrity, often involving the measurement o f the 
retention of lactate dehydrogenase or ATP by isolated cells (Dickson and Pogson, 
1977). The trypan blue exclusion method has been shown to be reliable when 
compared to measurements of ATP content of freshly isolated hepatocytes (Evans 
1986) and that these cells can be maintained under physiological conditions for up to 
8  hours with little alteration in viability (Dickson and Pogson, 1977).
Hepatocytes are usually prepared from smaller and younger animals than used in 
these experiments, and result in preparations in which >95%  of the cells are viable 
as measured by trypan blue dye exclusion (Geelan et al., 1978; Evans, 1986; Morand 
et al., 1988). While it was possible to approach this level o f viability in the present 
work using unmated female 200-250g rats (93 ±  4%, mean ±  S .E .M .), we were
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unable to achieve a preparation o f such high yield from weight-matched lactating 
animals (84 ±  6 %, mean ±  S.E.M .). As mentioned previously, the isolated 
hepatocytes were suspended in KHB incubation medium and achieved a concentration 
o f between 5 and 8 x 10  ^ cells/ml.
2.2.7 Wet Weight Determination
Aliquots o f hepatocyte suspension (1ml) were pipetted into pre-weighed Eppendorf 
tubes, centrifuged (8000g x 90 seconds) and the supernatant removed. The tubes were 
blotted dry and re-weighed. All determinations were performed in triplicate allowing 
some results to be expressed on a wet weight basis.
2.2.8 DNA Estimation of Hepatocvtes
The quantitative determination of DNA in hepatocytes was made using the method of 
Labarca and Paigen (1980). This method employs the use o f a fluorochrome 
(Bisbenzimide) and relies upon the enhancement of fluorescence seen when this 
compound binds to DNA in solution. Such determinations give a measure of 
cellularity and so allow results to be standardized and expressed on a mg DNA basis.
Most samples for DNA determination were taken following cell incubations when 
samples were being prepared for various enzyme measurements, and were commonly 
stored at -80°C after being snap frozen at a dilution o f 1:100 with respect to g wet 
weight o f sample. Further dilutions to achieve assay duplicates o f 1:500 and 1:1000 
with respect to g wet weight of tissue sample are required for this assay, and were 
made using DNA assay buffer (2M NaCl; 50mM NaH2 PO4, pH 7.4 with ION
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NaOH). Subsequently, 1ml DNA assay buffer was added to 0.5ml o f each of the 
sample dilutions and was incubated at room temperature for 1 hour with 1.5ml 
bisbenzimide reagent (200/ig/ml in DNA assay buffer). Similarly a calibration curve 
was constructed using a standard solution o f DNA in 2mM EDTA (20/tg/ml). On 
completion o f the period o f incubation, flourescence o f each sample was measured 
using a luminescence spectrometer (Perkin Elmer LS-50) set at an excitation 
wavelength o f 355nm and emission wavelength o f 445nm.
This procedure proved to be a reliable and fast assay to perform and gave a DNA 
value in the range o f 3-6mg per g wet weight hepatocyte pellet.
2.3 IN VITRO EXPERIMENTS USING RAT HEPATOCYTES
2.3.1 Materials
The sources of all chemicals, enzymes, radiochemicals and hormones are given in 
Appendix 1.
2.3.2 Assay for the determination of cyclic AMP
The adenylate cyclase cascade which employs the second messenger cAMP, is one 
o f the two major signalling pathways involved with the transduction mechanisms of 
G-protein linked receptors. Examination o f the effects o f agents which achieve their 
physiological responses via a stimulatory coupling to adenylate cyclase can be made 
by measuring the changes in intracellular cAMP concentrations and from such 
determinations, the intracellular cAMP status can provide a measure o f responsiveness
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of a particular tissue to the agent of interest.
The assay used in this study is based upon the method developed by Gilman (1970), 
which involves competition of binding between unlabelled cAMP and a known fixed 
amount o f the tritum labelled compound, to a protein which has a high affinity and 
specificity for cAMP. This method has been modified by Tovey et al., (1974) to 
include a step to allow improved separation of the bound and unbound cyclic 
nucleotides, by employing adsorption o f free nucleotide onto activated charcoal. 
Following charcoal adsorption the separation of the charcoal-nucleotide complex is 
performed by centrifugation and an aliquot o f the cAMP-binding protein complex 
(which remains in solution) is counted for radioactivity to give a calculable 
measurement o f the cAMP concentration. Such an assay allows a simple and direct 
measurement o f cAMP in a range of biological samples.
AIM
To determine the intracellular cAMP status o f hepatocytes isolated both from mid- 
lactating and weight-matched virgin female rats, in response to a range o f isoprenaline 
concentrations.
CELL INCUBATIONS
Following a 40 minute pre-incubation o f the cell suspension, a 1ml aliquot 
(approximately 10’ cells) was incubated in a final volume o f 2.5ml "full" KHB with 
10/xl aliquots o f drug/hormone added where indicated. All incubations were carried 
out in polycarbonate flasks at 37°C and in an atmosphere o f 95% O2 : 5% CO2 as
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described previously. The following concentrations (M) of (-)-isoprenaline were 
used: zero, 2 x 10*^ °; 2 x lO"^ ; 2 x 10 *; 2 x lO ’; 2 x lO'^; 2 x 10^, along with a 4 x 
lO'^M glucagon concentration to serve as a measure o f maximal response. A stock 
solution o f isoprenaline (lOmM) in ImM  ascorbic acid was freshly prepared on the 
day of the experiment and subsequent dilutions were made in KHB (not containing 
1.5% w/v BSA). A stock solution o f glucagon (1 mg/ml) was prepared in ImM- 
hydrochloric acid and stored in aliquots at -20°C to be thawed individually and 
diluted on the day o f the experiment in KHB (not containing 1.5% w/v BSA). Each 
incubation was terminated after a period of 60 seconds, as our preliminary 
experiments and published values (Cherrington et al., 1976) had shown that 
intracellular cAMP concentrations peak at this time point.
SAMPLE PREPARATION
Each reaction was terminated by removing 1ml o f incubation suspension 
(approximately 4 x 10  ^cells) and adding this rapidly to 1ml of ice-cold 6 % perchloric 
acid in a disposable polypropylene tube, the contents were then immediately mixed 
using a Vortex mixer. The sample was then centrifuged in a bench top centrifuge at 
3 ,0 0 0  rpm for 10 minutes and 1ml of supernatant removed to a polypropylene tube. 
Held on ice 1.1ml o f a 1:1 mixture of trioctylamine : 1,1,2-trichlorotrifluoroethane 
was added and mixed vigorously for 15 seconds (Khym, 1975). This was then 
centrifuged again at 3,000 rpm for 10 minutes, following which the neutralized 
perchloric acid-free aqueous upper layer was removed and stored in aliquots at -70°C 
(after snap-freezing in liquid nitrogen) for up to six weeks before assay.
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ASSAY PROCEDURE
This assay for the determination of cAMP is based upon the competition between 
unlabelled cAMP and a known fixed amount o f pHjcAMP for binding to the protein 
cAMP-dependent protein kinase.
The following materials are required for this assay:-
(A) Assay buffer consisting of 50mM Tris-HCl and 4mM EDTA at pH 7.0 at 
room temperature (pH 7.5 when cooled to 4°C),
(B) 0.4mg/ml stock solution of cAMP-dependent protein kinase (Sigma; product 
no. P-5511) in assay buffer containing 5mg/ml Fraction V BSA,
(C) Stock solution of unlabelled cAMP (ImM  solution in double distilled water). 
Further dilutions of this stock are made with assay buffer to give the 
appropriate final concentrations (20, 40, 80, 160 nM cAMP) for the cAMP 
standard curve,
(D) Stock pH]cAMP solution containing 0.5)itCi/fcl pHJcAMP. Such a stock 
solution is diluted 1 :1000  in assay buffer to give the correct amount for the 
assay (50/d aliquot per tube contains approximately 20,000 c.p.m .),
(E) 26mg/ml suspension of activated charcoal in assay buffer containing 20mg/ml 
Fraction V BSA.
All tests, standards and the charcoal blank were made in duplicate. The cAMP 
standard curve was made of the following concentrations (pmol cAMP/50/il): 8 , 4, 
2, 1 and O; 50/d aliquots of sample were assayed concurrently with 50/d aliquots of 
the dilutions prepared from the cAMP stock for the standard curve. All assay
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procedures were carried out at 4°C and the following assay protocol was followed:-
(1) Into each Eppendorf tube 50/tl o f sample or cAMP standard was dispensed. 
No further dilution of the sample prepared as described in the previous section 
was necessary, as preliminary tests had shown that the dilution was 
comparable to the standard curve (0 -8  pmol).
(2) Into each tube 50/d pBTJcAMP (1:1000 dilution of stock) was dispensed.
(3) To all tubes 80/d o f assay buffer was dispensed except for the charcoal blank,
in which lOOfil assay buffer was dispensed as these tubes are incubated in the 
absence of the 2 0 /tl aliquot of binding protein.
(4) Finally, 20/d binding protein (cAMP-dependent protein kinase) was added to 
start each reaction (except the charcoal blank tubes) and the tubes were 
whirlymixed for 5 seconds and then incubated for 4-5 hours at 4°C.
(5) At the end of the incubation period a 100/d aliquot of charcoal suspension was
added to each tube and whirlymixed for 5 seconds. Tubes were allowed to 
stand for at least 90 seconds (no longer than 6  minutes) and then spun in a
bench Eppendorf centrifuge for 2 minutes at full speed.
(6) A 200/d aliquot from each tube was removed without disturbing the charcoal 
sediment and was placed into a scintillation vial.
(7) To each scintillation vial 10ml of an aqueous compatible scintillation cocktail 
(Optifluor or Optiphase HiSafe) was added and the samples were counted 
using an LKB Wallac 1215 Rackbeta liquid scintillation counter. 
Additionally, a 50/d aliquot o f pHTJcAMP solution was counted during each 
assay to give an accurate value for the total amount of radioactivity per tube.
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CALCULATIONS
For the calculation of results, c.p.m . values from the scintillation counter were 
meaned for each standard and test sample. The average c.p.m . value for the 2 
charcoal blanks represents the assay blank and this was subtracted from the standard 
sample containing 0 pmol cAMP, to give the standard blank (C J. The assay blank 
was subtracted from all subsequent test and standard mean values to give the 
corrected value (C j. The C^iCx ratio was calculated for all the standards and a plot 
o f CqICx against pmol cAMP (from standards 0-8 pmol) gave a standard line. From 
this it was possible to interpolate the cAMP values of the test samples from their 
CoiCx ratios.
2,3.3 Determination of the A-Kinase Activity Ratio
Measurement of the activity ratio of A-kinase in principle offers the possibility of a 
more precise determination o f the intracellular cAMP status, than can sometimes be 
made by the direct measurement of cellular cAMP content (Corbin, 1983; Clegg and 
Ottey, 1990). Additionally, the level of activation of A-kinase is also useful to know 
when comparing the response o f enzymes "down-stream" to the cAMP signal.
Two main isozymic forms of the enzyme exist (referred to as type I and II) which 
differ in their regulatory (R) subunits, but both are composed of a regulatory subunit 
dimer and two catalytic (C) subunits (Swillens, 1983). Activation of the kinase by 
cAMP is accomplished by dissociation o f the inactive holoenzyme according to the 
equation:
95
+ 4 cAMP^ R^icAMP)^ + 2C
From examination of this equation, assay o f A-kinase activity will detect the active 
enzyme form (C-subunits) only; measurement o f the total enzyme activity can be 
achieved by addition of a high concentration of cAMP to the assay, which will act to 
shift the equilibrium completely to the right. This provides the basis for the 
determination of the A-kinase activity ratio (activity in the absence of cAMP divided 
by activity in the presence of cAMP), which represents the fraction of the total 
enzyme (R2C2 +  C) in the active C form.
The two isozymic forms of the enzyme, type I and type II, show a wide and varied 
distribution in a range of tissues and species and consequently the assay procedure 
must be adapted accordingly for each tissue, to allow in all cases an accurate 
estimation o f cellular protein kinase activity ratio (Corbin, 1983). For example, rat 
liver is known to contain nearly equal amounts o f protein kinase I and II (Cherrington 
et al., 1976) and as a consequence of this, various modifications of the sample 
preparation procedure and the composition o f the buffer used are necessary (see 
Corbin, 1983).
AIM
To measure the activity ratio of A-kinase in hepatocytes isolated from weight-matched 
virgin female and primiparous mid-lactating (10-14 days) rats, in response to a range 
o f concentrations of isoprenaline.
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CELL INCUBATIONS
Following the 40 minute pre-incubation procedure of the cell suspension, 1ml cell 
suspension (5 - 8 x 10  ^ cells/ml) was incubated with 3.9ml "full" KHB and 100/tl 
aliquot of hormone/drug at 37°C, under an atmosphere of 95% O2 : 5% CO2 as 
described previously. The following final concentrations (M) of (-)-isoprenaline were 
used: zero, 2 x 10'^ ;^ 2 x 10' ;^ 2 x 10'*; 2 x 10’’; 2 x 10 ;^ 2 x 10'^, along with 4 x 
10^ M glucagon to serve as a measure of maximal response. Isoprenaline and 
glucagon stocks were as described previously and the range of dilutions required were 
made using KHB (without 1.5% w/v BSA present).
Samples were harvested after an incubation period of 2 minutes, as preliminary 
experiments had shown (in agreement with the findings o f others) that 60-80 seconds 
was the time point for a cAMP concentration peak in these cells and that A-kinase 
peaks later at about 2 minutes (Cherrington et al., 1976). All incubations were 
terminated by pouring the entire flask contents (5 ml) into an ice-cooled centrifuge 
tube containing 25ml ice-cold KHB buffer (containing no glucose or BSA); these were 
then immediately centrifuged at 3000 rpm for 20 seconds in a bench top centrifuge 
(MSB Coolspin bench centrifuge). The supernatant was discarded and the pellet 
immediately processed as described below for storage and ultimately A-kinase assay.
SAM PLE PREPARATION
The pellet formed was resuspended in buffer according to the precautions outlined by 
Corbin (1983). Immediately following sedimentation the pellet was resuspended in 
100 vols ice-cold A-kinase homogenisation buffer (lOmM Mes/NaOH; 150mM KCl; 
0.2mM EDTA; O.lmM dithiothreitol (DTT); 0.5mM 3-isobutyl-1-methylxanthine
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(IBMX); pH 6 .8  at 0°C with NaOH) to which protease inhibitors were added just 
prior to use, to give final concentrations of ImM benzamidine hydrochloride; 2/xg/ml 
soyabean trypsin inhibitor and O.lmM phenylmethylsulfonylfluoride (PMSF). The 
suspension was homogenised using a Polytron (setting 4 for 2 x 15 seconds). From 
the resulting suspension, duplicate aliquots (1ml) were taken for DNA determination 
and separate duplicate 1ml aliquots were taken into Eppendorf tubes and spun at 
speed for 2 minutes in a bench top Eppendorf centrifuge. The supernatant was 
carefully removed and BSA (fraction V) was added to achieve a concentration of 
lOmg/ml (ie. 1 % w/v) and the solution was gently mixed before each sample was 
snap frozen in liquid N2 and stored at -80°C.
ASSAY PROCEDURE
The assay of A-kinase is based upon the incorporation of ’^P from [7 -^ ’P] ATP into 
a suitable protein substrate, which in this case is the synthetic peptide Kemptide 
(Kemp and Clark, 1978). Incubations o f tissue extract and radiolabelled ATP are 
made under three distinct conditions: in the absence of cAMP and the presence of a 
protein kinase inhibitor (Walsh inhibitor); in the absence o f both cAMP and the 
protein kinase inhibitor and finally, in the presence o f cAMP and the absence of 
inhibitor. Such measurements allow the determination o f the basal and the total 
activity and hence the activity ratio of A-kinase.
The following solutions are required for the A-kinase assay:-
(A) A-kinase Assay Buffer containing 40mM Mops/KOH and 32mM Magnesium 
acetate, pH 7.0 at room temperature.
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(B) 2mg/ml solution o f Kemptide in double-distilled water,
(C) lOmM ATP solution in double-distilled water,
(D) 400mM dithiothreitol (DTT) in double distilled water,
(E) 4/xM cyclic AMP solution in double-distilled water,
(F) Walsh protein kinase inhibitor (synthetic peptide; Cheng et al. , 1986) at a 
concentration of 10/zg/ml in 50% glycerol/ImM  DTT,
(G) [gamma-^’P] ATP diluted in double-distilled water to approximately l/xCi//zl.
The following assay procedure based on the methods of Corbin and Reimann (1975)
and Roskoski (1983), was carried out:-
(1) A radioactive ATP/Kemptide mix at 4°C  was made up from the appropriate 
solutions as above on the day of assay and contained the following per 1ml of 
mixture:-
Mg-Mops buffer 500/d
ATP 10/xl
Kemptide 100/d
DTT 10/xl
[7 -^ ’P] ATP in distilled water . 380/xl
(* Quantity o f labelled ATP should be such that the above mixture contains 
approximately 2/>tCi/ml).
(2) Into Eppendorf tubes held on ice, 40/d of the radioactive ATP/Kemptide mix 
was dispensed along with a 10/d aliquot o f either Walsh inhibitor peptide, 
distilled water, or cAMP. For each sample, each incubation condition was 
performed in triplicate.
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(3) All tubes were pre-warmed for 3 minutes (in a timed sequence coordinated 
with the timed addition of sample extract to start the reaction) in an Eppendorf 
hot-block maintained at 30°C.
(4) As described previously, samples for A-kinase assay were stored at -80°C at 
a sample dilution o f 1:100 with respect to cell wet weight. Preliminary 
experiments showed that a final sample dilution o f 1 :1 0 0 0  in hepatocyte 
extracts was within the range of dilutions over which the assay was linear with 
respect to sample added. Hence, upon thawing of the samples they were 
diluted a further 10-fold using A-kinase homogenisation buffer containing 
lOmg/ml fraction V BSA.
(5) The kinase reaction was started at timed intervals by adding 10/xl o f the 
diluted (1:1000) hepatocyte extract to each relevant tube. Tubes were mixed 
and incubated in the hot block at 30°C for 15 minutes.
(6) The reaction was stopped by spotting 30/xl of reaction mixture onto prelabelled 
squares (2cm x 2cm) of Whatman P81 cation exchange cellulose paper. The 
aliquot o f sample was allowed to spread over the paper for a few seconds and 
then dropped into a stirred beaker containing 300ml o f 75mM phosphoric 
acid. Such filter squares were left washing until all the incubations were 
complete and then was left for a further 3 minutes.
(7) All the filter squares were then transferred to 300ml o f fresh 75mM 
phosphoric acid and allowed to stir for 3 minutes. This procedure was then 
repeated twice more.
(8) After the final wash, all filters were removed, blotted on a paper towel and 
placed into Packard scintillation vials. For scintillation counting, 10ml o f
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Packard Optiphase scintillation cocktail was added to each filter and samples 
were counted on a LKB Wallac 1215 Rackbeta liquid scintillation counter. 
Two sets o f blanks were run, which involved spotting 20/cl o f radioactive 
ATP/Kemptide mix onto filters and adding them to the wash step, two before 
the experimental series and two after. This allowed a background 
measurement o f filter contamination and also verified a sufficient washing 
procedure. Additionally, 40/cl of radioactive mix was spotted onto filter 
squares and placed directly into vials for scintillation counting, in order to 
determine the specific radioactivity for each batch o f mix.
CALCULATIONS
For the calculation o f results, c.p.m . values from the scintillation counter were 
averaged for each assay incubation mix for each sample, and values adjusted using 
the mean blank value to give a corrected value of c.p.m . The specific radioactivity 
of the mix and the DNA determinations for each sample allowed the results to be 
expressed as nmoP’P incorporated per minute per mg of homogenate DNA. From 
the three assay incubation conditions, the basal activity value was determined as the 
activity when incubated with water minus the activity in the presence of Walsh 
inhibitor and the total activity as that in the presence of cAMP minus the activity 
when incubated with inhibitor peptide. Consequently, the activity ratio was 
determined as the basal activity divided by the total activity.
2.3.4 Assay of the enzyme Glvcogen Phoshorvlase
The breakdown of glycogen is controlled mainly by glycogen phosphorylase through
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mechanisms involving the phosphorylation and dephosphorylation of the enzyme. In 
the liver, two different signalling mechanisms for the phosphorylation and activation 
o f glycogen phosphorylase have been described. The first involves an increase in the 
intracellular cAMP concentration by hormones such as glucagon or B-adrenergic 
agonists, and the second involves a Ca’"^-dependent mechanism such as is seen with 
vasopressin, angiotensin II or «i-adrenergic agonists (see Hems and Whitton, 1980 
for review).
The phosphorylation of phosphorylase b to the active phosphorylase a state, is 
catalysed by the enzyme phosphorylase kinase, and the inactivation of phosphorylase 
a is brought about by the enzyme phosphorylase phosphatase. In addition to the 
covalent modification of the enzyme through phosphorylation/dephosphorylation, 
glycogen phosphorylase activity is affected by a number o f allosteric regulators (eg: 
AMP and ATP). Phosphorylase b is stimulated by AMP and this stimulation is 
prevented by ATP, a negative allosteric regulator, whereas phosphorylase a is 
relatively independent o f AMP. The enzyme phosphorylase kinase also exists in an 
active and less active form, and the inactive state may be converted to the active form 
via phosphorylation by A-kinase. Phosphorylase kinase is additionally dependent 
upon Ca’"^ , and a Ca’^-dependent signalling pathway has also been shown to operate, 
with Ca’"*" causing activation by binding to the 6-subunit (calmodulin) of 
phosphorylase kinase (see Cohen, 1987 and Martin, 1988).
AIM
In the present study, the measurement o f glycogen phosphorylase activity was
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undertaken to further examine the role o f the cAMP signalling cascade in rat 
hepatocytes isolated from control virgin female and primiparous mid-lactating 
animals, having already defined the properties of A-kinase in these cells. This was 
performed by measuring phosphorylase a  and total phosphorylase {a +  b) under 
incubation conditions where hormones causing an elevation in intracellular cAMP 
concentration (eg: isoprenaline and glucagon) were used.
CELL INCUBATIONS
Following the 40 minute pre-incubation period of the suspension of freshly isolated 
hepatocytes, 1ml cell suspension (5-8 x 10  ^cells/ml) was incubated with 3.9ml "full" 
KHB and 100/d aliquot o f hormone/drug, under the same incubation conditions as 
described previously. The same final concentrations of (-)-isoprenaline and glucagon 
were used as in all previous hepatocyte experiments.
Samples were harvested after an incubation period o f 1 minute, after preliminary 
experiments had shown that at this time point the activation of phosphorylase was 
maximal following challenge with 2 x lO'^M isoprenaline. Such findings are in 
agreement with the results o f Hutson et al (1976) where maximal activation of 
glycogen phosphorylase was found to occur between 1 and 2  minutes, when cells 
were challenged with adrenaline (Kf^M) and glucagon (lO ’M). At the appropriate 
time, an aliquot of 0.4ml ( =  approx. 7 x 10  ^ cells; approx lOmg wet wt.) o f flask 
contents was withdrawn and snap frozen in liquid nitrogen for later use. By 
performing hepatocyte dilution experiments, it was determined that such a volume of 
incubation suspension was appropriate for glycogen phosphorylase determinations.
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SAM PLE PREPARATION
Immediately before the start of the glycogen phosphorylase assay, the frozen 0.4ml 
aliquot of sample was thawed on ice and homogenised in an equal volume of ice-cold 
phosphorylase homogenisation buffer (lOOmM glycyl glycine; 20mM EDTA; lOOmM 
NaF; 0.5% w/v glycogen; pH 7.5 with NaOH) for 30 seconds using a Polytron, 
keeping the sample on ice at all times. The above sample preparation procedure is 
based on that used by Blackmore and Exton (1985) and reduces activation artifacts 
by thawing and homogenising samples at 0°C in the presence of EDTA, which 
inhibits protein kinase action and sodium fluoride, which inhibits phosphoprotein 
phosphatase activity. Following this aliquots o f homogenate were centrifuged at 
speed for 1 minute in an Eppendorf centrifuge cooled with an ice pack, and the 
resulting supernatant was taken for use in the assay.
ASSAY PROCEDURE
Glycogen phosphorylase reversibly cleaves off glucose units from the branched chain 
polymer glycogen in the presence of inorganic phosphate to give glucose-l-phosphate. 
Most reported studies of glycogen phosphorylase involve assays in the reverse (or 
"unphysiological") direction, employing the ability o f phosphorylase to incorporate 
^'^C-labelled glucose from ^'^C-glucose 1-phosphate into glycogen, which is then 
precipitated onto filter squares by immersion into a  solution of ethanol (Wang and 
Esmann, 1972; Golden et al., 1977). For the assay of the a form of the enzyme, the 
incubation is carried out in the absence of 5 ’AMP, but in the presence of 
methylxanthines (eg: theophylline and caffeine) to inhibit any small stimulatory effect 
o f AMP (endogenous to the sample) on phosphorylase b. In contrast, for the assay
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of total phosphorylase {a +  b), this incubation is made in the presence o f 5 ’AMP to 
allow stimulation of phosphorylase b, and in the presence of ethylene glycol dimethyl 
ether, which is a good activator o f phosphorylase b (Uhing et al., 1981).
The procedure used for the assay of phosphorylase a and total phosphorylase activities 
was based on the methods described by Stalmans and Hers (1975) and Blackmore and 
Exton (1985). The following reagent solutions were required:-
(A) Stock solution of glucose-1 -phosphate (100/tCi/ml) diluted 1/10 in a 
solution of 150mM glucose-1 -phosphate,
(B) 3.75% (w/v) glycogen in a solution containing 187.5mM B-glycerophosphate 
and 0.375% (w/v) B-mercaptoethanol,
(C) 2.4M KF solution in double distilled water,
(D) 15mM theophylline solution in double distilled water,
(E) 15mM 5’AMP solution in double distilled water,
(F) ethylene glycol dimethyl ether (1,2-dimethoxyethane),
(G) 25mM caffeine solution in double distilled water.
For each test sample, three incubation conditions were set up in duplicate, and 
included a blank, assay for phosphorylase a (ie: "a" mix) and assay for total 
phosphorylase ("a +  b" mix). The blank involved incubating an aliquot of 
phosphorylase homogenisation buffer with the "a" mix. The composition o f the "a" 
and "a +  b" mixes were as follows:-
"a" Mix
* Mixture of solutions A, B and C 47.5/d/tube
Solution D 5 .0/d/tube
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Solution G 7.5/xl/tube
"a 4- b " Mix
* Mixture o f solutions A, B and C 47.5/tul/tube
Solution E 5.0/xl/tube
Solution F 7.5/d/tube
(* where the ratio of the mixture A : B : C was 10 : 8 : 1)
Once the appropriate incubation mixes were set up the following steps were taken:-
(1) All mixtures were pre-heated at 37 °C in an Eppendorf heating block for a 
period o f 6  minutes at timed intervals.
(2) The reaction was started by the addition of 20/tl o f sample, or in the case of 
blanks, by the addition of 20/tl phosphorylase homogenisation buffer. All 
tubes were incubated for a period of 10 minutes at 37®C, during which time 
product formation was linear with respect to time as confirmed by preliminary 
assay time course studies.
(3) The reaction was terminated by spotting 40/tl o f reaction mixture onto 
prelabelled squares (2cm x 2cm) of Whatman no. 1 filter paper. The aliquot 
o f mixture was allowed to spread over the paper for a  few seconds and then 
dropped into a stirred beaker containing 300ml of 6 6 % ethanol solution. Such 
filter squares were left washing until all the incubations were complete and 
then was left a further 10 minutes.
(4) All the filter squares were then transferred to 300ml o f fresh 6 6 % ethanol 
wash solution and allowed to stir for 10 minutes.
(5) Finally, the filters were transferred to a beaker containing 300ml o f acetone
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(AR) and allowed to stir for a further 10 minutes.
(6) After the final washing stage, all the filter squares were removed from the 
acetone and allowed to dry before being placed in scintillation vials and 
adding 10ml o f Packard Optiphase scintillation cocktail. Samples were then 
counted on a LKB Wallac 1215 Rackbeta liquid scintillation counter.
CALCULATIONS
The counting efficiency for "^*C of the scintillation counter was determined using an 
LKB *'*C-labelled standard, and the counting efficiency was always found to be 
90% + . Following the counting of samples, the values were averaged for each 
incubation condition for each sample, and the mean blank was subtracted from the "a" 
and the "a +  b" values, to give these measurements in terms o f net c.p.m . 
Consequently, the net d.p.m. values could be determined and by calculating the 
specific activity o f the [‘"*C] glucose- 1 -phosphate solution used in the assay (ie: 
solution A), the results for each test activity were expressed in terms o f nmol "^^ C 
incorporated per minute per ml of extract. Finally, the activity ratio for glycogen 
phosphorylase was determined as the ratio of the phosphorylase a activity compared 
to the total phosphorylase (a +  h) measurement.
CHAPTER 3
CHARACTERIZATION OF THE HEPATIC ADRENOCEPTOR 
POPULATION IN THE ADULT AND MID-LACTATING RAT
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3.1 OBJECTIVES
The role of catecholamines in the control o f hepatic carbohydrate metabolism is a 
well established phenomenon (see Garrison and Haynes, 1973; Schmelck and 
Hanoune, 1980) and much work has concentrated on the hepatic glycogenolysis 
induced by catecholamines (see Hems and Whitton, 1980). As mentioned previously, 
variations in the responsiveness o f rat liver to o l-  and B-adrenergic agents have been 
shown in relation to the sex, age and hormonal status o f the animal (see section 1.3). 
In view o f these findings and the known effects of adrenergic agents on hepatic 
carbohydrate metabolism, lipogenesis and lipolysis, catecholamines may prove to be 
important in the control of liver metabolism during the period of lactation. Hence, 
characterization of the adrenoceptor population in the liver during this period, would 
therefore be useful in determining the potential o f such a role o f the adrenergic 
system.
The aim of the experiments described in this chapter was to determine the number, 
type and subtype of hepatic adrenoceptors in the mid-lactating rat. Membranes were 
prepared from primiparous mid-lactating animals and weight-matched virgin females 
to investigate whether any change in the size or nature o f the adrenoceptor population 
during this reproductive period could be demonstrated. The B-adrenoceptor 
population was measured using the radiolabelled non-subtype selective B-antagonist 
(-)-[*^I]iodopindolol, and the total a-adrenoceptor population enumerated using the 
respective a j-  and « 2-selective antagonists, pHjprazosin and pH]RX781094.
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3.2 RESULTS
The binding characterstics o f all radioligands were determined in virgin female and 
mid-lactating rat liver membranes prepared as described in section 2.1.3 o f Materials 
and Methods.
3.2.1 Characterization of rat liver fi-adrenoceptors 
(-)[‘^ I]IODOPINDOLOL BINDING ASSAYS
A range of [^^I]IPIN binding assays were carried out using liver membranes from 
both mid-lactating and control adult female animals. Additionally, saturation assays 
were performed using liver membranes from adult male rats and young female (lOOg 
body weight) animals, for comparison with binding values from mid-lactating and 
adult female liver membranes and finally, saturation assays were performed using 
membranes isolated from foetal (day 2 0  post coitum) rat livers and cerebral cortical 
membranes from adult male rats, as a means of validating this radioligand binding 
assay. All membranes were prepared using the same method (as detailed in section 
2.1.3 of Materials and Methods) following the excision of the appropriate tissue, and 
in the case of foetuses pooled livers from 3 litters were used.
Protein dilution profile
Total and specific ligand binding increased linearly with increasing protein 
concentration over the protein concentration range studied (0-0.4mg protein per 
incubation), and non-specific binding also increased linearly with protein 
concentration, but was always <  25 % of total binding in protein dilution profiles (data 
not shown). From such studies a working protein concentration o f 0.2mg/assay tube
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was chosen to be used in subsequent assays.
Association time course
The binding o f (-)-[^^I]IPIN to both virgin female and mid-lactating rat liver 
membranes showed a typical hyperbolic time course of association with the time for 
total and specific binding reaching a plateau at around 25 minutes. Non-specific 
binding showed a sharp increase in the first minute, and then a slight decrease to 2 0  
minutes, after which time this component maintained a constant value for the 
remainder of the time studied. Similar curves were obtained for both membrane 
preparations and Figure 3:1 shows data obtained from liver membranes isolated from 
mid-lactating animals.
As previously described, the association of a radioligand with its receptor is a second 
order reaction, although, if  less than 1 0 % of the ligand present is specifically bound 
at equilibrium, a pseudo first order reaction is assumed. Such a reaction is described 
by the rate equation:
In
B -B .
L.B_
B.
(See section 1.4.2.4 Radioligand binding studies, for full details and abbreviations). 
This equation may be applied to this association time course assay, as the binding
satisfies the above criteria. When In
B. is plotted against time (in seconds)
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a linear plot is obtained (see Figure 3:1) of gradient L.B_
B.
. When the
association time course data shown in Figure 3:1 was expressed in this way an 
association rate constant (K J of 1.64 x 10  ^M'^ s'^  was obtained.
Dissociation time course
When isoprenaline was added to an incubation mixture containing membranes from 
mid-lactating rat liver with [^^I]IPIN bound at equilibrium, such that a concentration 
o f isoprenaline of 0.5mM was achieved, the radioligand was displaced from the 
membrane in a time-dependent manner (Figure 3:2), with 50% of the specifically 
bound ligand displaced in approximately 20 minutes. The dissociation o f a 
radioligand from its receptor is a first order reaction described by the equation:
Log
B.
K_^-t
23Ü3
B.
against time (in seconds) wasBy applying this equation, a plot of log
shown to be linear with a gradient equal to K ./2.303 (Figure 3:2 inset) and when the 
dissociation time course data presented (Figure 3:2) was expressed in this way a 
dissociation rate constant (K .J o f 6.4 x 10^ s’* was obtained.
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Figure 3:1 Time course of association of f^ I^JIPIN binding to liver membranes
from lactating rats. Inset shows a linear representation of the data
(see text for details).
C
'cD
4—»o
C L
C D
C
03
n
E
C D
E
O )
" O
C
3o
n
CL
5
" A
4
3
3.5
2.5
2
CD 1.5
0.5
0..01 200 400 600 800 1.00C
Incubation Period (sec)
0
0 1 0  2 0  3 0  4 0
Incubation Period (min)
Specific  Binding Total Binding N on-Specific  Binding
—Q— —A—  0....
5 0
The data shown are from a single experiment using a radioligand concentration of 70pM.
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Figure 3:2 Time course of dissociation of [^^TjIPIN binding to liver membranes
from lactating rats. Inset shows a linear representation of the data (see
text for details).
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Calculation of dissociation constant from rate constants:-
Using the values determined for Kj and K.j the dissociation constant (Kj) may be 
obtained:
•  %  ( « V )
Hence, the dissociation constant determined from kinetic analysis is therefore:-
6.4 X  lO"* (s-‘) = 39/jM
1.64 X  10’
Saturation assay
Saturation binding assays showed non-specific binding ranging from 15 to 35% of the 
total binding, as shown by a typical binding isotherm in Figure 3:3. The saturation 
isotherm has a characteristic rectangular hyperbola shape such that the value can 
be estimated as the plateau value of the ligand bound, as the concentration of ligand 
approaches infinity, and the as that value of ligand concentration producing half 
maximal binding. The hepatic B-adrenoceptors o f lactating female rats did not differ 
significantly in their properties from those o f weight-matched non-lactating female 
animals, and in both cases Scatchard plots were linear (see inset Figure 3:3), with 
Hill coefficients o f unity (means ±  S.E.M . of 1.00 ± 0 . 1  for lactating and non- 
lactating rats) indicating an absence of cooperative interactions in the binding of the 
non-subtype selective radioligand iodopindolol.
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Figure 3:3 Representative saturation assay of [*^ I^]IPIN binding to liver membrane
preaprations from lactating rats. Inset shows a Scatchard plot of the
data (see text for details).
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The Kj and B^ax values obtained by Scatchard analysis of saturation assays are shown 
in Table 3.1. The dissociation constant (K^) for the radioligand did not differ 
significantly between lactating and non-lactating rats and similarly, there was no 
difference in the total number o f hepatic B-receptors between these two groups of 
animals. However, both parameters were shown to be greater in liver membranes 
from males of comparable body weight, and in young females of lOOg body weight 
(Table 3.1).
In addition to these saturation binding experiments, two separate saturation assays 
were performed using "near term" foetal (20  day post coitum) rat liver and
cortical membranes, as a means of validating this radioligand binding 
procedure. Saturation assays for both membranes gave characteristic hyperbolic 
binding curves (data not shown) and Scatchard analysis gave values o f 31.5 and
89 fmol mg'^ membrane protein, and Kj values of 90 and 170pM, for "near term"
*
foetal liver membranes and adult rat brain membranes, respectively. These values 
are in close agreement with previous studies o f (-)-f ^ I]iodopindolol binding to foetal 
rat liver membranes (Snell and Evans, 1988) and rat brain membranes (Dax et al., 
1986).
Inhibition profile
For membranes both from control female and lactating rats, displacement binding 
curves o f bound p^I]IPIN were carried out using ICI 118551 (B2-antagonist), atenolol 
(Bj-antagonist) and (-)-isoprenaline (non-selective B-agonist). Such compounds
*Both radioligand binding validation experiments are each the mean of two separate 
determinations.
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TABLE 3.1.
ri25p|iPIN binding data in rat liver membrane preparations
Animal Data B-Adrenoceptors
Reproductive Body ®max Kd
Sex status weight (g) (fmol/mg protein) (pM)
Female
(n=7)
Lactating 200-250g 8.5 ±  0.71 84.6 ±  8 .8
Female
(n=5)
Non-lactating 200-250g 8.4 ±  0.4 81.9 ±  9.8
Female
(n=3)
Non-lactating 100-120g 13.4 ±  2.5* 141.2 ±  16.6*
Male
(n=3)
- 200-250g 14.9 ±  1.1*** 174.8 ±  15.6**
Values o f B^ ^x Kj were determined as described in Materials and Methods.
Values are shown as means ±  S.E.M . Statistical analysis was by means o f Student’s
t-test. Significant differences, relative to the corresponding values in the non-lactating 
200-250g female group are indicated by:- 
* : P < 0 .0 5
** : P < 0 .0 1
*** :P < 0 .0 0 1
*The graphical representation of the results of displacement experiments have not been 
shown as some difficulty was experienced in producing characteristic sigmoidal 
displacement curves. Such a finding may be a consequence of the small P-adrenoceptor 
population of these membranes.
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displaced the radioligand in a concentration dependent manner and showed a rank 
order o f displacing potency of ICI 118551 >  (-)-isoprenaline >  atenolol, indicating
a predominance o f receptors conforming to the B2-adrenoceptor subtype (data not
*
shown). However, the small size of the total B-adrenoceptor population of these 
membranes, precluded the absolute quantitation of the relative contribution o f each 
subtype to the total.
3.2.2 Characterization of rat liver «-adrenoceptors
pH]PRAZOSIN BINDING ASSAYS 
Protein dilution profile
Using liver membranes from both lactating and virgin female animals, total and 
specific binding was shown to increase linearly with an increasing membrane protein 
concentration, over the protein concentration range o f 0 - 0.35mg protein per 
incubation (data not shown). The non-specific binding component also increased with 
increasing protein content but was always found to be < 2 0 % of the total binding 
component in protein dilution profiles.
Association time course
The time course o f association of pH]prazosin binding to mid-lactating rat liver 
membranes gave a typical hyperbolic relationship, with a time for total and specific 
binding reaching a plateau at approximately 20 minutes (see Figure 3:4). Non­
specific binding showed a sharp increase within the first few minutes and then 
maintained a relatively constant value for the remainder o f the time studied.
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Using a linear transformation of this data (see inset Figure 3:4) an association rate 
constant (K J of 1.27 x 10  ^M'^ s*^  was determined.
Dissociation tim e course
The time course o f dissociation for the binding o f pHjprazosin to liver membranes 
from mid-lactating rats was determined using an excess of the non-subtype selective 
«-antagonist phentolamine, at a final concentration of 25pM. Figure 3:5 illustrates 
that this radioligand was displaced from the membranes in a time-dependent manner, 
with 50% of the specifically bound ligand displaced in approximately 30 minutes. 
Hence, the binding of pHJprazosin to these membranes was shown to be a reversible
reaction and a linear first order plot o f log versus time (in seconds) after
B,
the addition o f excess competing agent (see Figure 3:5 inset) allowed the 
determination of a dissociation rate constant (K.J of 3.62 x 10^s'\
Calculation of dissociation constant from rate constants:-
Using the values determined for Kj and K.% for the binding of pHjprazosin to the 
above mentioned rat liver membranes, the dissociation constant (K^) o f this 
radioligand may be obtained:
a :  (iW) = £ i  = 3.62 X  ')  ,  o.285«M
1.27 X  10*
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Figure 3:4 Time course of association of pHjprazosin binding to liver membranes
from lactating rats. Inset shows a linear representation of the data (see
text for details).
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The data shown are from a single experiment using a radioligand concentration of 0.5nM.
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Figure 3:5 Time course of dissociation of pH]prazosin binding to liver
membranes from lactating rats. Inset shows a linear representation of
the data (see text for details).
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The data shown are from a single experiment using a radioligand concentration of 0.5nM.
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Saturation assay
The binding o f pHjprazosin to the liver membranes from control adult female, mid- 
lactating, young female ( 100- 120g body weight), and adult male rats was shown to 
be saturable in all cases, with the non-specific binding component ranging from 30- 
40% o f the total binding, as shown by a representative binding isotherm in Figure 
3:6. The Scatchard plots of specific binding data were linear (see inset Figure 3:6), 
confirming binding o f the ligand to a single population of receptors, and Hill 
coefficients o f unity were also obtained (means ±  S.E.M . of 1.00 ±  0.1), indicating 
an absence o f cooperative interactions in the binding of this radioligand.
The Kd and values obtained by Scatchard analysis of saturation assays are shown 
in Table 3.2. Alpha-1 adrenoceptors were found to be abundant in liver membranes 
from adult female rats and no significant difference in the or values was 
found between lactating and adult female control animals. However, mean values for 
both these parameters were shown to be significantly greater in males o f comparable 
body weight and in young females (100- 120g body weight).
Inhibition profile
To confirm the selectivity o f pHjprazosin binding under the incubation conditions 
employed, the inhibition o f pH]prazosin binding to liver membranes from mid- 
lactating rats was studied using a range of a-adrenergic agonists and antagonists. 
These agents competed for specific pH]prazosin binding in the potency order o f : (-)- 
adrenaline >  phenylephrine and phentolamine >  yohimbine (see Table 3.3). Such 
a potency range is indicative of pHjprazosin binding to a-adrenoceptor subtypes in
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the rat liver membrane preparations, and is in agreement with similar findings from 
Geynet et al., (1981) in which adult female rat liver membranes were used.
TABLE 3.2
r^HIPrazosin binding data in rat liver membrane preparations
Animal Data a-A drenoceptors
Reproductive Body ®max Kd
Sex status weight (g) (fmol/mg protein) (nM)
Female
(n = 6)
Lactating 200-250g 229.6 ±  20.0 0.33 ±  0.03
Female
(n=5)
Non-lactating 200-250g 215.1 ±  18.5 0.21 ±  0.04
Female
(n=3)
Non-lactating 100- 120g 357.6 ±  5 .3 t t 0.63 ±  0 .0 6 f t t
Male
(n=3)
- 200-250g 273.8 ±  26.0 0.87 ±  0 .0 4 f t t
Values of and were determined as described in Materials and Methods. 
Values are shown as means ±  S.E.M. Statistical analysis was by means o f Student’s 
t-test. Significant differences, relative to the corresponding values in the non-lactating 
200-250g female group are indicated by:-
t
t t
t î t
P <  0.05 
P <  0.01 
P <  0.001
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TABLE 3.3
Prazosin displacement from  liver m em branes of m id-lactating ra ts
Ki (fxM)
Experimental results * Literature values*
Displacing drug:
(-)-adrenaline 3.20 ±0 .18 7.8
(-)-phenylephrine 23.50 ±1 .30 24.9
phentolamine 0.14 + 0 .0 2  I 0.108
yohimbine
; 0.69 ±0 .03
0.992
• Geynet er û/., 1981
Values for inhibition o f binding at each concentration were the mean of triplicate 
determinations and K% values were calculated from IC50 values according to Cheng 
and Prusoff (1973).
^Experimental data is the mean ±  S.E.M. for 3 separate determinations. 
pH]RX781094 BINDING ASSAYS
Protein dilution profile
Using liver membranes from both lactating and virgin female rats, total binding was 
shown to increase with increasing protein concentration, over the range of 0 - 0.5mg 
membrane protein per incubation. However, total binding was low over the protein 
concentration range studied and was indistinguishable from the parallel non-specific 
binding measurements made in the presence of 10/iM phentolamine (data not shown).
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Association time course
Examination of the association time course o f pH]RX781094 binding to hepatic 
membranes from lactating rats showed an erratic increase in total binding with time, 
over the 30 minutes studied. Again, the total binding was low and indistinguishable 
from the non-specific binding measurements (data not shown).
Dissociation time course
Due to the apparent lack of specific binding shown in other assays, this assay was not 
attempted with this radioligand.
Saturation assays
Saturation assays with f  H]RX781094 were performed using hepatic membranes from 
adult female, mid-lactating, young female (100- 120g body weight) and adult male 
rats. In all cases total and non-specific binding increased with increasing pH]- 
RX781094 concentration, and as previously found no specific binding was evident in 
any of the groups of animals studied (data not shown).
Inhibition profile
To verify that phentolamine was an appropriate agent to be used in the pH]RX781094 
binding assays as a means of determining the non-specific binding component, the 
actions of a range of a-adrenergic agents were examined. The displacing agents 
yohimbine, (-)-adrenaline and phentolamine at final concentrations ranging from 10* 
’M to lO'^M were used to compete with pH]RX781094 binding to adult female liver 
membranes. No displacement was seen with any of these agents except at a final
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concentration of ImM, where in all cases there was a 20-30% reduction in 
pH]RX781094 binding (data not shown). However, at such a high concentration of 
inhibitor it is probable that the agent is causing a non-selective displacement of the 
radioligand.
Validation of the PH1RX781094 binding assay
The results described imply that hepatic a 2-adrenoceptors are not sufficiently abundant 
to be quantifiable in the rats of body weight used in this study. To validate this 
result, the pH]RX781094 binding assay technique was applied to membranes from 
rat cerebral cortex as a positive control.
Initially, a protein dilution profile was performed with rat cortical membranes 
(prepared as described previously) and the radioligand pH]RX781094, in the presence 
and absence of lOfiM phentolamine. Total and specific binding was shown to 
increase linearly with an increasing membrane protein concentration over the range 
studied, and the non-specific binding component was found to be 30-40% of the total 
binding value (data not shown). From this study, a protein concentration of 
0 .3 mg/incubation was chosen for a saturation binding study, which was performed 
under the same assay conditions as the previous saturation binding o f pH]RX781094 
to rat liver membranes. The saturation isotherm was a  characteristic rectangular 
hyperbolic shape (see Figure 3:7) and Scatchard analysis gave values for and IQ 
of 175 fmol/mg protein and 1.7 nM, respectively. Such findings are in reasonable 
agreement with literature values o f 230 fmol/mg protein and 2.8nM , respectively 
(Hewlett er û/., 1982).
* Values given are the means of two experimental determinations.
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Figure 3:6 Representative saturation assay of pHJprazosin binding to liver
membrane preparations from adult female rats. Inset shows a
Schatchard plot of the data (see text for details).
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Figure 3:7 Saturation assay of pH]RX781094 binding to rat cerebral cortical
membranes. Inset shows a Scatchard plot of the data (see text for
details).
3 0 0
0.3mg membrane protein
Q -  2 5 0
~  CO
J D
CD 2 0 0
pH] -RX781094 bound (fmol)
150
H—
n  ^00
C D
O
..0- ‘
50
4 6 140 2 8 10 12
concentration [^H]-RX781094 (nM)
Specific  Binding Total Binding N on-Specific  Binding
■ ■ ■ I I I I I  I — "  "  — • • • • •
128
3.3 DISCUSSION
3.3.1 (-)-P^niodoDÎndolol Binding Assay
[^^^I]Iodopindolol is a relatively new ligand that has proved useful in characterizing 
B-adrenoceptors in tissues in which other ligands have proved unsuitable due to their 
high non-specific binding (Barovsky and Brooker, 1980, Ezrailson et al., 1981). In 
this study, the binding of [^^1]1P1N to rat liver membranes was rapid, saturable, 
reversible and showed displacement characteristics typical o f binding to fi- 
adrenoceptors. Kinetic analysis confirmed the time of incubation of the radioligand 
with the membranes and also allowed the determination of the dissociation constant 
(Kj). This radioligand showed no selectivity for fij or fi2-adrenoceptors and the 
reaction between [*^I]1P1N and its binding site was characterized as a second order 
reaction between a unilavent, homogeneous ligand and a homogeneous, non­
interacting receptor population, by virtue of the linearity of the Scatchard plots and 
the unity of the Hill coefficient. Linearity o f the Scatchard plots was verified using 
the computer program L1GAND:SCAF1T, so confirming a one site model.
The dissociation constant (K^) obtained from kinetic analysis o f [^^1]1P1N binding to 
liver membranes from lactating animals was somewhat lower than the value obtained 
by Scatchard analysis of saturation assays (mean ±  S.E.M . =  84.6 ±  8 .8pM 
compared to 39pM). The value obtained from analysis of saturation binding data is 
in agreement with literature values obtained in rat liver, which range from 60-90pM 
(McMillian et al., 1983; Dax et al., 1986; Snell and Evans, 1988), and the 
comparatively lower Kj value determined by kinetic analysis has also been similarly
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reported in the literature (Dax et al., 1986). However, a true comparison o f the 
value obtained by these two methods of data analysis in this study cannot be made, 
as only one full kinetic analysis was determined. Scatchard analysis o f specific 
binding data gave similar values for mid-lactating (Mean ±  S.E.M . =  84.6 ±  
8 .8pM) and weight-matched adult female animals (81.9 ±  8 .8pM). Using liver 
membranes from "near term" foetal rats as a means of validating this assay 
procedure, a value of 90pM was determined and found to be in line with the 
findings o f Snell and Evans (1988). However, this parameter was shown to be 
significantly greater in both liver membranes prepared from body-weight matched 
males (mean ±  S.E.M . =  174.8 ±  15.6pM) and young females (100-120g body 
weight) (141.2 ±  16.6pM) and in rat cerebral cortical membranes (170pM). 
Previous studies have shown that the values for [*^^1]1P1N determined by saturation 
analysis tend to be consistent within each tissue type, for example in hepatic 
membranes from rats during different developmental stages (McMillian et al., 1983; 
Dax et al., 1986), but between different tissues may show significant variation 
(Ezrailson et al., 1981; Dax et al., 1986). Hence, the Kj value o f this radioligand 
obtained from binding studies with rat cerebral cortical membranes was in line with 
literature values (Dax et al., 1986) but the elevated values for hepatic membranes 
from adult male and young female (100- 120g body weight) rats are in contrast to the 
findings that the K<, values tend to be consistent within this tissue for a range o f ages.
As for the total B-adrenoceptor population in rat liver membranes, the measurements 
made in this study found only small numbers o f B-adrenoceptors in adult female rat
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(200-250g body weight) liver (mean ±  S.E.M . =  8.4 ±  0.4 fmol/mg membrane 
protein). Relatively few studies of adrenergic receptors have been made on female 
livers compared to male livers and the majority of the work has concentrated on 
assessing the relative importance of a-  and B-adrenergic pathways, by measuring their 
respective intracellular signalling mechanisms in isolated hepatocytes challenged with 
catecholamines (Studer and Borle, 1982). However, the measurements made in this 
study are in agreement with more recent findings by Studer and Ganas (1988), in 
which the hydrophillic B-antagonist pH]CGP-12177 was used to study the B- 
adrenoceptor sites o f both intact hepatocytes and liver membrane preparations. In 
such studies, the B„^ value of hepatic membranes from female rats (250-300g body 
weight) was found to be 14.5 ±  4 fmol/mg membrane protein and 10.7 ± 1 . 7  
fmol/mg membrane protein in hepatocytes isolated from the same body weight female 
rats.
To our knowledge no previous measurements of adrenoceptor population in liver 
membranes from lactating rats have been reported and in our study no significant 
differences in the B ^  value was observed in such membranes when compared to 
values from weight-matched virgin females. However, hepatic membranes from 
young female (100-120g body weight) and adult male (200-250g body weight) rats 
were shown to have higher B^^ values of 13.4 and 14.9 fmol/mg membrane protein, 
respectively. It is generally accepted that there is a postnatal decline in the B- 
adrenoceptor concentration in rat liver (Snell and Evans, 1988) and that this decline 
continues into adult life (McMillian et al., 1983). Such a phenomenon is based upon 
findings from liver membranes of male rats and has been reinforced by evidence of
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age-related changes in the fi-adrenoceptor-mediated responses of rat liver (Blair et al. , 
1979; Morgan et al., 1983a). If  such a phenomenon were true for female rats, then 
a larger 8 -adrenoceptor concentration in young female (100- 120g body weight) rats 
compared to mature females (200-250g body weight) would prevail. Such findings 
were made in this study, although the value for young females ( 100- 120g body 
weight) was somewhat lower than the published value o f 60 fmol/mg membrane 
protein (Guellaen et al., 1978; Munnich et al., 1981) for liver membranes from 
weight-matched female animals. However, the literature values are determined from 
saturation binding experiments using the radioligand pH]dihydroalprenolol, which has 
been previously reported to show a non-stereospecific displaceable binding component 
which is believed to be a consequence of the liposolubility of this ligand (Dax and 
Partilla, 1982). For this reason, no published values for the binding of 
pHjdihydroalprenolol to mature female liver membranes are available, as the non- 
stereospecific binding was found to be too high to allow accurate quantitation o f the 
specific binding in liver membranes of mature rats (Dax et al., 1981). Hence, the 
binding o f pH]dihydroalprenolol to female liver membranes does not seem to be 
comparable with the binding of [^^^IjlPIN, which is less liposoluble and more 
stereoselective for 8 -adrenoceptors in these membrane preparations. Our results in 
this study, though only preliminary, do tend to suggest a slight decline in the hepatic 
8 -adrenoceptor population of female rats during the developmental transition from a 
young adult (100-120g body weight; approximately 30 days old) to mature adult (200- 
250g body weight; approximately 80 days old).
The Bmax value for liver membranes from adult male rats (body weight 200-250g) of
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14.9 fmol/mg membrane protein is in good agreement with the literature value of 
16.5 fmol/mg membrane protein in liver membranes from male rats o f body weight 
250-300g (Studer and Ganas, 1988). The radioligand used by these workers to 
enumerate the 8 -adrenoceptor population of these membranes was pHjCGP-12177 and 
in relation to such measurements, the binding of [*^^I]IPIN to liver membranes from 
mature male and female rats would appear to be comparable to that o f pHJCGP- 
12177 binding (Studer and Ganas, 1988). Interestingly, additional experiments 
performed by these workers, using intact hepatocytes from the adult male rat, could 
not identify any 8 -adrenoceptors accessible to this ligand, whereas similar values 
were obtained from crude preparations o f liver membrane and from membranes 
prepared from isolated hepatocytes. This was interpreted to mean that 8 - 
adrenoceptors were not being expressed at the external plasma membrane surface of 
hepatocytes from mature male rats, unlike hepatocytes from adult female rats. Such 
a finding is o f fundamental importance when considering the sexual dimorphism in 
the adrenergic regulation o f hepatic glycogenolysis (Studer and Borle, 1982) and 
could account for the finding that in adult male rat liver adrenaline increases 
phosphorylase a activity via an «-mediated, cAMP-independent pathway, despite the 
apparently similar 8 -adrenoceptor populations found in both adult male and female 
liver membrane preparations.
In summary, the radioligand [^^^I]iodopindolol proved to be a suitable ligand for 
labelling 8 -adrenoceptors in the liver membranes studied and allowed accurate 
quantitation o f such 8 -adrenoceptor populations. No significant difference in the 
hepatic 8 -adrenoceptor number was observed in the transition from adult virgin
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female to weight-matched lactating rat and preliminary studies using liver membranes 
from adult male and young female (100- 120g body weight) animals have shown them 
to have slightly higher 8 -adrenoceptor populations when compared to adult virgin 
female rats.
3.3.2 r^HlPrazosin Binding Assay
The compound pHjprazosin has been shown to be an «^-selective antagonist and is 
widely used for the detection and measurement o f «^-adrenoceptors in a variety of 
tissues (Greengrass and Bremner, 1979; Bobik, 1982, Goodhardt er a / . , 1984). This 
radioligand has been extensively used in experiments to label «^-adrenoceptors in rat 
liver preparations in preference to the non-subtype selective antagonist pH]- 
dihydroergocryptine, as the use of «-subtype selective radioligands enables the 
enumeration of small «-subtype selective adrenoceptor populations (Hoffman et al., 
1981).
In the present study, the binding of pHjprazosin to rat liver membranes was rapid, 
saturable, reversible and showed selective binding to a single class of receptors. 
Kinetic analysis confirmed the time of incubation of the radioligand with hepatic 
membranes and also allowed the determination of the dissociation constant (K^). The 
Kd obtained from kinetic analysis of pHJprazosin binding to liver membranes from 
lactating animals (0.285nM) was in good agreement with the value obtained by 
Scatchard analysis of saturation assays (mean ±  S.E.M . =  0.33 ±  0.03nM) and 
Scatchard analysis of specific binding data gave similar Kj values for mid-lactating 
(0.33 ±  0.03nM) and weight-matched adult female animals (0.21 ±  0.04 nM).
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These values for pETJprazosin are comparable to the literature values for this 
ligand, which range from 0.1 - 0.25nM (Geynet e ta l. ,  1981; Goodhardt e ta l. ,  1984; 
Schwarz et al., 1985; Studer and Ganas, 1988). However, liver membranes from 
both adult male (200-250g body weight) and young female (100-120g body 
weight)rats gave values for pH]prazosin that were significantly greater than the 
values obtained from hepatic membranes from weight-matched adult female and mid- 
lactating animals. Studies by McMillian et al., (1983) using liver membranes from 
"near term" foetal and young rats (3-26 days old) found the apparent Kj for pH] 
prazosin to be independent o f age and to give an average value o f 1.4 +  O.lnM. 
Such an elevated from young male rat liver membranes may provide an 
explanation for the raised IQ value found in this study for pHjprazosin binding to 
liver membranes from young female rats (100- 120g body weight).
Alpha-1 adrenoceptors were, as expected, abundant in liver membranes from adult 
(2(X)-250g body weight) female rats, with a mean value of 215 fmol/mg 
membrane protein. The characterization of «-adrenoceptors in female liver, as with 
those of 6 -adrenoceptors, has received little attention in the literature. However, 
some recent work by Studer and Ganas (1988) employing pHjprazosin binding to 
isolated hepatocytes from adult male and female rats (250-3(X)g body weight), has 
shown that there are equal amounts of «^-receptors in both, with values o f 247 ±  28 
and 249 ±  27 fmol/mg protein for females and males respectively. Hence, our 
results for the «^-adrenoceptor population o f liver membranes from adult female rats 
(2(X)-250g body weight) are comparable to the findings of Studer and Ganas (1988),
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as too are our findings of the «i-adrenoceptor concentration of liver membranes from 
weight-matched adult male rats (mean ±  S.E.M . =  273.8 ±  26 fmol/mg membrane 
protein). Similarly, no differences were observed in the values for hepatic «j- 
adrenoceptor populations in the transition from the adult virgin to the lactating state. 
However, our findings do suggest a decline in the hepatic «i-adrenoceptor population 
in the transition from young female (100-120g body weight; B ^  =  357.6 ±  5.3 
fmol/mg membrane protein) to adult female rat (200-250g body weight; B ^  =  215.1 
± 1 8 .5  fmol/mg membrane protein). Such a phenomenon has been observed in the 
male rat liver, where ageing is associated with dramatic changes in the cAMP 
response of isolated hepatocytes to catecholamines (Blair et al., 1979; Morgan et al., 
1983a) and preliminary work in our study has shown that the hepatic 6 -adrenoceptor 
population of young female rats appears to be greater than that of the mature female 
animal. However, similar experiments by Morgan et al., (1983b) using hepatocytes 
isolated from juvenile male (80-1 lOg body weight) and ageing male rats (300g) have 
shown that there is no evidence that the maturation of the male rat is associated with 
any alteration of the a^-adrenergic mediated Ca '^^ efflux response and radioligand 
binding studies have indicated that there is also no change in the «j-adrenoceptor 
number in rat liver plasma membranes from the time o f weaning to maturity (Butler 
et al., 1980; McMillian et al., 1983). Indeed, hepatocytes from juvenile male rats 
seem to resemble those isolated from adult female animals, in the sense that they both 
possess a - and 6 -adrenoceptor mediated responses to adrenergic agonists, so 
providing a dual mechanism for the activation of glycogen phosphorylase (Studer and 
Borle, 1982; Morgan et al., 1983a,b). However, the ontogeny o f hepatic 
adrenoceptors and the hepatic adrenergic-mediated responses of female rat liver have
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not been studied to the same extent as those of the male rat and hence it remains 
uncertain as to whether hepatic «j- and 6 -adrenoceptor populations in immature 
female animals undergo the same changes as in young male rats.
3.3 .3  r^HlRX781094 Binding Assay
For the selective labelling of «g-^drenoceptors the following are the preferred 
radioligands: pH]yohimbine and its diastereoisomer pHJrauwolscine, and the 
compound pH]RX781094. All are antagonist compounds and the latter is the 
radioligand of choice as it possesses a higher selectivity ratio than yohimbine 
or rauwolscine (Dettmar et ah, 1981; Doxey et al., 1983). pH]RX781094 has been 
commonly used to label « 2-&(lrenoceptors in the rat brain cortex and the specific 
binding of this radioligand has been found to be saturable (80% specific binding), 
reversible and of high affinity (Howlett et al., 1982; Pimoule et al., 1983).
The application of pH]RX781094 to quantify rat hepatic «g-^drenoceptors in crude 
liver membranes in our study proved to be unsuccessful. The binding assay technique 
was checked using rat cerebral cortical membranes as a positive control and the 
binding characteristics were in agreement with published results (Howlett et a l. , 1982; 
Pimoule et al., 1983). For the membranes from the different groups o f rats used in 
the previous studies of 6 - and «^-adrenoceptors, the total pH]RX781094 binding 
component remained low and no specific binding was evident. Such findings imply 
that hepatic « 2-adrenoceptors are not sufficiently abundant to be quantifiable in the 
membranes used in this study. Previous reports o f « 2-adrenoceptor populations of 
liver membranes from mature male rats (250-350g) have been made using pH]-
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dihydroergocryptine (Hoffman et al., 1980) and pHJyohimbine (Hoffman et al., 
1981). Both studies demonstrated that the proportion of « r  and « 2-^drenoceptors 
present was 80% and 20% respectively. Hence, the « 2’adrenoceptors in liver appear 
to constitute a minority of the total «-adrenoceptor population. More recently, 
ontogeny studies o f male rat hepatic «2-adrenoceptors have been performed employing 
the radioligand pH]rauwolscine (McMillian et al., 1983) and a dramatic fall in « 2- 
adrenoceptor concentration has been shown to occur during the transition from late 
gestation to birth, to such an extent that adult levels (35-45 fmol/mg membrane 
protein) were shown to be reached by the second postnatal week. Hence, such results 
confirm that the number of «2-adrenoceptors in adult male rat liver plasma 
membranes are small in comparison with the number of «j-adrenoceptors. Further 
supportive evidence from experiments using hepatocytes isolated from male rats have 
shown that any « 2-adrenoceptors that are present exert little, if  any, effect in the 
regulation o f glycogen phosphorylase activity, as the use o f yohimbine was shown not 
to modulate the adrenaline-induced activation of this enzyme (Morgan et al., 1983a).
In conclusion, it appears from the literature that «2-adrenoceptors constitute only a 
small percentage of the total «-adrenoceptor population present in liver membranes 
from adult rats. In this study, the radioligand pH]RX781094 was used to quantify 
« 2-adrenoceptors in liver membrane preparations from young female ( 100- 120g) and 
weight-matched (200-250g body weight) male, female and mid-lactating animals and 
in all cases no specific « 2-adrenoceptors could be measured. As previously mentioned 
this radioligand is known to have a considerably higher « 2/«rselectivity ratio than the 
other commonly used « 2-adrenoceptor radioligands and consequently is assumed to
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be a more accurate label for such receptors, especially in tissues which have a 
considerable «j-adrenoceptor population. The liver has been shown to be such a 
tissue and it seems that «2-&drenoceptor binding sites are indeed negligible in liver 
membranes from both male and female rats.
3 .3 .4  Sum m ary of Findings
From our hepatic adrenoceptor enumerations it can be concluded that the adult female 
liver possesses a predominance of «i-adrenoceptors compared to 6 -adrenoceptors, in 
the ratio of approximately 25:1 and this ratio may be decreased in younger animals, 
as evidence suggests that there may be a reduction in 6 -adrenoceptor number during 
maturation of the rat (McMillian et al., 1983). These binding studies also suggest 
that liver membranes from adult male rats have similar «j- and 6 -adrenoceptor 
populations to adult female livers. However, previous measurements o f intracellular 
mediators have implicated a predominant role of the «i-adrenergic pathway in 
hepatocytes from adult male rats (Studer and Borle, 1982) and more recent 
radioligand binding studies have led to the suggestion that the 6 -adrenoceptors o f male 
rat hepatocytes, although present in the cell are not recognized at the external cell 
surface (Studer and Ganas, 1988).
No differences in hepatic adrenoceptor populations have been shown between control 
adult female rats and weight-matched mid-lactating animals, although it remains 
possible that alterations in signal transduction mechanisms may occur which would 
alter adrenergic responsiveness without necessarily causing a change in adrenoceptor 
number (see section 1.4.1.4 Receptor Regulation for details). The significance of
139
these findings and those of subsequent chapters involved with the effects o f adrenergic 
agents on a range o f post-receptor events, both in hepatocytes from mid-lactating and 
weight-matched female rats, will be considered in Chapter 6 .
CHAPTER 4
CHARACTERIZATION OF THE HEPATIC ADRENOCEPTOR 
POPULATION IN THE ADULT FEMALE AND LACTATING EWE
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4.1 OBJECTIVES
As discussed previously, the roles of the liver with regard to glucose and lipid 
provision differ markedly between lactating and non-lactating ruminant and 
monogastric animals. In both of these groups of animals, catecholamines are believed 
to be important in the regulation of hepatic metabolic processes and hence we sought 
to determine the hepatic adrenoceptor status in the lactating and non-lactating sheep 
to allow comparision with the reported data for the rat.
Hepatic adrenoceptor populations were characterized by performing radioligand 
binding assays with liver membrane preparations isolated from adult female, pregnant 
and lactating ewes (see section 2.1.1 and 2.1.3) and the same radioligands as used for 
the characterization of rat liver adrenoceptors were employed.
4.2 RESULTS
4.2.1 Characterization of sheep liver fi-adrenoceptors
(.).[125i j i o d OPINDOLOL b i n d i n g  a s s a y s
Protein dilution profiles, the time course of association and dissociation, and 
inhibition studies for a range of adrenergic agents were carried out using mebranes 
from control female ewes (non-pregnant, non-lactating). Limited time and cost o f the 
radioligand prevented a complete range of assays from being carried out at all 
reproductive stages, but dissociation constants (IQ) for [^^I]IPIN obtained from 
saturation assays (Table 4.1) and results from inhibition profiles, confirmed that it
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was reasonable to assume that [*^I]IPIN was binding to the same receptor population 
for each group of animals.
Protein dilution profile
Total and specific ligand binding increased linearly with increasing protein 
concentration up to a membrane protein content of 0 .2 mg per assay tube and at higher 
protein concentrations the data points deviated from linearity. Non-specific binding 
also increased linearly with protein concentration, but was always < 1 0 % o f the 
corresponding total binding component (Figure 4:1). From such measurements it was 
decided to use a protein concentration of 0 .1  mg protein per assay tube in all 
subsequent binding assays.
Association time course
The time course of association of f^^I]IPIN with control female liver membrane 
preparations showed a typical hyperbolic increase of total and specific binding, 
reaching a plateau at around 25 minutes; non-specific binding showed a sharp increase 
in the first two minutes and then fell to a relatively constant value representing 
approximately 20% of the total binding component at each time point studied (Figure 
4:2). Using a linear transformation of this data (see inset Figure 4:2 and section
1.4.2.4 Radioligand Binding Studies) an association rate constant (K J of 1.5 x 1 0 % ' 
s^'^  was determined.
Dissociation time course
When excess isoprenaline was added to an incubation mixture containing membrane
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Figure 4:1 Protein dilution profile of f  ^ ^IjlPIN binding to liver membranes 
isolated from control female sheep.
1 6 ,000
14 ,0 0 0
12,000
0 _ 10,000 
“6
ID
c
3  8,000
n
CL 6,000
4 ,0 0 0
2,000
0 .2 50 .1 5 0.20 .0 5 0.10
Membrane protein per assay tube (mg)
S pecific  binding Totai Binding N on-Specific  Binding
— I—I—  — / \  — - .... • • ■
The data shown are from a typical experiment using a radioligand concentration of 70pM.
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Figure 4:2 Time course of association of p^ I^jlPIN binding to liver membranes
from adult female sheep. Inset shows a linear representation of the
data (see text for details).
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The data shown are from a single experiment using a radioligand concentration of 70pM.
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Figure 4:3 Time course of dissociation of f  ^ I^jlPIN binding to liver membranes
from adult female sheep. Inset shows a linear representation of the
data (see text for details).
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The data shown are from a single experiment using a radioligand concentration of 70pM.
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from control female sheep livers with [‘^ ^I]IPIN bound at equilibrium, the radioligand 
was displaced from the membrane in a time dependent manner with 50% of the 
specifically bound ligand displaced in approximately 12 minutes (Figure 4:3). A 
dissociation rate constant (K.,) of 8.5 x 10^s*‘ was determined from the linear plot of 
this binding data (see inset Figure 4:3).
Calculation o f the dissociation constant from rate constants:-
Using the values determined for Kj and K.j the dissociation constant (K j may be
obtained:
=  5.66 X 10 "  M or 56.6 pM
Saturation assay
The binding of [*^^I]IPIN to sheep liver membranes was shown to be a saturable 
process as evidenced by the representative saturation isotherm (Figure 4:4); the non­
specific binding element was shown to represent approximately 10-20% of the total 
binding component. Transformations of all the saturation binding assays performed 
gave linear Scatchard plots (see Figure 4:4 inset for example) so confirming that the 
ligand was binding to a single population of receptors.
The Kj and values obtained by Scatchard analysis o f saturation assays are shown 
in Table 4.1. No differences in hepatic 8-adrenoceptor number or radioligand affinity 
were noted between preparations from lactating and non-lactating sheep and additional
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preliminary findings suggested that the 8 -adrenoceptor profile of pregnant sheep livers 
was similar to that of non-pregnant individuals.
Inhibition profile
For membranes isolated from control adult ewes, displacement binding curves of 
bound were carried out using the compounds ICI 118551, atenolol and (-)-
isoprenaline. Such compounds displaced the radioligand in a concentration dependent 
manner and showed a rank order of displacing potency of ICI 118551 >  (-)- 
isoprenaline >  atenolol (data not shown), indicating a predominance o f the 82- 
adrenoceptor subtype within the hepatic 8 -adrenoceptor population.
4.2.2 Characterization of sheep liver of-adrenoceptors 
pHJPRAZOSm BINDING ASSAYS
Protein dilution profiles, the time course of association and dissociation, and 
inhibition studies for a range of adrenergic agents were carried out using membranes 
from control female ewes (non-pregnant, non-lactating). Limited time prevented a 
complete range of assays from being carried out at all reproductive stages, but 
dissociation constants (K j for pHjprazosin obtained from saturation assays (Table 
4.2) and results from inhibition profiles, confirmed that it was reasonable to assume 
that pHjprazosin was binding to the same receptor population for each group o f 
animals.
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Figure 4:4 Representative saturation assay of [*^ I^]IPIN binding to liver
membranes from lactating ewes. Inset shows a Scatchard plot of the
data (see text for details).
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TABLE 4.1
r^^niPIN binding data in sheep liver membrane preparations
ANIMAL DATA B-ADRENOCEPTORS
Physiological l^ max Kd
Sex status (fmol/mg protein) (pM)
Female Lactating 44.0 ±  4.5 83.6 ±  9.5
(n=6)
Female Non-lactating 53.4 ±  12.0 85.7 ±  3.9
(n=4)
Female Pregnant 37.8 84.3
(n=2)
TABLE 4.2
r^HlPrazosin binding data in sheen liver membrane preparations
ANIMAL DATA ai-ADRENOCEPTORS
Sex
Physiological
status
®niax
(fmol/mg protein)
Kd
(nM)
Female Lactating 48.1 ±  5.6 0.20 ±  0.02
(n=6)
Female Non-lactating 51.3 ±  3.5 0.18 ±  0.04
(n=4)
Female Pregnant 43.1 0.25
(n=2)
Receptor number and radioligand affinity (K J were obtained from saturation 
assays (see text for details). Values are given as means ±  S.E.M . Statistical 
analysis was by means of Student’s t-test and significant differences, relative to the 
corresponding values in the non-lactating ewe are indicated by * : P < 0 .0 5 , ** : 
P < 0 .0 1 , *** : P < 0 .0 0 1 .
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Protein dilution profile
Total and specific binding of pHjprazosin increased linearly with increasing protein 
content over the concentration range studied (0-0.4mg protein/incubation). The non­
specific binding component also increased linearly with membrane protein 
concentration and was shown to range between 30-40% of the corresponding total 
binding element (data not shown). From such measurements it was decided to use 
a protein concentration o f 0.2mg protein per incubation in all subsequent binding 
assays.
Association time course
The time course of association of pH]prazosin binding to liver membranes from 
control adult ewes showed a typical hyperbolic increase in total and specific binding, 
reaching a plateau at approximately 20 minutes. In contrast, the non-specific binding 
element showed a sharp increase in the first five minutes of the timescale studied, and 
then remained at a relatively constant value of approximately 30% of the total binding 
component, for the remainder of the time studied (Figure 4:5). Using a linear 
transformation of this data (see inset Figure 4:5 and section 1.4.2.4 Radioligand 
Binding Studies) an association rate constant (Kj) of 7.9 x 10  ^M'^s'^ was determined.
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Figure 4:5 Time course of association of pHjprazosin binding to liver membranes
from adult female sheep. Inset shows a linear representation of the
data (see text for details).
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The data shown are from a single experiment using a radioligand concentration of 0.5nM.
151
Figure 4:6 Time course of dissociation of pH]prazosin binding to liver
membranes from adult female sheep. Inset shows a linear
representation of the data (see text for details).
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Dissociation time course
When excess (-)-adrenaline was added to an incubation mixture containing membrane 
from control adult female sheep livers with pHjprazosin bound at equilibrium, the 
radioligand was displaced from the membrane in a time dependent manner, with 50% 
of the specifically bound ligand displaced in approximately 10 minutes (Figure 4:6). 
A dissociation rate constant (K .J o f 1.14 x 10‘^ s*^  was determined from the linear 
secondary plot of this binding data (see inset Figure 4:6 and section 1.4.2.4 
Radioligand Binding Studies).
Calculation of the dissociation constant from rate constants:- 
Using:
Then:
„  = l -1 4 x lQ - ^ r ' ^ 1 .44x10-’°M = O .m n M
“ 7 .9xlO « '
Saturation assay
A typical saturation profile of pH]prazosin binding is shown in Figure 4:7, together 
with the Scatchard plot of these data. It can be seen that the binding o f this 
radioligand to these hepatic membranes is a saturable process and the linearity o f the 
Scatchard analyses confirms that pH]prazosin is binding to a single population of 
receptors. The non-specific binding was found to range between 25-45 % o f the total
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Figure 4:7 Representative saturation assay of pHjprazosin binding to liver
membranes from lactating ewes. Inset shows a Scatchard plot of the
data (see text for details).
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binding component. The and values obtained by Scatchard analysis of the 
saturation assays are shown in Table 4.2. Alpha-1 adrenoceptors were not found to 
be abundant in liver membranes isolated from adult ewes and no significant difference 
in the or values was found for the hepatic membranes isolated from the three 
groups of sheep studied.
Inhibition profile
In order to confirm the selectivity o f pHjprazosin binding under the assay conditions 
employed, the displacement of pHjprazosin binding to liver membranes from control 
adult female sheep was studied using a range of adrenergic compounds. These agents 
competed for specific pHjprazosin binding in the potency order of: (-)-adrenaline >  
methoxamine and prazosin >  yohimbine (data not shown). Such a potency range is 
indicative of pHjprazosin binding to aj-adrenoceptor subtypes in the sheep liver 
membrane preparations and is comparable with similar findings o f pHjprazosin 
displacement in a range of biological membranes (Greengrass and Bremner, 1979; 
Geynet et al., 1981; Bobik, 1982).
PH]RX781094 BINDING ASSAYS 
Protein dilution profile
Using liver membranes from both lactating and control adult ewes, the total binding 
of pHjRX781094 was shown to increase with increasing protein concentration over 
the range of 0 - 0.5mg membrane protein per incubation. The non-specific binding 
component also showed a similar increase with increasing protein content and was 
found to be indistinguishable from parallel measurements o f total binding. Thus, over
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this protein concentration range no specific binding of pH]RX781094 to either 
membrane preparation could be identified (data not shown).
Association time course
Examination of the association time course of pH]RX781094 binding to hepatic 
membranes from lactating ewes showed a small increase in total and non-specific 
binding over the first 10 minutes of incubation and this level of binding was retained 
over the remaining 30 minute period studied (data not shown). As with the protein 
dilution assay, the total and non-specific binding elements were indistinguishable, so 
suggesting an absence of any specific binding of this radioligand.
Dissociation time course
Due to the apparent lack of specific binding, this assay was not attempted with this 
radioligand.
Saturation assays
Saturation binding assays using pH]RX781094 were performed with hepatic 
membranes prepared from control adult, lactating and pregnant ewes. In all cases 
total and non-specific binding increased with increasing radioligand concentration and 
again total and non-specific binding values were similar at each concentration of 
pH]RX781094 used (data not shown). Such findings appear to confirm an absence 
o f any specific saturable binding of pH]RX781094 in these liver membrane 
preparations.
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Inhibition profile
The compounds (-)-adrenaline, methoxamine, clonidine and yohimbine at a final 
concentration range of lO"* to 10'  ^ M were used to compete with pH]RX781094 
binding to liver membranes from lactating ewes. No significant displacement o f this 
radioligand was observed with any of these agents, except at the highest 
concentration, where it is probable that the compound causes a non-selective 
displacement o f the radioligand.
Validation of the r^H1RX781094 binding assay
The results described above imply that hepatic ^ 2-adrenoceptors are not sufficiently 
abundant to be quantifiable in the liver membranes used in this study. To validate 
this conclusion, two approaches were taken, firstly to verify the assay conditions 
employed with this radioligand and secondly to validate the use o f this radioligand in 
such measurements.
The assay conditions used in this study have previously been verified using rat 
cerebral cortical membranes as a positive control (see section 3.2.2 Characterization 
o f rat liver a-adrenoceptors) and some preliminary work using sheep omental fat cell 
membranes, as a further positive control was additionally undertaken. Results from 
these experiments (not shown) indicated a significant degree of specific binding of 
pH]RX781094 to these membranes under the incubation conditions described 
(Chapter 2 Materials and Methods). Detailed binding assays using sheep omental fat 
cell membranes were not undertaken and no quantification of the (X2-adrenoceptor 
population o f these membranes was made beyond further validating the binding assay
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protocol for the radioligand pH]RX781094.
Additionally, the radioligand pHjrauwolscine was available to perform some binding 
assay measurements using liver membranes from control and lactating ewes. The 
binding assay procedure was identical to that performed when using either 
pH]prazosin or pH]RX781094 (see Chapter 2 Materials and Methods) and was 
comparable with literature references for pH]rauwolscine binding assay protocols 
used with various biological membrane preparations (McMillian et al, 1983; Kobatake 
et al., 1991). For both liver membranes from adult control female and lactating 
sheep a protein concentration of 0.2mg/incubation tube was chosen and saturation 
assays were performed over the radioligand concentration of 0.2 - 8nM, using 100/xM 
(-)-adrenaline to determine the non-specific binding component. In both o f these 
experiments the total and non-specific binding values increased with increasing 
radioligand concentration and no specific binding could be distinguished at any o f the 
radioligand concentrations studied (data not shown). In addition, no displacement of 
pHJrauwolscine binding to these hepatic membranes was evidenced with a range of 
concentrations (10'* - lO^M) of either (-)-adrenaline or yohimbine, when these 
membranes were incubated with a radioligand concentration of approximately the 
value for pH]rauwolscine (ie: 2nM from McMillian et at., 1983). Hence, the results 
from these two binding experiments would seem to suggest that hepatic «2" 
adrenoceptors are not sufficiently abundant to be quantifiable in the membrane 
preparations from these animals.
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4.3 DISCUSSION
4.3.1 (-)-r^^niPIN Binding Assay
In this study, the binding o f f^ IjlP IN  to sheep liver membranes was rapid, saturable, 
reversible and showed displacement characteristics typical o f binding to B- 
adrenoceptors. The linearity o f Scatchard plots of saturation binding data confirmed 
that the ligand was binding to a single population of receptors. The dissociation 
constant (Kj) of p^I]IPIN  binding to control sheep liver membranes calculated from 
kinetic analysis was somewhat lower than the value obtained by Scatchard analysis 
o f saturation assays (mean ±  S.E.M . =  85.7 ±  3.9pM compared to 56.6pM). 
However, saturation binding assays were carried out with all the other remaining 
sheep liver membrane preparations and hence, the values were predominantly 
determined using Scatchard analysis o f such data. No significant difference in the IQ 
value o f this radioligand for the hepatic membranes from the different groups of 
sheep was found, and the value was in agreement with previous findings using hepatic 
membranes from adult female and mid-lactating rats, and with reported literature 
values obtained with various rat liver membrane preparations (McMillian et a l. , 1983; 
Dax et al., 1986; Snell and Evans, 1988). Indeed, the similar values o f [*^I]IPIN 
binding to liver membranes from both adult female and lactating sheep and rats, 
appears to be a reflection of the overall similarities between the binding 
characteristics of this radioligand with hepatic membranes from both o f these animal 
species. Hence, [^^IJIPIN would appear to be a useful radioligand for characterizing 
B-adrenoceptors in these liver membrane preparations and in both cases, the relatively 
low non-specific binding component encountered is highly desirable in view o f some
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of the previously reported problems involved in the characterization and quantitation 
of hepatic B-adrenoceptors (Dax et al., 1981).
A greater number of B-adrenoceptors were found in sheep liver membranes (Table 
4.1) than in rat liver preparations (Table 3.1) and as with rat hepatic membranes, no 
differences in receptor number were noted between preparations from lactating and 
non-lactating sheep. In addition, the B-adrenoceptor profile o f pregnant sheep livers 
was similar to that in non-pregnant individuals. To our knowledge, no previous 
measurements of the hepatic adrenoceptor population of adult female sheep have been 
reported. Work by Apatu and co-workers (1986) has shown the B-adrenoceptor 
binding capacity o f adult male sheep liver membranes to be similar to that of the adult 
female rat such that only a small population of B-adrenoceptors were present in either 
membrane. In support of this finding, experiments using hepatocytes isolated from 
adult male sheep and adult female rats have shown these two cell types to exhibit 
similar increases in intracellular cAMP levels in response to challenge with adrenaline 
(Morand et al., 1988). In the light o f our findings with adult female sheep liver 
membranes, it would appear that these membranes along with those from adult male 
sheep (Apatu et al., 1986) do not contain an abundance of B-adrenoceptors. In 
addition, our study showed there to be no significant change in this receptor 
population in the transition from the non-pregnant, non-lactating to the lactating 
reproductive state. Such findings are consistent with those of Faulkner and Pollock 
(1990) who found no significant differences between hepatocytes from lactating and 
non-lactating ewes in the sensitivity or responsiveness of a post-receptor metabolic 
event (glucose production) to the adrenergic agonist isoprenaline.
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4.3.2 r^BnPrazosîn Binding Assay
The binding of pH]prazosin to sheep liver membranes, as with the rat, was rapid, 
saturable, reversible and showed selective binding to a single class of receptors. 
Kinetic analysis of binding allowed confirmation of the optimum incubation time for 
the radioligand with these membranes and further showed the rapid reversibility of 
this binding reaction. The value obtained from kinetic analysis of pH]prazosin 
binding to hepatic membranes from control adult ewes (0.144nM) was in good 
agreement with the mean value obtained from Scatchard analysis o f saturation binding 
assays using these membranes (mean ±  S.E.M . =  0.18 ±  0.04nM) and Scatchard 
analysis o f specific binding data for membranes isolated from pregnant and lactating 
ewes gave comparable values for this radioligand. These values are also in 
agreement with IQ values previously found for pHjprazosin binding to adult female 
and mid-lactating rat liver membranes in this study and with the previously reported 
literature values of 0.1 - 0.25nM for pHjprazosin binding to adult rat liver 
membranes. Hence, pH]prazosin would appear to be a suitable radioligand for 
detecting and measuring cxj-adrenoceptors in both rat and sheep liver membrane 
preparations, in view of the similar binding characteristics and affinity of the 
radioligand exhibited in these preparations.
The «i-adrenoceptor population of adult female sheep liver membranes was found to 
be o f a similar size to the corresponding B-adrenoceptor population (ie: « r  
adrenoceptor population of 51.3 ±  3.5 fmol/mg protein; B-adrenoceptor population 
o f 53.4 ±  12.0 fmol/mg protein). Hence, the hepatic membranes from adult ewes 
contain neither an abundance of «i- or B-adrenoceptors, which is in accordance with
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binding studies using hepatic membrane preparations from adult male sheep (Apatu 
et al., 1986). Furthermore, this study showed there to be no significant difference 
between the a,-adrenoceptor populations of liver membranes isolated from control 
adult, pregnant and lactating ewes. This finding is consistent with the report that 
there was no difference in the response of glycogenolysis to the a-adrenoceptor 
agonist, phenylephrine, in either hepatocytes isolated from the livers of lactating or 
non-pregnant, non-lactating ewes, and that the stimulation was prevented by prazosin 
but not by yohimbine (Faulkner and Pollock, 1990).
4 .3.3 PH1RX781094 Binding Assay
The use of pH]RX781094 as a radioligand probe for «g-^drenoceptors in sheep liver 
membrane preparations led to the conclusion that this adrenoceptor subtype was not 
sufficiently abundant to be quantifiable in such membrane preparations. A similar 
finding was made when using this ligand with rat hepatic membranes.
To our knowledge, no such previous measurements of «g-^drenoceptor number have 
been reported in liver membranes or hepatocytes isolated from adult female, pregnant 
or lactating sheep. Findings by Faulkner and Pollock (1990) have shown the « 2“ 
antagonist yohimbine has no effect upon the phenylephrine-induced stimulation of 
glycogenolysis and such a finding may possibly be a consequence o f an absence of 
such adrenoceptors. Hence, our findings suggest that the a 2-adrenoceptor population 
o f adult female hepatic membranes appears to be negligible and no significant change 
in this adrenoceptor number is evidenced in the transition to the stage o f late 
pregnancy and early lactation.
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4.3.4 Sum m ary of Findings
In summary, our hepatic adrenoceptor enumerations show the adult female sheep to 
possess approximately equal populations o f both a j- and B-adrenoceptors, and 
seemingly an absence of « 2-adrenoceptors. Such findings suggest that catecholamines 
may utilize both cAMP and Ca^'^-dependent pathways in the livers o f these animals, 
in a similar way to that observed in hepatocytes from adult female rats (Studer and 
Borle, 1982; Morand et al., 1988). Studies using hepatocytes isolated from male 
sheep have confirmed the stimulation of both signalling pathways by the 
catecholamine adrenaline (Morand et al., 1988) and in view o f the apparently similar 
hepatic adrenoceptor complement of adult male (Apatu et al., 1986) and female 
sheep, it is probable that the same signalling pathways operate in both sexes.
No differences in hepatic adrenoceptor populations have been shown between adult 
ewes and pregnant or lactating sheep. Such a finding would seem to be consistent 
with the fact that during lactation in the ruminant, increased rates of gluconeogenesis 
and a negligible change in the low rates o f hepatic lipogenesis are evident in the 
prevailing hypoinsulinaemia, so consequently no change in the action o f potential 
antilipogenic regulator(s) would be anticipated in view o f such rates o f lipid synthesis. 
However, as mentioned previously for similar binding studies in rat liver membranes, 
a change in sensitivity o f such mechanisms cannot be excluded and experiments using 
intact ovine hepatocytes are necessary to study such catecholamine - induced 
responses.
The significance of these findings and a comparison with data found for rat liver will
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be discussed in Chapter 6.
CHAPTER 5
lî-ADRENERGIC EFFECTS ON POST-RECEPTOR EVENTS 
IN HEPATOCYTES ISOLATED FROM ADULT FEMALE 
AND MID-LACTATING RATS
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5.1 OBJECTIVES
Isolated cells are a very valuable tool in the investigation of a variety o f post-receptor 
events and metabolic pathways. Cells in vitro may be exposed to known 
concentrations o f agents for a fixed length of time, avoiding complications such as 
absorption, distribution, metabolism and excretion of the agents which arise when in 
vivo studies are performed. Similarly, measurement o f the levels o f substrates, 
intermediates or products of metabolism is greatly simplified in cell preparations. 
Additionally, a large number of cells may be obtained per liver such that a range of 
experiments may be performed using cells from the same animal. However, it must 
be borne in mind that the very advantages of working with isolated cells in vitro, are 
also the disadvantages which limit the interpretation o f observations and their 
extrapolation to the in vivo situation. In addition to the lack of influences o f other 
tissues and organs on isolated hepatocytes, disruption of the liver and the preparation 
of parenchymal cells in suspension may result in loss of liver architecture and intra­
organ influences. Also, more recently, zonation of the liver has been proposed such 
that hepatocytes from the two acinar zones (ie: afferent periportal area and an efferent 
perivenous region) exhibit differences with regards to carbohydrate (Chen and Katz, 
1988) and fatty acid metabolism (Guzman and Castro, 1989). Additionally, caution 
is needed in the interpretation of findings which have used hepatocytes in culture, 
particularly when studying adrenergic mechanisms, as the acquisition o f 15- 
adrenoceptors by adult rat hepatocytes during primary culture is a well documented 
phenomenon (Nakamura et at., 1983; Refsnes et at., 1983; Schwarz et a l., 1985).
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In the present study, hepatocytes were prepared by a procedure based on the method 
o f Berry and Friend (1969) with the incorporation of the modifications by Seglen 
(1976), which involves the tissue dispersion of the entire liver (without the selective 
preparation of cells from specific acinar zones) and hence, it is assumed that the 
resultant cell suspension will contain a randomised mixture o f the two types o f 
parenchymal cells. Also, in all cases, freshly isolated hepatocytes were used 
immediately after the statutory pre-incubation period to minimise any post-preparative 
changes.
In Chapter 3 the adrenoceptor complement of hepatic membranes prepared from mid- 
lactating and weight-matched female rats were compared and showed no difference 
in the number, type or subtype of adrenoceptor present. If  adrenergic mechanisms 
are involved in the regulation of liver metabolism during lactation, then it would be 
expected that there would be some change in the responsiveness or sensitivity o f liver 
cells to adrenergic agents. The paradox of increased rates of hepatic lipogenesis in 
association with the prevailing hypoinsulinaemia in the lactating rat, would be 
reconciled if there was a lessening in the effectiveness of an antilipogenic regulator 
which could overcome the effects of the decreased concentration o f insulin. As 
previously mentioned, acetyl-CoA carboxylase catalyses the rate-limiting reaction for 
lipogenesis in the liver and other tissues and hormones exert their actions on the 
enzyme via changes in its phosphorylation state (Hardie et al., 1984; Hardie 1989). 
Insulin stimulates the phosphorylation of the enzyme and so enhances fatty acid 
synthesis in isolated hepatocytes (Geelen et al., 1978; Holland and Hardie, 1985), 
whereas reversible phosphorylation (at a site(s) distinct from those responsive to
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insulin) and inactivation occurs in response to cAMP-elevating hormones through the 
action of A-kinase (Holland et al., 1984; Hardie, 1989), although recent studies have 
also implicated the involvement of an AMP-activated protein kinase in the 
phosphorylation and inactivation of acetyl-CoA carboxylase in hepatocytes and 
adipocytes (Carling and Hardie, 1986; Sim and Hardie, 1988; Haystead et ah, 1990). 
Hence, the proposal that catecholamines act as counter-regulatory hormones to the 
action of insulin at the level of hepatic metabolism during lactation would be 
compatible with a reduction in the responsiveness of the intracellular events leading 
to a decrease in fatty acid synthesis.
As previously described, B-adrenoceptors mediate their actions via the cAMP second 
messenger system and so it was decided to examine a number of post-receptor events 
initiated by the activation o f hepatic B-adrenoceptors in hepatocytes isolated both from 
mid-lactating and weight-matched virgin female rats. Dose-response relationships for 
the B-agonist isoprenaline were determined, initially for the cAMP response and then 
for responses of enzymes "down-stream" of cAMP such as A-kinase and glycogen 
phosphorylase activity.
5.2 RESULTS
Hepatocytes were isolated from mid-lactating and weight-matched adult female rats 
as described in section 2.2 of Materials and Methods. Hepatocytes prepared by this 
method resulted in a large yield of cells of high viability. However, such methods 
o f hepatocyte isolation are usually applied to smaller, younger animals and result in
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preparations in which >95%  of the cells are viable as measured by trypan blue dye 
exclusion. It was possible to approach this level of viability in our studies using adult 
female rats (90-95% viability) (Schwarz et al., 1985; Morand et al., 1988) but we 
were unable to achieve such a high yield from mid-lactating rats (80-85% viability). 
Hepatocytes used in the current studies had a wet weight of 12-14 m g/10  ^cells and 
contained 3-6 fig o f DNA per mg wet weight of hepatocyte pellet (Brass and Garrity, 
1990).
5.2.1 Effects of isoprenaline on cyclic AMP levels in isolated ra t hepatocytes 
All cAMP measurements were carried out using isolated hepatocytes from mid- 
lactating and weight-matched adult virgin female rats as detailed in Chapter 2 
(Materials and Methods).
Initial experiments were performed using hepatocytes from both lactating and non- 
lactating rats to determine the time after maximal activation of B-adrenoceptors (with 
lO'^M isoprenaline) at which cellular cAMP reached a maximal level. This was 
found to be 60 seconds in both cases (data not shown). The cAMP response to the 
saturating dose of glucagon (4 x lO^M) followed the same time course, with a 
maximum at 60 seconds (see Figure 5:1). The time period of our sampling protocol 
was such that this value cannot be distinguished from that of 80 seconds, previously 
reported for the cAMP response of glucagon in hepatocytes from young male rats 
(Cherrington et al., 1976) but is clearly shorter than the 4 minute time-resolution o f 
sampling previously found for 200g female Wistar rats (Morand et al., 1988). The 
reasons for this discrepancy are not clear and similar differences in cAMP response
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times to adrenergic agonists have been observed in hepatocytes with relation to the 
age, sex and strain of rats used (Blair et al,, 1979; Studer and Borle, 1982). The 60 
second time interval was used in all our subsequent measurements and the release o f 
cAMP into the incubation medium was shown to be negligible during this time 
interval. In parallel with cell incubations containing a range o f concentrations of 
isoprenaline, one containing 4 x lO'^M glucagon was included to standardize the 
response of each hepatocyte preparation.
The relationship between isoprenaline concentration and hepatocyte cAMP levels was 
measured using cells from lactating and non-lactating, non-pregnant rats. Since the 
liver membranes prepared from these two groups of animals were indistinguishable 
in terms of the number and affinity of their B-adrenoceptors we proposed that any 
differences in the amplitude and/or sensitivity of the cAMP response would have been 
attributable to differences in the efficiency o f coupling between B-adrenoceptors and 
adenylate cyclase or in the activity of adenylate cyclase itself. Direct measurement 
o f adenylate cyclase showed that its maximal activity was the same in hepatocyte 
membranes from lactating and non-lactating rats (data not shown). Dose-response 
curves for isoprenaline-stimulated cAMP production in hepatocytes from rats in these 
two experimental groups are shown in Figure 5:2. Basal cellular cAMP content and 
responsiveness to isoprenaline were indistinguishable in the two groups and at the 
highest concentration of isoprenaline used (2 x lO'^M) there was a decline in the 
cAMP levels. The sensitivity of the cAMP response to isoprenaline was similar in 
hepatocytes from lactating and non-lactating rats, with an EC^o value o f approximately 
0.05ftM (where EC50 is defined as the concentration of isoprenaline required to
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Figure 5:1 Representative time course o f the cAMP response of hepatocytes isolated from 
adult virgin female rats to a saturating dose of glucagon (4 x lO^M). Each 
point is the mean duplicate determinations.
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Figure 5:2 Dose-response curves for isoprenaline-stimulated cAMP production for 
hepatocytes isolated from non-lactating (panel A) and lactating rats 
(panel B). Values given are means (±  S.E .M .; n= 6 ). Values 
differing significantly (Student’s paired sample t-test) from the 
corresponding value at zero isoprenaline are indicated as*, P <  0.05; 
**, P <  0.01; ***, P <  0.001. When the mean value for cAMP 
content hepatocytes from lactating rats at any single concentration of 
isoprenaline is significantly different from that in the non-lactating 
group (Student’s non-paired sample t-test) this is indicated by $, P <  
0.05.
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achieve half the increment between basal and maximally stimulated cAMP levels) in 
both cases. However, a consistent depression of cAMP in the presence o f 2 x lO'^M 
isoprenaline was seen in hepatocytes from virgin rats but not in those from lactating 
animals, where 2 x ICf^M isoprenaline caused a significant elevation o f cAMP relative 
to that provoked by the same isoprenaline concentration in non-lactating rats.
In contrast to these findings, the cAMP levels resulting from exposure o f rat 
hepatocytes to a maximally stimulating dose of glucagon (4 x lO'^M) were shown to 
differ such that the mean values were 5.61 ±  0.32 pmol/mg wet weight in non- 
lactating animals and 2.5 ±  0.27 pmol/mg wet weight in lactating rats (means ±  
S.E .M .; n = 6  for each group). Expressed individually as a percentage of their paired 
basal value before averaging, these values are 473 ±  26% and 194 ±  18% 
respectively for each group and differ significantly (P <  0.001) from each other.
5.2.2 Effects of isoprenaline on ra t hepatocyte A-kinase activity 
All A-kinase determinations were performed using freshly isolated hepatocytes from 
mid-lactating and weight-matched adult virgin female rats, as detailed in Chapter 2 
(Materials and Methods).
Preliminary experiments were performed to determine the optimum hepatocyte 
dilution for the A-kinase assay (data not shown) and it was found that considerable 
dilution of hepatocyte samples (1:1000 with respect to hepatocyte wet weight) were 
necessary to achieve a linear response between activity and quantity of sample, when 
assaying over the 15 minute time period. Such findings are in line with those of
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others who have illustrated some pitfalls o f this assay, due to the presence of 
endogenous inhibitors and/or activators of protein kinase activity in a range of tissue 
extracts (Corbin, 1983; Clegg and Ottey, 1990). Moreover, as well as the suggested 
additions to the homogenisation medium when using tissue from rat liver (see Corbin, 
1983; Cherrington et al. , 1976) the sample preparation procedure was such that bovine 
serum albumin was always present at a concentration of lOmg/ml to avoid the 
inactivation of the A-kinase catalytic subunit that occurs in very dilute solutions of 
protein. Following this, experiments were performed using hepatocytes from both 
lactating and non-lactating rats challenged with a saturating concentration of glucagon 
(4 X lO^M), in order to determine the time resolution o f our sampling protocol. The 
time at which the A-kinase activity ratio peaked following such a challenge was found 
to be 2 minutes in both experimental groups tested (data not shown). Such a time 
span is in agreement with previous findings by Cherrington and co-workers (1976) 
and was used in all our subsequent measurements. In addition to the dose range of 
isoprenaline used, a saturating concentration of glucagon (4 x lO^M) was included 
in every assay to standardize the response of each hepatocyte preparation.
Curves illustrating the effects o f a range o f concentrations o f isoprenaline on the A- 
kinase activity ratio of hepatocytes from both non-lactating and lactating rats are 
shown in Figure 5:3. Basal activity ratios for A-kinase were similar in the two 
groups o f cells studied and are comparable with previous findings by Cherrington and 
co-workers (1976) and Corbin (1983), using hepatocytes isolated from male rats. 
Challenge with isoprenaline resulted in an increase in the activity ratio of liver A- 
kinase which was brought about by an increase in basal activity, as well as a decline
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Figure 5:3 Effects of isoprenaline on A-kinase activity in hepatocytes isolated from non- 
lactating (panel A) and lactating rats (panel B). Values given are means 
(S .E .M .; n= 4 ). Values differing significantly (Student’s paired sample t-test) 
from the corresponding value at zero isoprenaline are indicated as *, P <  
0.05; **, P <  0.01; ***, P <  0.001. When the mean value for the A-kinase 
activity ratio of hepatocytes from lactating rats at any single concentration of 
isoprenaline is significantly different from that in the non-lactating group 
(Student’s non-paired sample t-test) this is indicated by $, P <  0.05.
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in the maximally cAMP-stimulated rate. The sensitivity o f the activation o f A-kinase 
to isoprenaline challenge was found to be similar in hepatocytes from lactating and 
non-lactating rats, with an EC50 value of approximately 0.2/iM  (where EC50 is defined 
as the concentration of isoprenaline required to achieve half the increment between 
basal and maximally stimulated A-kinase activity ratio) in both cases. At the highest 
concentration of isoprenaline used (2 x lO^M) there was a consistent decline in the 
activity ratio of A-kinase in both groups of isolated cells, which is similar to the 
cAMP response previously observed in these types of cells at this concentration of 
isoprenaline (see Figure 5:2). Furthermore, 2 x 10‘^ M isoprenaline caused a 
significant decrease in the measured activity ratio of A-kinase in hepatocytes from 
lactating rats, relative to that caused by the same concentration o f isoprenaline in 
hepatocytes from non-lactating animals. Additionally, in agreement with the findings 
for isoprenaline challenge, the sensitivity of the activation of A-kinase by a maximally 
stimulating concentration of glucagon (4 x 10"^  M glucagon) was found to be similar 
in hepatocytes from both groups of rats, with mean activity ratio values o f 0.53 ±  
0.02 in non-lactating animals and 0.54 ±  0.02 in lactating rats (means ±  S.E .M .; 
n =  4 for each group).
5.2.3 Response of glvcogen phosphorvlase activity to isoprenaline challenge of 
rat hepatocytes
Glycogen phosphorylase activity was determined as the ratio of phosphorylase a 
activity relative to total phosphorylase activity, as detailed in Chapter 2 (Materials and 
Methods). In all cases experiments were performed using freshly isolated hepatocytes 
from mid-lactating and weight-matched adult virgin female rats.
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Preliminary experiments were performed to determine the optimum hepatocyte 
dilution for this assay and to verify the time resolution of our sampling protocol. 
Figure 5:4 shows a typical hepatocyte sample dilution profile, in which basal 
phosphorylase activity shows a linear increase with increasing hepatocyte sample size 
up to a sample aliquot of 0.6 ml ( =  approx 1 x 10  ^cells). From such studies it was 
decided to use a 0.4 ml sample aliquot ( =  approx. 6 - 7 x 10  ^cells; approx. lOmg 
wet weight) o f hepatocyte incubation mixture for all subsequent assays, when assaying 
over a 10 minute time period. The time point at which phosphorylase was maximally 
activated by glucagon (lO’^ M) or isoprenaline (2 x lO^M) was 1 minute after initial 
exposure to the hormone of the hepatocyte suspension (data not shown). This time 
point is in agreement with previous findings (Hutson et ah, 1976; Studer and Borle, 
1982) that 60-80 seconds following hormone challenge is the optimum time point at 
which to sample for phosphorylase activity. However, in these studies and those o f 
others (Cherrington et al., 1976), the A-kinase activity response was found to peak 
later, at about 2 minutes, which seems to suggest that the activity ratio crosses a 
threshold at which maximum phosphorylase activation is achieved prior to this. 
Consequently, all subsequent phosphorylase measurements were made by sampling 
at 1 minute following hormone challenge of cells.
The response o f the enzyme phosphorylase following isoprenaline challenge of 
hepatocytes isolated from both lactating and weight-matched non-lactating animals are 
shown in Figure 5:5. Basal activity ratios of phosphorylase were similar in the two 
groups of cells studied, although both responsiveness and sensitivity to the B- 
adrenoceptor agonist were diminished in hepatocytes from lactating rats. Sensitivity
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Figure 5:4 Representative hepatocyte dilution profile for basai glycogen phoshphorylase 
activity of hepatocytes isolated from adult female rats. The hepatocyte 
incubation mixture consisted of approximately 1.6 x 10  ^cells/ml. Each point 
is the mean of duplicate determinations.
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Figure 5:5 Activity ratio of phosphorylase in response to isoprenaline challenge on 
hepatocytes from lactating and non-lactating rats. Mean values (±  S.E.M .; 
n = 4 ) are plotted for non-lactating (panel A) and lactating rats (panel B). 
Values differing significantly (Student’s paired t-test) from the corresponding 
value at zero isoprenaline are indicated as *, P <  0.05; ** p  <  0.01, ***, 
P <  0.001.
0.6
rz 0.5 *  *
*  *
0.4
*  *■
LU 0.3
% 0.1 
CL
0
2x10®2x10 ® 2x10 " 2x102x10
Log [isoprenaline] (M)
>  0.4
O 0.2
X  0.1
2x10 2x10" 2x10 '
Log [isoprenaline] (M)
2x10 2x10
180
measured as EC50 was 1.64 x 10"^M in lactating rats, whereas hepatocytes from non- 
lactating rats were much more sensitive with an EC50 value of 7,55 x lO'^M. 
Lactation-induced changes in responsiveness to isoprenaline were much less marked, 
although the absolute level of hepatocyte phosphorylase a activity at the highest 
concentration of isoprenaline tested (2 x lO'^M) was somewhat lower in lactating than 
in non-lactating rats, this difference was not statistically significant (0.71 ±  0.15 and 
0.86 ±  0.22 ^mol incorporated per min per mg DNA respectively, mean ±  
S.E.M . for 4 determinations ). In contrast, the response o f glycogen phosphorylase 
to glucagon (4 x 10*^M) was found to be similar in both groups o f hepatocytes, and 
maximal activity ratios were also similar with values o f 0.58 ±  0.06 in non-lactating 
animals and 0.64 ±  0.05 in lactating rats (means ±  S.E.M . for 4 determinations).
5.3 DISCUSSION
All our hepatocyte studies concentrated on measuring post-receptor events following 
8 -adrenoceptor agonist-receptor occupation and subsequent activation. Studies were 
made at points early in the hepatic cAMP signalling cascade (cellular cAMP 
concentration; A-kinase activation) and at a target protein distal to A-kinase 
(phosphorylase). Such measurements were made to investigate any changes in the 
hepatic responsiveness or sensitivity of this intracellular signalling cascade to B- 
adrenergic agents,in the transition from the virgin to the mid-lactating reproductive 
status.
5.3.1 Coupling of rat hepatocyte B-adrenoceptors to adenylate cvclase
The cAMP response in intact isolated adult female rat hepatocytes following challenge
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with a range of concentrations o f the B-adrenergic agonist isoprenaline was found to 
be in agreement with a previous literature report of similar studies using hepatocytes 
from adult female (200g body weight) rats (Morand et al., 1988). Low 
concentrations of isoprenaline (10"^° to 10 ’®M) did not noticeably stimulate adenylate 
cyclase (ie 2 x lO'^M isoprenaline produced only an approximate 1.3-fold rise in the 
basal level ofcAMP)and the cAMP response was shown to peak at a concentration of 
2 X lO'^M isoprenaline, producing an approximate 2.75-fold rise in the basal level of 
intracellular cAMP. The effects of adrenergic agonists on cAMP levels have been 
investigated in hepatocytes isolated from a range of rats of differing developmental 
and reproductive states and the cAMP response has been shown to vary with the sex 
(Studer and Borle, 1982) and age (Blair et al., 1979; Morgan et al., 1983a,b) o f the 
rats used, as well as the incubation and cell culture conditions employed (Sandnes et 
al., 1983). Such variations, as previously mentioned, have been shown to correlate 
with changes in hepatic B-adrenoceptor density, such that the number o f B- 
adrenoceptors are known to be increased in foetal and immature individuals (Snell and 
Evans, 1988; McMillian eta l.,  1983), females (Studer and Ganas, 1988) and cultured 
hepatocytes (Schwarz et al., 1985). As was found in our B-adrenoceptor 
enumerations in earlier chapters, the responses o f cellular cAMP to isoprenaline were 
unaffected by lactation. The dose-response plot for the isoprenaline effect on 
hepatocytes isolated from lactating rats was not significantly different from that 
obtained from cells from weight-matched virgin female animals. Hence, it would 
appear that the hepatic intracellular cAMP status, as an index of the coupling o f B- 
adrenoceptors to adenylate cyclase, shows no variation in responsiveness between the 
two reproductive states studied. However, published work has illustrated that
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maximal effects on enzymology may be achieved by sub-maximal effects on 
intracellular cAMP levels, as evidenced by workers using adipocytes (Honnor et al., 
1985) and hepatocytes (Morand et al., 1988). Hence, the determination of A-kinase 
activity ratios may provide an indirect measurement of the cAMP response which is 
directly relevant to physiological processes, and similarly the activation of substrates 
distal to A-kinase may again highlight any lactation-induced changes in 
responsiveness.
In addition to the range of isoprenaline concentrations used, the single glucagon 
concentration (4 x lO^M) employed to monitor the response-competence o f the 
hepatocytes from the animals in each physiological group, was shown to cause a 
significant stimulation of cAMP production in adult female rat liver cells. Such a 
response was found to be in agreement with literature values and was also shown to 
be considerably higher than the response observed for an identical concentration of 
isoprenaline (Studer et al., 1984; Morand et al., 1988). However, in contrast to the 
findings for isoprenaline, it is noteworthy that the responsiveness to glucagon (4 x lO" 
^M) of cAMP generation was markedly diminished in hepatocytes from lactating rats 
compared to those from non-lactating females. Since neither maximal adenylate 
cyclase activity nor isoprenaline-stimulated activity was affected by lactation, the 
decreased responsiveness of cAMP production to glucagon must be due to a decreased 
number o f glucagon receptors or to an attenuation of receptor coupling to adenylate 
cyclase. It has been previously argued that the observed stimulation of lipogenesis 
in mammary tissue during lactation is facilitated by the inability o f this tissue to 
respond to glucagon due to a lack of receptors for this hormone (Robson et al..
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1984). In view of this finding, the diminished hepatic cAMP response to glucagon 
demonstrated for lactating rats in this study, may serve a similar function in enabling 
the observed enhancement of hepatic lipogenesis during lactation. In the light o f this 
possibility a more detailed study o f the dose-response plot for glucagon effect would 
be of interest.
5.3.2 Responses of enzymes ”down-stream ” of cAMP
As previously mentioned, measurement of the activity ratio of A-kinase offers the 
possibility of a more precise determination of the intracellular cAMP status. 
Treatment of hepatocytes isolated from adult female rats with a range of 
concentrations of isoprenaline resulted in a dose-dependent increase in the activity 
ratio of hepatic A-kinase. Such an increase was brought about both by an 
enhancement of the basal level of activity (measured in the absence o f cAMP), 
reflecting an increased concentration of the active dissociated catalytic subunit (C- 
subunit) of A-kinase and a decline of the total A-kinase activity, which is measured 
in the presence of a concentration of cAMP which is maximally effective in the 
dissociation of C- from regulatory (R-) subunits of this enzyme (see Chapter 2 section
2.3.3. and Swillens, 1983 for protein kinase system general equation). A-kinase 
activity ratios have previously been assessed in hepatocytes isolated from male rats 
but a parallel comparison in female liver cells has not been reported. In our present 
study, the basal activity ratio (zero isoprenaline concentration) for A-kinase o f adult 
female hepatocytes was found to be comparable with literature values reported for 
adult male rat hepatocytes (Cherrington et al., 1976; Corbin 1983). Over the 
isoprenaline concentration range studied, the maximal stimulation of A-kinase
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obtained with 2 x lO^M isoprenaline represented a 2.3-fold increase over base line, 
whereas at this concentration maximal stimulation of cAMP was also obtained and 
showed a similar 2.75-fold increase over basal levels. A close correlation between 
cAMP levels and A-kinase activity ratio was observed whatever the isoprenaline 
concentration in adult female liver cells and low concentrations (between lO*^ ® and 10' 
’M) o f isoprenaline did not significantly increase cAMP production or A-kinase 
activity. Furthermore, at the highest concentration of isoprenaline studied (2 x lO'^M) 
there was a consistent decline in both the measured activity ratio o f A-kinase and the 
cAMP level. It is possible that the decline in the A-kinase activity ratio is a 
consequence of the reduced cAMP response and it may be that the measured 
intracellular cAMP response shows an insufficient increase at this supra-maximal 
isoprenaline concentration due to the action of endogenous phosphodiesterases 
(Houslay et al., 1983), which have previously been shown to be important in isolated 
mammary acini (Mullaney and Clegg 1984; Clegg and Mullaney, 1985) and 
hepatocytes (Morand et al., 1988).
Hepatocytes isolated from primiparous mid-lactating rats showed a similar sensitivity 
o f activation of A-kinase to challenge with a range o f isoprenaline concentrations, 
with a consistent decline in activity ratio at 2 x Kf^M isoprenaline. Such results were 
found to be in accordance with the similar findings for isoprenaline dose-response 
measurements of intracellular cAMP generation in cells from both virgin and lactating 
females. Consequently, the hepatocyte responses of cellular cAMP and A-kinase to 
isoprenaline appear to be unaffected by lactation. Similarly, the response to a single 
concentration of glucagon (4 x lO^M) was found not to be significantly different 
between the two groups of hepatocytes and furthermore was comparable with reported
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literature activity ratios found for male rat hepatocytes (Cherrington et al., 1976; 
Corbin, 1983). However, the similar activation states of hepatocyte A-kinase in cells 
from lactating and virgin female rats is in contrast to the diminished responsiveness 
of cAMP generation to an identical glucagon concentration in hepatocytes from 
lactating rats. Such a finding may imply that the high levels of cAMP generated by 
glucagon in adult female hepatocytes are not required for the stimulation o f A-kinase, 
although a full dose-response plot for glucagon effect would be essential to validate 
such a proposal.
Our final point of examination o f the hepatic cAMP signalling cascade was made at 
the level of the enzyme glycogen phosphorylase, a classical target o f A-kinase 
phosphorylation in hepatocytes and other cells. The response of glycogen 
phosphorylase activity (expressed as the ratio o f phosphorylase a to total 
phosphorylase activity) to increased A-kinase activation, as a consequence o f 
isoprenaline challenge of isolated hepatocytes, was measured in cells from both 
lactating and adult virgin female animals. The degree o f activation o f phosphorylase 
was increased by treatment with isoprenaline in a dose dependent manner in 
hepatocytes isolated from adult virgin female rats and for the range o f concentrations 
between 2 x 10'* and 2 x lO'^M, isoprenaline caused a significant activation of 
phosphorylase in relation to the determined basal level (zero isoprenaline). 
Consequently, it would appear that low concentrations of isoprenaline (2 x Ifi^ and 
2 X 10 *M), that apparently caused only a small stimulation o f adenylate cyclase 
(resulting in an approximate 1.5-fold rise in cAMP over basal values) with 
commensurately minor increases in the activity ratio of A-kinase (approximately 1.5-
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fold increment) may significantly increase phosphorylase activation. Such results 
indicate that a low variation in the hepatic intracellular cAMP level is sufficient to 
markedly stimulate glycogen phosphorylase activity; the reciprocal of this finding has 
been reported by Morand and co-workers (1988) using isolated hepatocytes from adult 
female rats, which have shown that experiments carried out with isoprenaline (ICf  ^
and lO'^M) in the presence of a phosphodiesterase inhibitor produced significant 
increases in the isoprenaline-stimulated accumulation o f cAMP but considerably lower 
variations in phosphorylase a activity.
However, both responsiveness and sensitivity to isoprenaline where shown to be 
diminished in hepatocytes from lactating rats. Basal activity ratios (zero isoprenaline) 
of phosphorylase were similar in the two groups o f liver cells studied but 
phosphorylase activation was much more sensitive to isoprenaline in hepatocytes from 
non-lactating rats, and significant increases over the basal value o f activity ratio for 
phosphorylase in hepatocytes from lactating animals was only achieved at isoprenaline 
concentrations o f 2 x 10'  ^and 2 x lO'^M. Lactation-induced changes in isoprenaline 
responsiveness were shown to be less marked but nevertheless the absolute level of 
phosphorylase a activity at the highest concentration of isoprenaline tested (lO^M) 
was somewhat lower in lactating than non-lactating rats. In contrast, no lactation- 
induced change was found in the sensitivity of activation of phosphorylase by 4 x 
lO'^M glucagon.
5.3.3. Summ ary of Findings
In conclusion, as was found for hepatic adrenoceptor properties, the responses of
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cellular cAMP and A-kinase to isoprenaline were unaffected by lactation. However, 
our results do demonstrate an attenuation in the cascade of events "down stream" of 
the adrenergic cAMP signalling system, in view o f the fact that we have shown that 
phosphorylase activation was much less sensitive to this B-agonist in hepatocytes from 
lactating rats.
In addition, preliminary experiments (i.e. using only one putatively saturating 
concentration of glucagon) have shown that the responsiveness to glucagon of cAMP 
generation was markedly diminished in hepatocytes from lactating rats compared to 
those from non-lactating females. This contrasts with our findings of the unchanged 
responsiveness to glucagon of the activation states of A-kinase and glycogen 
phosphorylase in hepatocytes from lactating and non-lactating rats but is compatible 
with the suggestion that the cAMP-independent mediated pathway of glucagon action 
may be important in the hepatic actions of this hormone (Studer et al., 1984; 
Combettes a/., 1986).
Indeed, we have shown that B-adrenoceptors comprise only a small proportion of the 
total andrenoceptor complement of hepatocytes in lactating and virgin female rats and 
in view of these findings it is possible that the a-adrenergic and glucagon-mediated 
signals predominate in importance over B-adrenergic mechanisms in the regulation of 
liver metabolism in lactating, as well as non-lactating rats. The significance of these 
findings and their implications with regards to the changes in liver metabolism 
induced by lactation will be discussed in detail in Chapter 6.
CHAPTER 6
DISCUSSION
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6.1 ADRENERGIC CONTROL OF HEPATIC METABOLISM 
DURING LACTATION
Much of our knowledge of mammalian metabolism and its regulation comes from 
studies on the rat, as this species lends itself well to laboratory investigation. In the 
liver of this animal, the regulation of the rates o f glycolysis, gluconeogenesis and of 
fatty acid synthesis, oxidation and estérification, have been shown to be a highly 
integrated process (see Geelen et al., Martin, 1988 for review). However, this 
metabolic pattern is not typical of all animals, as for example ruminants have low 
rates of hepatic lipogenesis and glycolysis compared to high rates of gluconeogenesis 
in the fed state (Ballard et al., 1969), which is a situation usually associated with 
starvation in rats. Consequently, as previously described, the adaptations o f liver 
metabolism are markedly different between rodents and ruminants during pregnancy 
and lactation and it is also conceivable that potential metabolic regulators may have 
different levels of importance in these two groups of animals.
The central hypothesis addressed in this work concerns the possible differences in the 
efficacy o f catecholamines as hepatic counter-regulators of insulin action, both 
between rodents and ruminants and between lactating and non-lactating individuals in 
each model. In pursuit of such a hypothesis we sought to characterize the 
adrenoceptor population in lactating and non-lactating rat and sheep liver, and to 
measure a range o f catecholamine-induced post-receptor responses in isolated rat 
hepatocytes.
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6.1.1 Hepatic Adrenoceptor Complement
From our hepatic adrenoceptor enumerations it can be seen that the adult female rat 
liver possesses a predominance of «i-adrenoceptors compared to B-adrenoceptors, in 
the ratio of approximately 25:1, whereas the adult female sheep liver has an estimated 
small but equal population of both a ,-  and B-adrenoceptors. Additionally, studies on 
the hepatic membranes from adult females from both of these species show that «2- 
adrenoceptors constitute only a negligible percentage of the total a-adrenoceptor 
population. Adrenoceptor density varies greatly between different animal species 
(Sulakhe et al., 1988) and tissues (Greengrass and Bremner, 1979; Agrawal and 
Daniel, 1985; Dax et al., 1986) and hence it is not surprising that sheep and rat liver 
membranes show different adrenoceptor complements. Indeed, in view o f the 
differences in liver metabolism between these two groups of animals, it is possible 
that catecholamines and other hormonal regulators of hepatic metabolism may have 
different levels of importance in these two species.
Adrenergic control of liver metabolism may thus prove to be more important in the 
rat than in the sheep, in the light o f the higher hepatic adrenoceptor complement of 
the rat. However, both female rats and sheep show a small but similar population of 
hepatic B-adrenoceptors, which may in the case of the ruminant be anticipated in view 
of the minor lipogenic role played by the liver (Hanson and Ballard, 1967; Ingle et 
ah, 1972a,b). This is in contrast to the rat, where adipose tissue and liver contribute 
substantially to whole body lipogenesis (Levielle, 1967). However, although glucose 
in the ruminant is chiefly supplied by gluconeogenesis, and hence intestinally derived 
glucose and its storage as glycogen in the liver is a minor function, these animals
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show substantial amounts of glycogen deposited in the liver of gluconeogenic origin 
(Baird, 1977). Consequently, the control of glycogenolysis would appear to be an 
important process in ruminants as well as in monogastric species, and data has shown 
that in the ruminant as well as the female rat, adrenaline regulates hepatic 
glycogenolysis via both cAMP and Ca^^-dependent pathways (Morand et al., 1988). 
In contrast, the role of catecholamines in the control of hepatic carbohydrate 
metabolism in the rat is a well established phenomenon (see section 1.3.1 
Catecholamines) and variations in responsiveness to catecholamines have been shown 
to be dependent upon the sex (Studer and Borle, 1982), age (Blair et al., 1979; 
Morgan et al., 1983a) and hormonal status (Malbon et al., 1978) o f the animal.
However, the precise role of catecholamines in the hormonal regulation of hepatic 
lipogenesis is less well established. It is widely accepted that acetyl-CoA carboxylase 
catalyses a rate-limiting reaction for lipogenesis in the liver and other tissues, and it 
is generally considered to represent an important site for short-term hormonal 
regulation of fatty acid synthesis (see Geelen et al., 1980; Brownsey et al., 1979; 
Munday and Hardie, 1987). Acetyl-CoA carboxylase purified from rat liver has been 
shown to be reversibly inactivated by phosphorylation by cAMP-dependent protein 
kinase (Tipper and Witters, 1982) and there is also good evidence that this 
phosphorylation and inactivation occurs in hepatocytes in response to cAMP-elevating 
hormones (Geelen et ah, 1978; Holland et ah, 1984). Additionally, more recent 
evidence suggests that acetyl-CoA carboxylase may be inactivated by one or more 
cAMP-independent protein kinases, as shown in a variety of studies using isolated 
hepatocytes and adipocytes (Carling and Hardie, 1986; Sim and Hardie, 1988;
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Haystead et al., 1990; Davies et al., 1992). However, much remains to be learned 
regarding the mechanism of activation and the physiological roles o f the proposed 
AMP-activated kinase cascade, which has been shown to phosphorylate the regulatory 
enzymes of fatty acid synthesis, cholesterol synthesis and triglyceride/cholesterol ester 
breakdown (ie: acetyl-CoA carboxylase, 3-hydroxy-3-methylglutaryl-CoA reductase 
and hormone-sensitive lipase/cholesterol esterase, respectively) and initial indications 
are that it may play an important role in regulating the balance o f fatty acids and 
cholesterol in the body (Hardie et al., 1989). Whether the role o f catecholamines in 
the control of hepatic lipogenesis is as important and shows the same variations in 
responsiveness with relation to age, sex and hormonal status of the rat, as is observed 
with hepatic carbohydrate metabolism remains to be seen. Indeed, during lactation 
in the rat a reduction in the efficacy of catecholamines as hepatic antilipogenic 
regulators would be consistent with the elevated rates of hepatic lipogenesis in the 
prevailing hypoinsulinaemia.
Our results demonstrate that lactation does not influence the number or affinity of 
hepatic a-  or B-adrenoceptors in either rats or sheep. Although lactation is associated 
with a considerable increase in liver mass (Williamson, 1980; Vernon et al., 1987), 
this is predominantly a consequence of hypertrophy not hyperplasia. Hence, the 
increase in the number of B-adrenoceptors normally associated with hepatic cellular 
proliferation (Huerta-Bahena et ah, 1983) does not accompany lactation and neither 
does the changed hormonal status of the lactating animal cause alterations in the 
hepatic adrenoceptor complement. However, such alterations in adrenoceptor 
complement have been reported in a number o f tissues during the reproductive stage
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of lactation in both the rodent and ruminant. For example, in the rat, the B- 
adrenoceptor complement of mammary epithelial cells has been shown to increase 
(Lavandero et al., 1986; Marchetti et al., 1990) during lactation. Whether, such a 
change occurs in the B-adrenoceptor population of lactating sheep mammary tissue is 
as yet unknown, although it has been shown that the adrenoceptor complement of this 
tissue is similar to that found in rat mammary tissue (Clegg, 1988). Furthermore, 
lactation has been shown to increase the number of B-adrenoceptors in cattle (faster 
and Wegner, 1981), sheep (Watt et ah, 1989), and rat (Watt et ah, 1990) adipose 
tissue and in the case of the ewe such changes have been shown to be fat depot 
specific (Bowen, 1991). Hence, the above mentioned marked changes in B- 
adrenoceptor concentration during lactation suggest that this receptor population is 
highly sensitive to changes in the hormonal conditions o f this reproductive state. The 
findings in this study suggest that the liver does not undergo such changes in 
adrenoceptor number during lactation in either o f the animal species studied. 
However, it remains possible that there may be alterations in the signal transduction 
mechanisms of such receptors, which could involve a  change in hepatic adrenergic 
responsiveness without necessarily causing a change in actual adrenoceptor 
concentration (see section 1.4.1.4 Receptor Regulation for examples).
6.1.2 Adrenergic-M ediated Post-Receptor Responses in Isolated R at H epatocytes 
Post-receptor events were measured in this study, firstly at points early in the hepatic 
cAMP signalling cascade (cellular cAMP concentration; A-kinase) and then at a target 
protein distal to A-kinase (glycogen phosphorylase). As was found for the hepatic 
adrenoceptor population, the responses o f cellular cAMP and A-kinase to the B-
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adrenergic agonist isoprenaline were unaffected by lactation. It is noteworthy, 
however, that the responsiveness of cAMP generation to glucagon stimulation was 
markedly diminished in hepatocytes from lactating rats compared to those from non- 
lactating females. Such a finding lends support to the suggestion that cAMP- 
independent pathways o f intracellular signalling from glucagon may be important in 
the actions o f this hormone on rat hepatocytes (Studer et al., 1984; Combettes et al., 
1986; Wakelam et al., 1986). The same considerations do not appear to apply to the 
actions o f glucagon on ruminant hepatocytes, as an increase in the cAMP level in 
response to glucagon challenge has been observed but no accompanying calcium 
movements were evident (Morand et al., 1988). However, the interactions between 
calcium and cAMP in ruminants have yet to be fully elucidated.
Studies in the ruminant have shown an unchanged response of glucose production to 
glucagon in hepatocytes from lactating and non-lactating sheep (Faulkner and Pollock, 
1990). It is generally held that additional glucose demand during lactation, imposed 
by the biosynthetic activities of mammary tissue, is met by increased dietary intake 
in monogastric animals and additional hepatic gluconeogenesis in ruminants. 
Although the activities of individual liver enzymes of carbohydrate metabolism have 
been assessed in lactating and non-lactating rats (Smith, 1975), a parallel comparison 
of the gluconeogenic and glycogenolytic activities o f lactating and non-lactating rat 
hepatocytes, comparable to the study of Faulkner and Pollock (1990) in sheep, has 
not been reported. In contrast, the effects of lactation on hepatic lipogenesis in the 
rat are better documented. It has been previously argued that the observed 
stimulation o f lipogenesis in the mammary gland during lactation is facilitated by the
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inability of this tissue to respond to glucagon, due to an absence of receptors for this 
hormone (Robson et al., 1984). Since in the present study neither maximal adenylate 
cyclase activity nor isoprenaline-stimulated activity of isolated rat hepatocytes was 
affected by lactational status, the decreased responsiveness of cAMP production to 
glucagon may be due to a decreased number of glucagon receptors or to an 
attenuation o f receptor coupling to adenylate cyclase. However, such observations 
of glucagon response constitute only a preliminary study, and more extensive 
investigations, including detailed dose-response studies for glucagon action await 
examination, along with the definitive measurement of receptors for this hormone. 
Nevertheless, as mentioned with regard to lipogenesis in the mammary gland, the 
diminution in hepatic cAMP response to glucagon demonstrated for lactating rats in 
this study, may serve a similar function in enabling the observed enhancement of 
hepatic lipogenesis during lactation.
Other preliminary studies employing measurements of A-kinase activity ratios showed 
that similar activation states of this enzyme were achieved when hepatocytes isolated 
from both lactating and weight-matched virgin female animals were challenged with 
a single concentration o f glucagon (4 x lO^M). This concentration o f hormone was 
identical to that used in the studies measuring cAMP levels in isolated hepatocytes 
and represents a supraphysiological concentration of glucagon (ie: physiological 
concentration range 10'^° - 10%1). As a detailed profile of the response o f this 
enzyme to challenge with a range of concentrations of glucagon is not available for 
cells isolated from either control or lactating rat livers, it is not possible to strictly 
define any lactation-induced change in responsiveness of this intracellular event to the
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hormone glucagon.
Although neither responses of cellular cAMP or A-kinase to isoprenaline were 
affected by lactation, our results do demonstrate that down-stream attenuation of 
adrenergic cAMP signalling is associated with lactation. We have shown that 
phosphorylase activation was much less sensitive to the B-agonist in hepatocytes from 
lactating rats and that this difference arises at a post-receptor level. This observation 
raises interesting questions in relation to the mechanism of action o f this system and 
on the possibility of its ability to counteract the effects of A-kinase activation on other 
of its phosphorylation target proteins. Similar variations in the hepatic glycogenolytic 
response to catecholamines have been observed between both male and female rats 
(Studer and Borle, 1982) and between rat and sheep hepatocytes (Morand et al.,
1988). For hepatocytes isolated from adult male and female rats, the relative increase 
in phosphorylase a activity in response to a range of adrenaline concentrations was 
found to be twice as large in males compared to females and in the studies o f Morand 
and coworkers phosphorylase a activity was shown to be more sensitive to both 
catecholamines and glucagon in adult male sheep than in adult female rats. The exact 
mechanism by which such differences in the sensitivity of phosphorylase to 
catecholamines occur in rats and ruminants is as yet unknown, although it is known 
that both calcium-(a-mediated) and the cAMP-dependent (B-mediated) signalling 
pathways are significant in mediating the response to adrenaline, but the physiological 
importance o f each pathway in the activation of phosphorylase is also still to be 
defined. Whatever the mechanism of enzyme modulation, all these results indicate 
the existence in rat and sheep liver of a glycogen phosphorylase highly responsive to
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hormones.
Hepatic glycogen has been implicated to play an important role in supplying the 
demand for carbohydrate in the lactating rat (Munday and Williamson, 1983) and it 
would appear somewhat surprising that the responsiveness of phosphorylase activation 
to isoprenaline is diminished in hepatocytes isolated from mid-lactating rats. As 
mentioned, no measurements of the gluconeogenic and glycogenolytic activities o f 
lactating and non-lactating rat hepatocytes have been reported, although it has been 
shown that the hepatic balance between the pathways of glycolysis and 
gluconeogenesis change in the direction of glycolysis at the height of lactation (Smith, 
1975). In the lactating rat there is an enhanced turnover of glucose imposed by the 
biosynthetic demands of the mammary gland and the liver in relation to the synthesis 
of milk constituents (Williamson, 1980; Bumol et aL, 1983). In the liver, the 
increased utilization of glucose is channelled towards fatty acid synthesis, and greater 
rates o f hepatic lipogenesis occur during lactation compared to those in non-lactating 
animals (Robinson et al., 1978; Williamson, 1980). The increased demands for 
glucose are met in part by hyperphagia during lactation, but paradoxically, plasma 
insulin levels are substantially lower in the fed lactating rat compared to the virgin 
state (Robinson et al., 1978), which is seemingly not compatible with the observed 
increase in flux through the lipogenesis pathway in the liver during lactation. 
However, the important counter-regulatory hormones to insulin are glucagon and the 
catecholamines, and our studies have shown a decreased responsiveness of activation 
of an important enzyme involved in hepatic carbohydrate metabolism (phosphorylase) 
to the B-adrenergic agonist isoprenaline. Hence, a diminution in the effectiveness of
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such a counter-regulatory hormone may to some extent overcome the effects o f a 
lower circulating insulin concentration associated with lactation, and in this instance 
could accelerate glucose utilization and suppress glucose production in the liver. In 
contrast, no lactation-induced effects were found in the response of phosphorylase 
activity to glucagon in the preliminary studies, and these results have subsequently 
been independently verified (V.A. Zammit and R.A. Clegg, unpublished 
observations). In addition studies in the ruminant have revealed no lactation-induced 
changes in the effects o f glucagon and catecholamines on glycogenolysis and 
gluconeogenesis (Faulkner and Pollock, 1990), although the studies show that these 
hormones have a far greater effect on glycogen breakdown than on gluconeogenesis. 
This contrasts with the situation in the rat, where both processes are stimulated under 
these conditions (Cherrington et al., 1976). Indeed, whatever the mechanisms 
involved in the reduced sensitivity o f gluconeogenesis to short term hormonal control 
in ruminants, it appears that any transient deficit in the supply o f blood glucose is 
compensated for more by mobilisation of glycogen than by increased rates o f glucose 
synthesis. However, the finding that no lactation-induced modifications in the effects 
of glucagon or catecholamines on hepatic glucose production/release are evident in 
the ewe, is consistent with the observed increased rates of hepatic gluconeogenesis 
and negligible rate of fatty acid synthesis in the prevailing hypoinsulinaemic state of 
the lactating ruminant animal.
In considering the possible importance of catecholamines as hepatic counter-regulators 
of insulin action in the lactating animal, it is necessary to to take account o f any 
changes in the pattern of catecholamine secretion and circulating serum concentrations
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of these hormones. However, many difficulties have been met when estimating 
serum levels of catecholamines, due mainly to large individual variations between 
animals as a result o f varying levels o f sympatho-adrenal activity and/or 
environmental stimuli (eg: stress-induced differences) at the time of blood sampling. 
Studies have shown plasma levels of catecholamines to be very low (below Ing/ml 
of plasma) in a whole range of species studied (Buhler et al., 1978) and it has been 
estimated that adult rats have a total catecholamine concentration of 2-3 nM, which 
is approximately 2-fold higher than that found in the cow. Although no direct 
comparisons of plasma levels o f catecholamines have been made between lactating 
and virgin female rats, measurements of the plasma concentrations of adrenaline and 
noradrenaline have shown that both o f these hormones are released into the circulation 
during suckling in nursing rats (Clapp et al., 1985). Such findings have posed the 
possibility that catecholamines along with oxytocin and prolactin may play a direct 
role in the milk ejection process, as well as lending support to the evidence that these 
hormones are important in the regulation of the changes in metabolism in a variety 
of tissues in the lactating animal.
Although, adrenoceptors present in the livers o f various species have been shown to 
be functionally relevant, it is not clear whether the hepatic response through these 
receptors is elicited by blood borne catecholamines emanating from the adrenal 
medulla (mainly adrenaline), or catecholamines released from post-ganglionic 
sympathetic nerve terminals (mainly noradrenaline), or both. Studies by Clapp et al., 
(1985) have emphasized the importance of the adrenal source o f catecholamines in the 
lactating rat, as adrenalectomy was shown to block the release of adrenaline provoked
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by electrical stimulation of the abdominal mammary nerve. Additionally, studies of 
sympathetic nervous activity in brown adipose tissue of lactating mice and rats have 
shown that activity is significantly decreased during lactation (Trayhum and Richard, 
1985; Trayhum and Wusteman, 1987) and it is believed that this is likely to be 
responsible for the observed suppression of thermogenesis in this tissue during the 
period of lactation in rodents. Such studies also suggest that although the sympathetic 
nervous activity is reduced, the sympathetic responsiveness of the tissue is retained. 
As with brown adipose tissue, the liver is highly innervated by the sympathetic 
nervous system (Moghimzadeh et al., 1982) and it remains to be determined whether 
any lactation -induced changes in hepatic sympathetic nervous activity occur in either 
rodents or ruminants.
6.1.3 A gricultural Significance
Clinically, drugs acting via adrenergic receptors are widely used to treat a range of 
conditions. Recently, several B-agonists have been identified that alter body 
composition in many species o f animals. Some of these compounds have been shown 
to reduce body-fat deposition with little alteration of lean body mass accumulation 
(Arch et al., 1984), whereas others appear to cause a repartitioning o f nutrients 
resulting in a reduction of adipose tissue and an increase in muscle growth (Yang and 
McElligott, 1989). Such agents have obvious importance in the modification of 
carcass composition in the meat-producing industry and it is now quite clear that 
chronic B-agonist treatment decreases total carcass fat in meat-producing animals and 
laboratory rodents (see Yang and McElligott, 1989 and Bowen, 1991). However, the 
effects of chronic B-agonist treatment on the fatty acid synthetic activity of the liver
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are ill-defined, and as the decreased body fat response may be partly a consequence 
o f decreased fatty acid synthesis in adipose tissue and liver, a greater understanding 
o f the hepatic adrenergic mechanisms operating in both the rodent and ruminant 
should prove to be highly informative when considering the in vivo effects of these 
agents.
Additionally, the domestic ruminant is peculiarly susceptible to several metabolic 
disorders which arise during late pregnancy and early lactation, when the metabolic 
demands of the foetus and uteroplacental tissue or lactating mammary gland can be 
so great as to severely disrupt the function of maternal tissues and even to cause 
death. They are a consequence partly of the ruminant mode of digestion and partly 
o f intense genetic selection for characteristics such as milk production and number 
and size of offspring. Of particular concern are the conditions of spontaneous bovine 
ketosis and ovine pregnancy toxaemia which are both associated with 
hyperketonaemia, hypoglycaemia, a developing inappetence and a fall in milk yield 
(Baird, 1977; Bell, 1981). These conditions are believed to arise because 
gluconeogenesis cannot keep pace with the demand o f the lactating udder for glucose, 
and are a consequence of the prevailing hormonal status of the animal which is geared 
to maintain lactation in precedence over the metabolic demands of other body 
processes. Hence, as the role of the diminished circulating insulin concentration and 
the other hormonal changes in the induction of ruminant ketosis is far from certain, 
a greater understanding of the regulatory importance of catecholamines in the 
lactating ruminant, and in particular at the level o f the liver, may provide an 
indication for the successful management of hepatic ketosis in these animals.
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6.2 CONCLUSIONS
The work described in this thesis has shown that glycogen phosphorylase is much less 
sensitive to the B-agonist isoprenaline in hepatocytes from lactating rats and that this 
difference arises at a post-receptor level. Additionally, it has been shown that B- 
adrenoceptors comprise an equally small proportion of the total adrenoceptor 
complement of hepatocytes in lactating and non-lactating rats. In sheep also, the 
proportion of B-adrenoceptors is not changed by lactation, although it is somewhat 
greater than in rats. These findings suggest that, in lactating as well as in non- 
lactating animals, alpha-adrenergic and glucagon-mediated signals may predominate 
in importance over beta-adrenergic signalling pathways in the regulation of liver 
metabolism. In accordance with the hepatic a-adrenoceptor enumerations made in 
this study, similar studies of a-adrenoceptor-mediated post-receptor responses in 
hepatocytes isolated from both lactating and non-lactating rats would be informative. 
In particular, the impact of lactation on the response of phosphorylase to alpha- 
adrenergic agonists may prove to be important when examining the effects of 
catecholamines on hepatic glucose production in the lactating animal. Similarly, 
studies to explore in greater detail the putative lactation-induced changes in hepatic 
glucagon sensitivity and/or responsiveness would be valuable in defining the 
importance o f this physiological regulator in the control o f the hepatic metabolic 
changes associated with lactation.
The interactions between insulin and catecholamines in the liver of the lactating 
animal is a relatively unexplored area. However, the work reported here raises the
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possibility that the adrenergic responsiveness of liver metabolic function may be 
diminished during lactation and this could be evaluated further by measuring the 
responsiveness of lipogenesis and key lipogenic enzymes to adrenergic agonists. Such 
studies, along with those concerned with the adrenergic hormonal control o f hepatic 
carbohydrate metabolism, would provide a greater insight into the role of 
catecholamines as counter-regulatory effectors of insulin action in the lactating 
animal. Such studies involve measuring the effects of hormones on various post­
receptor events in a suspension of isolated hepatocytes, which is assumed to contain 
a mixture of the two types of parenchymal cells. However, recent evidence for the 
proposed zonation of liver metabolism (Chen and Katz, 1988; Guzman and Castro,
1989) raises many intriguing questions, not least of which is what relative impact 
lactation has upon the different cell types and their possible differential metabolic 
regulation.
This study has established that there are differences in the mechanisms o f the 
regulation of lactation between rodents and ruminants, with regard to the extent o f the 
hepatic adrenergic control which exists. Such a finding is consistent with the 
observed differences in the importance of various other endocrine hormones in the 
maintenance of lactation in these two species (Vernon and Flint, 1983; Forsyth, 1986; 
Vernon, 1989), and further supports the likelihood that lactation is governed by a 
number o f contrasting hormones in the rodent and ruminant.
APPENDIX 1
SOURCES OF CHEMICALS, ENZYMES, DRUGS AND
HORMONES
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1 Chemicals
All chemicals were of the purest grade available from the following supliers:-
Aldrich Chemical Company Ltd., Gillingham, Dorset.
Ethylene Glycol Dimethylether (1,2-Dimethoxyethane)
1,1,2-Trichlorotrifluoroethane 
Tri-w-Octylamine
BDH Chemicals Ltd., Poole, Dorset.
Ascorbic Acid 
CaClz
EDTA (Ethylenediaminetetra-acetic Acid - disodium salt)
D-Glucose
KCl
KH2PO4
Magnesium Acetate (hydrated)
MgCl2
M g S 0 4
fi-Mercaptoethanol
NaHCOs
NaOH
Orthophosphoric acid
Sucrose
Toluene (AR)
Triton X-100 (Scintran)
Fisons Scientific Equipment, Loughborough, Leicestershire.
KF
NaF
NaH2?04
Fluka Biochemika Ltd., Glossop, Derbyshire.
Bisbenzimide
EGTA (Ethylene G lyco l-0 ,0 ’-bis (2-aminoethyl)-N,N,N,N’-tetracetic acid)
FSA Lab. Supplies, Loughborough, Leicestershire.
Packard LKB Opti-Fluor O Liquid Scintillation Cocktail 
Pharmacia LKB OptiPhase HiSafe Liquid Scintillation Cocktail.
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K och-Lîght L td ., H averhill, Suffolk.
Unisolve E Liquid Scintillator 
M ay and  B aker L td ., Dagenham.
NaCl
Sigma Chemical Com pany L td ., Poole, Dorset.
Activated Charcoal (untreated powder)
5 ’ AMP (sodium salt, type II from yeast)
ATP (disodium salt)
Benzamidine-Hydrochloride
Bovine Serum Albumin (BSA-Praction V)
Caffeine
3 ’,5 ’-cAMP dependent Protein Kinase 
cAMP Free Acid 
DNA (salmon)
Dithiothreitol (DTT or Cleland’s Reagent)
Folin Ciocalteau Colour Reagent
of-D-Glucose 1-Phosphate (dipotassium salt, grade 1)
B-Glycerophosphate (disodium salt)
Glycogen (Type 2, Oyster)
Glycyl Glycine (Free Base)
Heparin (sodium salt, grade II)
Hepes (N-2-Hydroxyethylpiperazine N ’-2-ethanesulphonic acid)
3-Isobutyl-1 -Methylxanthine (IBMX)
Kemptide Synthetic Peptide
Mes (2-[N-Morpholino] ethanesulphonic acid)
Mops Free Acid (3-[N-Morpholino] propanesulfonic acid) 
Phenylmethylsulfonylfluoride (PMSF)
Sodium Pentobarbital
Soyabean Trypsin Inhibitor (Type II-S)
Theophylline 
Trizma Base
Trypan Blue Stain (0.4% solution)
Walsh Inhibitor (Protein Kinase Inhibitor [Rabbit; Synthetic])
2 Radiolabelled Chemicals
Amersham International pic, Amersham, Bucks.
[8-^H]Adenosine 3’,5’-cyclic monophosphate (ammonium salt) (20-30 Ci/mmol) 
[gamma-^^P]ATP (30Ci/mmol)
of-D-[U- '^*C] Glucose 1-Phosphate (potassium salt) (335 mCi/mmol)
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Standardized pH]Hexadecane 
[furanyl-5-^H]Prazosin (22-25 Ci/mmol) 
pH]RX781094 (40-43 Ci/mmol)
NEN Research Products, Stevenage, Herts.
(-)-[^^I]Iodopindolol (2200 Ci/mmol)
3. Enzymes
Sigma Chemical Company Ltd., Poole, Dorset.
Collagenase type VIII (Lot 19F 6817)
4 Drugs and Hormones
Ciba-Geigy Pharmaceuticals, Horsham, West Sussex,
Phentolamine Mesylate (gift)
Hannah Research Institute, Ayr, Scotland.
ICI 118551 (gift)
Pfizer Ltd., Sandwich, Kent.
Prazosin-Hydrochloride (gift)
Sigma Chemical Company Ltd., Poole, Dorset.
(-)-Adrenaline Free Base 
Atenolol
Glucagon (porcine)
(-)-Isoprenaline (+ )  Bitartrate 
(-)-Noradrenaline Free Base 
Phenylephrine-Hydrochloride 
Yohimbine-Hydrochloride
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